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Frank-Starling law of the heart describes a proportional relationship between the 
end-diastolic ventricular volume and the systolic output in the heart on a beat-to-beat 
basis. It is largely due to a phenomenon called length dependent activation (LDA) on 
the level of cardiomyocytes. With the increasing SL, there are two outcomes of LDA: 
the increasing maximum force production, and the increasing Ca2+ sensitivity. 
 Ca2+ binding to cardiac troponin C (cTnC) triggers a series of changes in thin 
filament structure that enable heart muscle cells to contract. A polarized fluorescence 
technique, FISS, was used to investigate the role of cTnC in the LDA. Using a 
purposely-built experimental set-up, force development and cTnC structural change 
were measured simultaneously as functions of [Ca2+] at SLs 1.9 and 2.3 μm. With the 
increasing SL, the Ca2+ sensitivity for force and cTnC structural change increased in a 
similar fashion, whereas the increase in maximum force production was not 
accompanied by an increase in the amplitude of cTnC structural change.  
    Although the inhibition of active force by 25 μM blebbistatin reduced the 
amplitude of cTnC structural change upon Ca2+ activation, the SL-dependent increase 
in the Ca2+ sensitivity was still presented. These results suggested that the 
force-generating cross-bridges were not essential for the SL-dependent changes of 
Ca2+ sensitivity in LDA. Taken together, our results suggested that the LDA was likely 
controlled via two signalling pathways. The SL-dependent Ca2+ sensitivity was mainly 
regulated by the thin filament, while the SL-dependent maximum force generation 
was controlled by the thick filament. 
    In addition, mimicking the SL stretching-induced reduction in interfilament 
spacing with 1% dextran did not reproduce the SL-dependent increase in the Ca2+ 
sensitivity, whereas further compression with 4% dextran significantly increased the 
Ca2+ sensitivity. This suggested that there might be another mechanism in the 
regulation of Ca2+ sensitivity by osmotic compression, which depends on the degree 
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1.1 General Introduction – from Heart to Cardiac Muscle 
 
The heart is a hollow, muscular organ found in all organisms with circulatory systems. 
It works as a pump that drives blood throughout the pulmonary and systemic blood 
vessels of the entire body by repeated contracting (beating). The pulmonary 
circulation exchanges the deoxygenized blood and carbon dioxide with freshly 
oxygenized blood from the lungs, which enters into the systemic circulation to 
transport oxygen to the body. The blood-flow continuously provides the body tissues 
with oxygen and nutrition, and removes the waste products to maintain homeostasis.  
The heart beats nonstop about 3 million times throughout an average human life 
span. These repeated, rhythmic contractions are triggered by a series of electrical 
impulses (action potentials, AP), that originated from the sinoatrial node (SA node, 
often known as the cardiac pacemaker) and propagated through the elaborate 
electrical conduction system of the heart to stimulate the rest of the cardiac muscle. It 
is the ordered stimulation of the myocardium that allows efficient contraction of the 
entire heart, thereby allowing blood to be pumped throughout the body. 
The vertebrate heart is principally made of connective tissue and cardiac muscle 
cells (cardiomyocytes). Cardiac muscle is an involuntary striated muscle that is found 
exclusively in the walls of the heart, especially in the myocardium which is the thick 
middle layer of the heart’s wall (Figure 1.1.1 A). It accounts for about 0.5% of the lean 
body mass in human.  
Like skeletal muscle, cardiac muscle is composed of individual cells that 
separated from each other by enclosing in endomysium. Generally, cardiac muscle 
cells are about 100 μm long and 20 μm wide, which are shorter and wider than 
skeletal muscle cells. They are predominantly mononucleated and typically branched 
instead of linear as the skeletal muscle cells. Cardiomyocytes contain a further 
thread-like collection of elongated structures — myofibrils, which can be of variable 
length and are composed by chains of the repeating subunits — the sarcomeres 





Figure 1.1.1: Cartoon representation of (A): the composition of the heart wall, the middle 
layer myocardium contains the biggest part of the cardiomyocytes (Blausen.com staff. 
"Blausen gallery 2014". Wikiversity Journal of Medicine. DOI:10.15347/wjm/2014.010. 























    
Figure 1.1.2: Cardiomyocyte geometry. (A): Confocal image of an adult rat cardiomyocyte 
stained sarcomeric actin (Green) and α-actinin (Z-lines, red), nucleus not shown. Image 
taken from http://diseasebiophysics.seas.harvard.edu/research/mechanotransduction/ (B): 
Electron microscopy image of the longitudinally sectioned rat’s cardiomyocytes which 
contains sarcomere units that repeat along the length of it. (a): Red blood cells (e), 
mitochondria (m), myofibrils (M) and a cellular nucleus (N) are visible. Chains of 
sarcomeres (S) show the presence of striated pattern. Scale bar is 2 μm; (b): Highly 
ordered sarcomere unit clearly shows the A-bands (A) and I-bands (I). The Z-disks (Z) 
define the length of one sarcomere unit. M-line in the centre of the sarcomere is also 
visible (detailed description in Section 1.2.1). Scale bar is 500 nm. Micrographs were from 
http://www.trincoll.edu/~alehman/PhotoBIOL152.htm. 
 
1.2 Ultrastructure of Cardiac Muscle 
 
1.2.1 The Sarcomere 
 












primarily responsible for the striated appearance and the basic machinery for muscle 
contraction. The repeating cross-banding pattern in myofibrils are characterised by 
the relatively high- and low-density regions in sarcomere units under electron 
microscopy (Figure 1.1.2). The striation pattern in cardiomyocyte results from the 
various optical properties of the proteins that make up the sarcomere. The 
establishment of myosin and actin as the major sarcomeric proteins causing the 
striation pattern within the sarcomere was through the work of Hanson and Huxley 
(1953) using electron microscopy and X-ray diffraction. They discovered that myosin 
and actin are localised differently on the filaments of the myofibrils (the myofilaments). 
The myofilaments are further divided into two types according to the diameter and 
protein constitution: the myosin-containing thick filament and the actin-containing thin 
filament.  
Each sarcomere is defined by two highly dense bands called the Z-disks or 
Z-lines. The length of the sarcomere — the distance between two adjacent Z-lines, 
typically ranges from 1.7 μm to 2.3 μm in human cardiomyocytes under physiological 
condition. Within each sarcomere, surrounding the Z-lines are the lighter, less dense 
I-bands which are composed of actin filaments without being superimposed by 
myosin filaments. The thin filaments extend to the Z-line on one side and run into the 
darker, denser A-band on the other. The A-band contains the entire length of a single 
thick filament, yet it has both the myosin and actin filaments as the components. In the 
central of the A-band there is a paler actin filament-free region called the H-zone 
where there is no myofilaments overlap. In the middle of the H-zone lies a thin darker 
M-line formed of cross-connection elements of the cytoskeleton. Electron microscopy 
images showing the main features of the striation pattern in sarcomeres are in Figure 
1.1.2, and the schematic drawing is shown in Figure 1.2.1. In the sarcomere, the 
overlapping myofilaments are organised in a hexagonal arrangement, in which each 
thick filament is surrounded by six thin filaments while each thin filament is 




Figure 1.2.1: Cartoon representation of the striation pattern in the sarcomere. (A) and (B): 
The two- and three-dimensional organisation of a sarcomere. The thick filaments are 
shown in blue and the thin filaments in red; (C): The cross-sectional patterns generated by 
the myofilaments are shown below their respective zones. Figure taken from 
http://faculty.pasadena.edu/dkwon/chapt_11/textmostly/slide30.html. 
 
Striated muscle contraction is achieved by the interactions between actin and 
myosin filaments (the actomyosin interaction) in the A-band of the sarcomere. In 
cardiac muscle, sarcomeric function plays a central role in the performance of the 
myocardium contraction, thus of the cardiac pump function. It is determined by the 
properties of the multiple protein constitutions in the sarcomere. Alterations in 
sarcomeric protein composition under pathological conditions will influence the 
contractile performance of the heart (Hamdani et al., 2008). The major proteins 
contained in the sarcomere are illustrated in Figure 1.2.2, including actin, tropomyosin 
(Tm), troponin (Tn) in the thin filament; myosin molecules and myosin binding protein 
C (MyBP-C) in the thick filament; the giant protein titin extends from the Z-line to the 






etc. The sarcomere is a complex system where every protein is essential to assure 
the structural and functional integrity of it. The unltrastructure of the major proteins 
involved in muscle contraction is discussed below. 
 
 
Figure 1.2.2: Major protein components in the sarcomere. Detailed description is in the 
text. cActin denotes α-actin, the actin isoform presents in cardiac muscle sarcomere. 
Figure taken from Frey et al. (2012).  
 
1.2.2 The Thin Filament 
 
1.2.2.1 Actin 
The multi-protein complex of the thin filament is essentially comprised of three major 




   Copyright © 2007 Pearson Education, Inc., publishing as Benjamin Cummings 
Figure 1.2.3: Schematic representation of the thin filament organisation, containing the 
double-stranded actin helix as the core of the filament, another double helical polymer 
tropomyosin and the ternary troponin complex. Each Tm spans seven actin monomers 
per strand in each 38 nm axial repeat, connects with adjacent molecules in a head-to-tail 
fashion. Picture illustrated by Benjamin Cummings. 
 
Actin monomer is a globular multi-functional protein with a molecular mass of 
~42kDa (G-actin). It is structurally divided into four sub-domains (I-IV) (Kabsch et al., 
1990) with an ATP and Ca2+ binding site in the cleft at the centre of the molecule 
(Figure 1.2.4 A). Due to the smaller mass of the sub-domain II, G-actin monomers are 
polarized — the exposed areas of sub-domains I and III are referred to as the “barbed” 
ends, whilst the exposed areas of domains II and IV are termed the “pointed" ends.  
G-actin monomers polymerize into filamentous actin (F-actin) in a 
double-stranded helical conformation which forms the core of the thin filament. An 
atomic structure of F-actin has been determined by a combination of X-ray 
crystallography and X-ray diffraction, as illustrated in Figure 1.2.4 B (Fujii et al., 2010; 
Holmes et al., 1990). The double-stranded filament has seven actin monomers per 
strand in each ca.38nm axial repeat. The assembly of one Tm and one Tn molecule 
binding with these seven actins in a ratio of 1:1:7 is often referred to as a regulatory 
unit (Ebashi et al., 1969). Under physiological conditions, actin polymerisation occurs 
preferentially at the barbed (+) end of the G-actin monomers powered by ATP 
27 
  
hydrolysis, whereas depolymerisation takes place at the pointed (-) end (Figure 1.2.4 
C). Within the sarcomere, actin is orientated with the (+) end in the Z-line and the (-) 
end pointing towards the M-line, preventing it from spontaneous depolymerisation by 









Figure 1.2.4: (A): Atomic structure of G-actin (PDB 1ATN) (Kabsch et al., 1990). G-actin 
consists of four sub-domains: I~IV. The central cleft with Ca
2+
 is shown in grey and the 
bound nucleotide is ATP ; (B): Atomic structure of F-actin based on the actin filament 
model of Holmes et al. (1990). The barbed- and pointed-end of the polarised filament are 
represented by (+) and (-), respectively. (Figure taken from 
http://en.wikipedia.org/wiki/Actin#mediaviewer/File:Actin_filament_atomic_model.png.); 
(C): The polymerization process occurs at the barbed (+) end of the filament and is 




Tropomyosin is also a double-stranded α-helical coiled-coil protein that resides in the 
thin filament. The two polypeptide chains of Tm bind symmetrically alongside each of 
the helical strands of filamentous actin (Brown et al., 2005) (Figure 1.2.3). Each of this 
400 Å long and 20 Å wide molecule spans seven actin monomers on each strand of 
F-actin over the 385 Å length of the thin filament. Neighbouring Tm molecules are 
linked up in a head-to-tail fashion, forming a continuous, flexible structure with high 














Tm is involved in regulating the interactions between actin and myosin by 
guarding the myosin heads binding sites on actin filament, thus plays a pivotal role in 
regulating muscle contraction.  
 
1.2.2.3 Troponin 
The troponin complex (Tn, relatively molecular mass ~80 kDa) was first identified as 
the regulatory unit of the thin filament by Ebashi et al. (1967). One Tn is associated 
with one Tm which binds to seven actin monomers at an interval of 38 nm along each 
strand of F-actin. This ternary complex consists of three subunits: troponin C (TnC, 
~18 kDa), the Ca2+ binding subunit; troponin I (TnI, ~24 kDa), the inhibitory subunit; 
and troponin T (TnT, ~35 kDa), the Tm binding subunit (Figure 1.2.5). 
The Ca2+ binding induced structural rearrangement in Tn is known to be the first 
step that initiates muscle contraction. Studies using electron microscopy and 
low-resolution X-ray crystallography divided Tn into two domains: the TnT1 extension 
domain, and the rest of Tn — the core domain, which contains most of the regulatory 
function of Tn complex (Flicker et al., 1982; Ohtsuki, 1979; Ohtsuki et al., 1988; 
Takeda et al., 1997; White et al., 1987). The crystal structure of the core domain of 
human cardiac troponin (cTn) in the Ca2+-saturated form was published by Takeda et 
al. (2003). The core domain of cTn is dominated by α-helices and is further organised 
into two structurally distinct sub-domains: the regulatory head and the IT arm (Figure 
1.2.5). The regulatory head contains the N-terminal lobe of cTnC (cNTnC) which 
provides the Ca2+ binding site, and binds with the switch peptide of cTnI upon Ca2+ 
binding. The IT arm is a rigid and asymmetrical structure (~80 Å long) which has an 
arrowhead shape containing a long α-helical coiled-coil formed between cTnT and 
cTnI, with the C-terminal lobe of cTnC (cCTnC) sandwiched between them. The two 
sub-domains are connected via flexible linkers, characterising the highly flexible 







Figure 1.2.5: X-ray crystal structure of the Ca
2+
-bound troponin core domain containing 
cTnC (red), cTnI (blue) and cTnT (gold) (PDB 1J1E, modified from Takeda et al. (2003)). 
The core domain can be divided into two sub-domains: the regulatory head and the IT arm. 
The two globular lobes in cTnC, i.e. the N-lobe and C-lobe are presented as cNTnC and 
cCTnC, respectively. The three Ca
2+
 ions bound to the Ca
2+
 binding sites II-IV are 
represented by black spheres (vision of the two high-affinity sites III and IV in cCTnC are 
obscured by the α-helices of the C-lobe). The inhibitory region of cTnI was not seen in the 
crystal structure and is represented as dashed line. Each helix within cTnI and cTnT is 
indicated by helix number, whereas those in cTnC are denoted by capital letter (A-H and 
N). 
 
cTnC has a dumbbell-shaped structure which consists of two globular lobes — 
the regulatory N-lobe and the structural C-lobe, connected by a flexible linker formed 
by helices D and E (the D/E-linker, Figure 1.2.5) (Herzberg and James, 1985). cTnC is 
the Ca2+ binding protein. It contains two high affinity divalent cation binding sites 
(Ca2+/Mg2+ sites, III and IV) in the C-lobe, and only one low-affinity Ca2+ binding site (II) 
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TnC. Due to amino acid substitutions at three coordinating positions in the loop, the 
functional site I is inactive in cTnC (Sia et al., 1997; van Eerd and Takahshi, 1976). 
Under physiological conditions, the high-affinity sites in the C-lobe are mostly always 
occupied with divalent metal ions. The open conformation of the C-lobe exposes a 
hydrophobic patch which binds the first N-terminal amphiphilic α-helix of cTnI (the 
cTnI-H1 helix in Figure 1.2.5), thus plays a structural role in anchoring cTnC in the 
cTn complex (Gasmi-Seabrook et al., 1999). The low-affinity binding site in the N-lobe 
of cTnC, on the other hand, is bound with Ca2+ ions upon an increase in the 
intracellular [Ca2+]. As the regulatory Ca2+-sensor, the N-lobe opens up a hydrophobic 
patch upon Ca2+ binding which interacts with the second amphiphilic α-helix of cTnI 
(the H3 helix, residues 147-163, known as the “switch peptide”). The binding of 
cTnI147-163 only occurs in the Ca
2+-saturated state of the N-lobe to form a 1:1 
cTnI/cTnC complex. This interaction between cNTnC and cTnI147-163 triggers the 
relocation of Tm along the actin filament which represents an essential step in the 
signally pathway of muscle contraction (further discussed later).  
Structure of the regulatory domain cNTnC in apo (Ca2+-free), Ca2+-saturated, and 
cNTnC ·Ca2+· cTnI147-163 states was confirmed by NMR studies (Li et al., 1999; Sia et 
al., 1997; Spyracopoulos et al., 1997). As illustrated in Figure 1.2.6, the conformation 
transition in cNTnC upon Ca2+ binding does not involve an opening of the N-lobe and 
the exposure of a substantial hydrophobic area, rather, it presents a similarly closed 
conformation as the apo state, in contrast with the skeletal TnC. Yet subsequent 
binding of the switch peptide of cTnI147-163 to the small hydrophobic surface of cNTnC 
largely open the regulatory domain by moving helices B and C away from N, A and D. 
The interaction between cTnI and cTnC stabilizes the open conformation of cNTnC 
via interfering with the AB helical interface. It leads to a series of conformation steps in 




Figure 1.2.6: Closed to open transition in the conformation of cNTnC (NMR structures as 
indicated). Left to right — cNTnC apo (Ca2+ free), cNTnC·Ca2+, cNTnC·Ca2+·cTnI147-163 
and cNTnC·Ca
2+
·cTnI147-168. Binding of Ca
2+
 alone only induces minor changes in the 
conformation. The subsequent binding of the switch peptide fully opens the N-lobe and 
stabilizes the open conformation. See text for detailed description. 
 
As the inhibitory subunit of cTn, cTnI inhibits the interactions between actin and 
myosin heads via the inhibitory binding to the actin filament at low [Ca2+] (Farah et al., 
1994; Syska et al., 1976; Talbot and Hodges, 1981). There are two regions in cTnI 
which are essentially responsible for the inhibitory binding of cTnI to actin in the 
absence of Ca2+ — the inhibitory region (residues 137-148) and the C-terminus of 
cTnI (cCTnI, residues 169-210). In the sequence between these two regions lies the 
switch peptide of cTnI (residues 147-163), which specifically binds with the 
hydrophobic cleft of cNTnC in the presence of Ca2+ (Figure 1.2.6). Thus, the 
interactions between cNTnC and the switch peptide of cTnI must remove both the 
inhibitory region and the C-terminal portion of cTnI from actin, resulting in the release 
of inhibition and the subsequent shifting of the equilibrium position for Tm (Campbell 
and Sykes, 1991; Kobayashi et al., 1999). As the link that connects helices H2 and H3 
of cTnI, the inhibitory region is not well defined due to the flexible feature.  
cTnT is the largest subunit in the cTn complex, which has an essential role in 
anchoring the cTn complex on the thin filament via interacting with Tm. There are two 
distinct Tm binding portions in cTnT: the N-terminus of cTnT (also known as the 
cTnT1 extension region) and the C-terminus of cTnT (denoted as cCTnT) (Ohtsuki, 




elucidated by Takeda et al. (2003), thus not presented in Figure 1.2.5. Even though 
cTnT1 is not part of the Tn core complex, it exclusively interacts with Tm to anchor the 
Tn complex independent of the intracellular [Ca2+] level, whereas cCTnT binds Tm in 
a more Ca2+ sensitive manner, i.e. stronger interaction occurs at low [Ca2+] 
(Pearlstone and Smillie, 1983). As shown in Figure 1.2.5, the H2 helix of cTnT forms a 
parallel α-helical coiled-coil with the H2 helix of cTnI. Together with the upstream 
α-helical H1 helix of cTnT and the H1 helix of cTnI, these long helices are integrated in 
a rigid and asymmetrical domain — the IT arm. The amino acid residues in the rigid 
domain are well conserved between species, suggesting the important physiological 
roles it must hold in characterising the function of cTn. The IT arm does not have 
direct interaction either with Tm or with actin. 
 
1.2.2.4 Structural Role of Troponin on Thin Filament 
The conformational rearrangements of the cTn complex upon Ca2+ binding are the 
first steps in the elusive signalling pathway of cardiac muscle contraction.  
Under physiological conditions, the interactions between cTnI and actin, cTnT 
and Tm stabilize the cTn complex onto the thin filament. All these interactions are 
Ca2+ sensitive except for the binding of the N-terminus of cTnT (cTnT1) to Tm. cTnT1 
remains binding to Tm regardless of the relaxation or activation of the muscle. At low 
[Ca2+], Tm is trapped in a position which covers the myosin heads binding sites on the 
actin filament by cTnT1, together with the two regions of cTnI which perform the 
inhibitory binding on actin in the absence of Ca2+ — the inhibitory region and the 
C-terminus of cTnI (cCTnI). The regulatory domain of cTn — the N lobe of cTnC 
(cNTnC), which is connected with the rest of cTn complex via the D/E-linker, rotates 
around its central D-helix searching for binding the switch peptide of cTnI (Sevrieva et 
al., 2014). As mentioned before (Figure 1.2.6), with an increasing [Ca2+] over the 
physiological range, cNTnC undergoes a transition from an apo Ca2+ free state to a 
slightly opened Ca2+-saturated state, and ends up in a substantially opening state with 
the subsequent binding of cTnI switch peptide, which in turn stabilizes cNTnC in the 
open conformation. As a consequence, the interaction between cTnI and cNTnC 
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triggers the release of the two adjacent regions of cTnI switch peptide — the inhibitory 
region and the cCTnI from their actin binding inhibitory sites, which enables the 
movement of Tm from its kept position along the actin filament and facilitates the 
actomyosin interactions to generate force. Thus, the conformational dynamics of the 
cNTnC upon Ca2+-activation surely play an important role in the regulation of cardiac 
muscle contraction. The IT arm of the cTn complex, on the other hand, does not move 
during activation, suggesting the C-lobe of cTnC (cCTnC), together with the 
coiled-coil helices of cTnT and cTnI, acts as a scaffold holding cNTnC and the actin 
binding regions of cTnI (Sevrieva et al., 2014). A cartoon representation of the 
interactions between components of cardiac thin filament upon Ca2+-activation is in 
Figure 1.2.7.  
 
Figure 1.2.7: Schematic representation of the Ca
2+
-dependent interactions between 
components of cardiac thin filament (figure adapted from Takeda et al. (2003)). The three 
subunits of cTn complex — cTnC is in green with three Ca2+ binding sites (site II on NTnC, 
site III and IV on CTnC, Ca
2+
 ions are denoted by red dots), cTnI is in blue (IR denotes the 
inhibitory region) and cTnT in yellow. Actin and Tm strands are in pink and cyan, 
respectively. See text for details of the Ca
2+




1.2.3 The Thick Filament 
 
The thick filament is mainly composed of myosin molecules and associated proteins, 
such as titin and myosin binding protein C (cMyBP-C) (Figure 1.2.2). Myosin is the 
most abundant component which forms the core of the thick filament. Titin is a giant 
elastic protein which spans 1 μm across half of the sarcomere with its N-terminus 
anchoring the Z-disk and C-terminus embedding in the M-line (Fukuda et al., 2009; 
Labeit and Kolmerer, 1995). It has an important role in generating passive force when 
the sarcomere is stretched beyond its slack length in the physiological SL range 
(Granzier and Irving, 1995; Linke et al., 1996).Titin interacts with both the thin and 
thick filament in the sarcomere. cMyBP-C is a myosin-associated protein which 
locates in the C-zone of the thick filament (C-zone — two 350nm long regions that 
flank the cross-bridge bare zone) (Previs et al., 2013). It was thought to bind to both 
myofilaments (Craig et al., 2014; Luther et al., 2011).  
Myosin is a highly asymmetric, hexameric molecule which contains six separate 
protein chains: two myosin heavy chains (MHC), two regulatory light chains (RLC) 
and two essential light chains (ELC) (Figure 1.2.8 A). The two heavy chains wrap 
together as a parallel coiled-coil at the C-terminus of myosin, extend over most of the 
length of the molecule to form the myosin rod/tail portion, and end in two globular 
domains (known as the myosin heads) at the N-terminus. Proteolytic digestion of 
myosin with trypsin divided the molecule into two fragments: a light meromyosin (LMM) 
and a heavy meromyosin (HMM) (Szent-Gyorgyi, 1953). Further proteolysis of the 
latter fragment HMM with trypsin yields two subfragments: the globular S1 and the 
coiled-coil S2 (Mueller and Perry, 1962). As shown in Figure 1.2.8 A, subfragment S2 
and LMM form the rod portion/tail of the myosin molecule. Subfragment S1, on the 
other hand, is the myosin head which forms the force-generating cross-bridge via 
interacting with actin. Structurally, S1 is divided into a motor domain which contains 
the ATP and actin binding sites, and a light chain domain (LCD, also known as the 
lever-arm) contains the regulatory and essential light chain. Figure 1.2.8 B is the X-ray 




         
Figure 1.2.8: Myosin organisation. (A): Schematic representation of the hexameric 
molecule consisting two heavy chains, two RLCs and two ELCs. The myosin molecule 
can be divided into two major fragments, LMM is an extended coiled-coil, whereas HMM 
contains two subfragments — the globular S1 (myosin heads) and S2. S2 and LMM form 
the backbone of the thick filament. Figure taken from 
https://www.uic.edu/classes/phyb/phyb516/BaranyUpdate4/Myosin/Myosin.html; (B): 
X-ray crystallographic structure of chicken skeletal myosin subfragment S1. S1 can be 
divided into the globular motor domain which has the actin- and nucleotide-binding site, 
and the extended light chain domain which contains the essential and regulatory light 
chains. The green, red/grey, and blue segments represent the 25 kDa, 50 kDa, and 20 
kDa segments of the heavy chain. The yellow and magenta parts correspond to the ELC 
and RLC respectively. (PDB 2MYS (Rayment et al., 1993b), figure modified from (Ruegg 

















1.2.3.1 The Cross-Bridge Cycle 
In striated muscle contraction, the subfragment S1 of the myosin molecule, also 
known as the myosin head region, is the molecular motor which interacts with the 
actin filament in a cyclic manner to form cross-bridges and generate force (Cooke, 
1997). The cyclic formation of cross-bridges is fuelled by ATP hydrolysis. In each 
cross-bridges cycle, the ATP-driven myosin motor undergoes a series of 
conformational changes in order to connect with actin and generate force (power 
stroke).  
Current investigations agree with a “swinging lever-arm” model, in which the S1 
myosin heads do not tilt as a whole, rather, the major conformational change 
determining the power stroke is confined to the LCD of the myosin molecule 
(Rayment et al., 1993a; Uyeda et al., 1996; Uyeda and Spudich, 1993). This model 
proposed that during the power stroke, the motor domain of myosin is relatively 
immobile, whereas the LCD acts as a rigid lever-arm which amplifies small 
conformational changes in the motor domain to produce an axial movement at the 
head-rod junction (Figure 1.2.9 A), producing pulling force at the cross-bridges which 
slides the actin filament towards the centre of the sarcomere (see Section 1.3.1 for the 
“sliding filament” theory). The “swinging lever-arm” model has received ample 
experimental supports by in vitro motility measurements with engineered lever-arms 
and in situ fluorescence polarization measurements in muscle fibres (Anson et al., 
1996; Irving et al., 1995).  
In an entire ATP-driven cross-bridge cycle, starting from the pre-power stroke 
state (from ④-① in Figure 1.2.9 B) for clear description, one molecule of ATP is 
hydrolyzed by myosin into ADP and Pi, swinging the lever-arm up and switching the 
myosin heads into high-energy configuration in preparation for the power stroke. At 
this state, myosin heads are attaching to actin forming weak binding cross-bridges 
with the lever-arm up. With the products of ATP hydrolysis dissociate from myosin 
heads, the conformational changes in the motor domain are amplified by the 
converter domain, which swings the LCD (the lever-arm) by ~70°, allowing switching 
to strong binding cross-bridges to generate force and slide actin filaments in the 
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power stroke (working stroke) state (Geeves and Holmes, 1999; Llinas et al., 2012). 
When a new ATP is attached, the interaction between actin and myosin heads ends 
with the cross-bridge detached and lever swinging down. Hydrolysis of the new ATP 
molecule induces the entering of the pre-power stroke state where the cocking of the 
myosin heads by upward swinging lever-arm occurs, ready to undergo another cycle.  
 
 
      
Copyright © 2006 Pearson Education, Inc., publishing as Benjamin Cummings 
Figure 1.2.9: (A): Cartoon representation of the power stoke of the “swinging lever-arm” 
model. The conformation change of a cross-bridge from pre-power stroke state (left) to 
post-power stroke state (right) is determined by the tilting of the light chain domain (LCD) 
Figure modified from Spudich (2001); (B): A typical cross-bridge cycle powered by ATP 
hydrolysis based on the “swinging lever-arm” model (see text for description). Figure 
illustrated by Benjamin Cummings. 
LCD 





1.3 Regulation of Cardiac Muscle Contraction 
 
1.3.1 The Sliding Filament Theory 
 
In the heart, the contraction-induced shortening of the cardiomyocytes, as a result of 
the shortening of the aligned sarcomere units on the molecular level, reduces the size 
of the ventricular chambers, thus ejects blood into two circulation systems. The 
molecular mechanism underlying the sarcomere shortening during muscle contraction 
was described as the sliding of the thin filaments with respect to the thick filaments — 
the “sliding filament” theory (Huxley and Niedergerke, 1954; Huxley and Hanson, 
1954). Using high resolution microscopy, researchers observed that during 
contraction, the A-bands of the sarcomere remained relatively central and constant in 
length, whereas the I-bands and H-zones shortened along with the sarcomere, 
indicating the sliding of the thin filaments towards the centre of the sarcomere is the 
cause of the sarcomere and muscle shortening. Neither of the two myofilament 
systems changes length when sliding occurs. The formation of cross-bridges by 
actomyosin interactions was first discovered and characterized as the motor that 
causes the sliding between myofilaments by Huxley (1957) using electron microscopy 
studies of rabbit psoas and frog sartorius muscle. When strongly bound, these cyclic 
interactions generate a pulling force on the actin filament, propelling them towards the 
centre of the sarcomere. The pulling force transmits from the actin filaments towards 
the ends of each sarcomere — the Z-disks, where through the mechanical coupling 
with the extracellular collagen network, ultimately reaches the heart’s cavity to cause 
myocardium shortening and produce ventricular pressure. The trigger for initiating all 
these events in muscle contraction was identified as the binding of Ca2+ to the thin 
filament protein-cTnC. The significance of Ca2+ in the regulation of muscle contraction 




1.3.2 The Ca2+ Regulation of Muscle Contraction 
 
Contraction of striated muscle is triggered by Ca2+ binding to the regulatory protein Tn 
in the actin-containing thin filaments, leading to an azimuthal movement of the Tm 
around the filament that reveals the myosin heads binding sites, allowing cyclic 
actomyosin interactions and force generation (Ebashi et al., 1969; Gordon et al., 2000; 
Greaser and Gergely, 1971). In cardiac muscle cell, the rapid rising of intracellular 
[Ca2+] ([Ca2+]i) from resting (~160 nM) to active (~2.7 μM) occurs with the arrival of 
action potentials (AP) from the pacemaker cells in the heart (Kirschenlohr et al., 2000). 
AP stimulation depolarises the cell membrane, leading to a small influx of Ca2+ 
entering the cell via the voltage-gated calcium channels in the membrane. However, 
the Ca2+ entry at this point is insufficient to induce a normal contraction. It binds to the 
ryanodine receptors (RyRs) on the sarcoplasmic reticulum (SR) and triggers the 
release of more Ca2+ from these intracellular Ca2+ stores — the Ca2+-induced Ca2+ 
release. The combination of Ca2+ entry and SR Ca2+ release transiently increases the 
[Ca2+]i, which binds to the regulatory N-lobe of cTnC and initiates the contraction at 
the sarcomere level by the sliding of actin over myosin filaments. At the end of the AP, 
voltage-dependent Ca2+ channels in the membrane become inactive, most of the Ca2+ 
is recaptured by the SR and extruded by the Na/Ca exchanger. Relaxation occurs 
when [Ca2+]i falls towards the resting level and Ca
2+ dissociate from cTnC. The events 
in the sarcomere regulated by Ca2+ binding or dissociation during activation and 
relaxation are described next.  
 
1.3.2.1 The steric blocking model 
The molecular basis for the Ca2+-regulated activation was first established after the 
identification of Tn and Tm as the principal proteins of Ca2+ regulation (Ebashi et al., 
1967; Ebashi and Endo, 1968). In these investigations, researchers characterised that 
Tn is the actual Ca2+ binding constituent of thin filaments. The position of Tm on the 
thin filament is key to myosin binding, depending on the presence or absence of Ca2+ 
on Tn. A steric blocking model describing the Ca2+-regulated thin filament activation 
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was proposed based on the X-ray diffraction experiments (Haselgrove and Huxley, 
1973; Parry and Squire, 1973). This model postulated a Ca2+-free (OFF) state when 
Tm sterically blocks the myosin heads binding sites on actin, along with a Ca2+-bound 
(ON) state when Tm moves azimuthally away from the binding sites upon Ca2+ 
binding to Tn, allowing actomyosin interactions. This simple two-state model was 
supported by electron microscopy and image reconstitution results which indicated 
Tm shifts along the actin filament from a periphery, closer to myosin binding sites 
position towards a closer to actin filament groove position upon Ca2+ activation 
(Lehman et al., 1994; Lehman et al., 1995; Milligan and Flicker, 1987; Spudich et al., 
1972; Vibert et al., 1997; Xu et al., 1999) (Figure 1.3.1 A).  
The two-state model was later updated to a three-state model where Tm was 
found to move further along the inner groove of the actin filament upon myosin heads 
binding (Figure 1.3.1 B), resulting in an equilibrium three states of Ca2+-dependent 
thin filament activation: blocked, closed, and open state (Lehrer, 1994; McKillop and 
Geeves, 1993). In association with the three thin filament states, there are two 
cross-bridge states: a weak binding cross-bridge (A-state) and a strong binding 
cross-bridge (R-state). In the absence of Ca2+, Tm occupies a position in which it 
imposes a steric hindrance to myosin binding, whereby no cross-bridges can be 
formed (blocked state). With the binding of Ca2+ to cTnC, conformational 
rearrangements in the Tn complex allow Tm to relocate towards the groove of the 
actin double helix, which partially exposes the myosin binding sites (closed state). At 
this state, myosin heads are able to interact weakly with actin to form weak binding 
cross-bridges with no force generation (A-state). The weak binding cross-bridges then 
undergoes an isomerisation to the strong binding, force-generating state (R-state) 
with high rates of ATP hydrolysis. Transition from weak to strong binding state is 
related with a further movement of Tm into the groove of the actin filament, shifting 
thin filament to a fully-activated open state. The further displacement of Tm fully 
exposes the myosin binding sites on actin filament at which more force-generating 














Figure 1.3.1: Movement of Tm over the surface of the actin filament. (A): Two-state model 
(Xu et al., 1999). From left to right: the Ca
2+
-free (OFF) state (Tm in red), the Ca
2+
-bound 
(ON) state (Tm in green) and a superposition of the two states. Actin filament is coloured 
in orange; (B): Three-state model (Gordon et al., 2001). (a): Major actin filament is shown 
in light grey, with weak and strong myosin binding sites in green and red, respectively; (b): 
In the absence of Ca
2+
, Tm (dark grey) blocks both types of myosin binding sites (blocked 
state); (c): Upon Ca
2+
 binding to cTnC, Tm moves into a closed conformation to uncover 
some of the myosin binding sites (mostly for weak binding) to form weak binding 
cross-bridges (closed state); (d): Transition from weak to strong binding cross-bridges (S1) 
further displaces Tm, fully expose the strong myosin binding sites for the formation of 
more strong binding cross-bridges (open state). 
















As recently proposed by Sun and Irving (2010), relaxation may not be a simple 
reverse of the process in activation, implying the possibility of an additional 
“pre-relaxing” state after Ca2+ dissociate from cTnC. At this state, Ca2+ dissociation 
occurs before the detachment of cross-bridges. Thus the strong binding cross-bridges 
may still be able to generate force and hold Tm in the clear position even when cTnC 
is free of Ca2+. 
 
1.3.2.2 Cooperativity 
Activation and relaxation of cardiac muscle is regulated by a narrow range of [Ca2+]i, 
i.e. the isometric steady-state force production is steeply dependent on [Ca2+]i. Small 
changes in [Ca2+]i can produce functionally significant changes in force production, 
thus in cardiac output. The steep force-[Ca2+] relationship facilitates rapid and 
synchronous activation, and minimises the metabolic cost of Ca2+ cycling. Although in 
cardiac muscle, each Tn complex provides only one regulatory Ca2+ binding site, the 
steepness of the force-[Ca2+] relationship (denoted by Hill coefficient nH, information 
regarding Hill equation is in 2.5.3) in skinned cardiac muscle (nH = 3~4) is much 
higher than would be expected for the single Ca2+ binding site (nH = 1), indicating 
highly cooperative Ca2+ regulation of muscle contraction. Over the years, the 
molecular basis underlying the cooperativity varies, including:  
1. Binding of myosin heads to actin switches on thin filament activation, 
generates a positive feedback to the activation by promoting further binding of Ca2+ in 
neighbouring Tn complex and further formation of strong binding cross-bridges 
(Hofmann and Fuchs, 1988; Kobayashi et al., 2008; Razumova et al., 2000; Regnier 
et al., 2004). 
2. Cooperativity is an intrinsic property of the thin filament. Initial Ca2+ binding 
enhances the Ca2+ binding affinity in adjacent regulatory units (RU, one Tn, one Tm 
and seven actin monomers), spread by the end-to-end coupling between adjacent Tm 
molecules (Sun and Irving, 2010; Sun et al., 2009). 
The widely accepted former possibility bases on a well-established biochemical 
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model in which myosin binding switches on the activation in rigor-like conditions (low 
[MgATP]) (Davis et al., 2007; Robinson et al., 2004; Rosenfeld and Taylor, 1985). 
However, trabecular studies in near-physiological conditions by inhibiting the 
formation of cross-bridges produced no significant change in the cooperativity, at 
variance with the first hypothesis (Sun et al., 2009). The downsides of the biochemical 
studies may be responsible for this discrepancy, such as the not well-reserved 
actomyosin interactions in the isolated proteins, and the lack of accurate force 
measurement in the biochemical studies. Sun and Irving (2010) concluded that 
although myosin heads binding switches on the thin filament activation in rigor 
conditions, it does not contribute significantly under physiological conditions, implying 
the effect of myosin binding in rigor is not a reliable model for its role in thin filament 
activation under physiological conditions. 
If strong binding cross-bridges do not account for the Ca2+ cooperativity, the 
second hypothesis regarding the cooperative regulation as an intrinsic property of the 
thin filament has been considered. The Ca2+ binding signal originating from the Tn 
complex in one RU spreads along the surface of the thin filament to the neighbouring 
RUs containing Ca2+-free (apo) troponins via the coupling between adjacent Tm 
molecules. Thus, the Ca2+ binding-induced impact on the conformation and/or position 
of the Tn and Tm molecules propagates along the thin filament to the adjacent RUs, 
exposing more myosin heads binding sites to form cross-bridges, thereby achieving a 
highly cooperative activation.       
 
1.4 The Frank-Starling Relationship 
 
The Frank-Starling relationship, also known as the Frank-Starling law of the heart, is a 
fundamental property of the myocardium, which describes a proportional relationship 
between the end-diastolic ventricular filling and the systolic output (stroke volume) in 
the heart on a beat-to-beat basis. First described by Otto Frank in Germany and 
Ernest Starling in England over a century ago, this relationship between ventricular 
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filling and stroke volume has long been appreciated for its critical function in the 
regulation of cardiac output. During the time course of one heartbeat, increasing the 
volume of blood filling (known as preload) stretches the ventricular wall, leads to a 
greater, more forcefully contraction in the heart. It allows greater ejection volume, thus 










Figure 1.4.1: Cartoon representation of the Frank-Starling law of the heart. Red and blue 
arrows respectively denote the direction of blood flow in the left and right ventricle. 
Increasing ventricular filling (preload) stretches the ventricular wall (left figure), leads to 
more forcefully myocardium contraction (afterload) in the next heartbeat, resulting in more 




As described by Moss and Fitzsimons (2002), Frank-Starling relationship has an 
essential role in the synchronization between cardiac output and venous return. An 
increase in the venous return leads to a corresponding increase in the end-diastolic 
ventricular filling, which in turn induces greater stroke volume for the next heartbeat, 
such that more blood is pumped into arteries to accommodate the increased venous 
return from last circulation, thus the blood amount in the vasculature throughout the 
entire body can be maintained at equilibrium state in the circulation. Moreover, 
Frank-Starling relationship is an intrinsic property of the heart to adjust the ejection 
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volume to meet the energy demands of the body tissues, completely separated from 
the central nervous system (Starling and Visscher, 1927). Studies have shown that in 
the patient with poor pump function or heart failure, the energy distribution by 
Frank-Starling relationship between supply and demand failed to function normally: 
increasing the ventricular volume resulted in a much smaller corresponding increase 
in the cardiac output. The output volume was inadequate to meet the demands of the 
body tissues, which would severely compromise organ system function and result in 
fluid build-up such as pulmonary oedema over time (Hanft et al., 2008). Therefore, 
despite the profound significance in the regulation of cardiac function, Frank-Starling 
relationship is also considered as a reference indicator of the physiological and 
pathophysiological features of the heart. 
Generally, the relationship is named as the Frank-Starling law of the heart after 
the two physiologists Otto Frank and Ernest Starling who first described it, although 
opinions vary in terms of the novelty of who discovered the relationship, details 
concerning this topic can be found in reviews by Zimmer (2002). 
Over the years, due to the great physiological significance of the Frank-Starling 
relationship in the regulation of cardiac function, the mechanism that underlies the 
enhancing cardiac contraction in response to the increasing ventricular filling on the 
cardiomyocyte level has been extensively investigated. A proportional relationship 
between myofilament SL and the maximum force generation, a phenomenon 
commonly referred to as the myofilament length dependent activation (LDA), is 
considered to be the main cellular basis of the Frank-Starling law of the heart (further 
explained in Section 1.6). 
 
1.5 Myofilament Length Dependence Activation 
 
1.5.1 The Cellular Basis of the Frank-Starling Relationship 
  
The Frank-Starling relationship is an intrinsic regulatory mechanism in the heart that 
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relates the diastolic ventricular filling with the systolic ejection volume. On the cellular 
level, an increase in the diastolic filling volume (preload) stretches the cardiomyocytes, 
leading to an increase in the SL. The increasing SL induces greater force 
development in the cardiac muscle contraction, which results in greater ventricular 
pressure at end-systole, and ultimately, more ejection volume. This direct 
proportionality between SL and force development, a phenomenon generally known 
as the myofilament length dependent activation (LDA), is the principle cellular basis 
that underlies the Frank-Starling modulation of cardiac output (Allen and Kentish, 
1985; Jewell, 1977).  
The speculation of active force as a proportional function of muscle length was 
first reported in skeletal muscle. Together with the sliding filament model of muscle 
contraction, this finding provides appealing explanation for the modulation of 
contractile force by muscle fibre length (Blix, 1894; Endo, 1972; Gordon et al., 1966). 
This was of particular interest to the cardiovascular investigations after the 
establishment of the Frank-Starling relationship, linking cardiac function to a 
fundamental property of the cardiomyocytes — the SL. Indeed, later study in isolated 
cardiac muscle has shown that the force production from sub-maximal Ca2+ activation 
is directly proportional to the SL (ter Keurs et al., 1980). 
The force-length relationship in muscle contraction, presented as the 
length-tension curve, is a property of both skeletal and cardiac muscles that relates 
the strength of an isometric contraction to the resting length of the muscle fibre 
(skeletal) or the sarcomere (cardiac). A net length-tension curve is a combination of 
both the active and passive elements. Active tension is produced by the interactions 
between actin and myosin heads upon Ca2+-induced activation, whilst passive tension 
(resting tension) is mostly the result of titin straining. As shown in Figure 1.5.1, there is 
an ideal fibre length or SL (L0 in Figure 1.5.1) at which muscles operate with greatest 
active force. Thus in order to maximize the active force, the range of length at which 
muscle contraction occurs should remain on the peak of the curve. However, in 
cardiac muscle, instead of remaining on the peak of the curve, it is more likely to 
function on the ascending limb of the length-tension curve, reserving great force 
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development potential that subject to the regulation by SL stretching as a result of 
more ventricular filling in the heart (Frank-Starling relationship).  
 
Figure 1.5.1: The length-tension curve for cardiac and skeletal muscle. The optimal SL 
(L0) is the ideal length at which muscle operates with the maximum active force. Unlike 
skeletal muscle, cardiac muscle functions on the ascending limb, rather than the peak 
(platue) of the length-tension curve. The ascending limb of the length-tension curve is 
steeper in cardiac muscle. Figure was adapted from Shiels and White (2008). 
 
In Gordon et al. (1966)’s experiments using frog fast-twitch skeletal muscle fibres, 
the shape of length-tension curve can be explained by the overlap between thick and 
thin filaments. Stretching muscle fibre towards the optimal length (the ascending limb) 
increases the optimal overlap between filaments, leading to increasing number of 
force-generating cross-bridges. As fibre is further stretched beyond the optimal length 
(across the plateau and descending limb), the number of cross-bridges decreases as 
a result of the decreasing filament overlap. However, this investigation was performed 
by the fully activation of skeletal fibres during isometric tetanic contraction.  
In general, skeletal muscle contraction is separated into twitch and tetanic 
contraction according to the duration of electrical stimulation. A single stimulation 
causes a twitch muscle contraction, yet the duration is so short that the muscle begins 
relaxing even before reaching peak force. A period of multiple stimulations, on the 
other hand, is able to induce the contraction to reach maximum force and plateaus, 




which the Ca2+ activated contraction is generally sub-maximal (at most half-maximal) 
under physiological conditions (Fabiato, 1981), thus subjects to the modulation of 
many factors including SL. This explains the fact that cardiac muscle operates on the 
ascending limb (SL 1.7 to 2.3 μm in human heart) rather than the peak of the 
length-tension curve. Studies showed that the ascending limb of the length-tension 
curve in cardiac muscle becomes progressively steeper as the level of Ca2+ activation 
rises (Figure 1.5.2 A), indicating that factors such as the filament overlap become less 
dominant in cardiac muscle contraction when Ca2+ activation is sub-maximal, at 
variance with the optimal filament overlap theory (Allen et al., 1974; Lakatta and 
Jewell, 1977; ter Keurs et al., 1980).  
As the cellular basis of the Frank-Starling relationship, it was initially assumed 
that the SL dependent modulation of the force production is determined on the 
molecular level by an increase in the amount of Ca2+ released to the myofibrils with 
increased SL. Early investigations by Fabiato and Fabiato (1975) suggested that 
there was indeed an increasing amount of Ca2+ released from the SR in response to 
increased SL in skinned ventricular cells, which might be responsible for the greater 
force production at longer SL. However, later investigations showed that upon 
changing muscle length, force development increased immediately and markedly, 
whereas the transient [Ca2+], which measured by a Ca2+-sensitive photoprotein 
aequorin, did not change as fast and significant (Allen and Kurihara, 1982). Kentish et 
al. (1986) using skinned isolated cardiac muscle also demonstrated that over the 
ascending limb of the length-tension curve, the SL-induced maximum force increase 
was accompanied by the increasing Ca2+ sensitivity rather than the increasing Ca2+ 
supply (Figure 1.5.2 B). The Ca2+ sensitivity, indicates the level of [Ca2+]i that required 
for 50% myofilament activation normalized to the maximum activation at saturating 
levels (Ruegg, 1998). Thus, the SL-dependent increase in the maximum force 
production is not due to the increasing [Ca2+]i, but the increasing Ca
2+ sensitivity in 
response to increased SL. More force is generated at a given [Ca2+]i as SL is 
increased. Therefore, with the increasing SL, the outcome of LDA has two aspects: 







Figure 1.5.2: Kentish et al. (1986). (A): Ascending limb of the length-tension curve in 
cardiac trabeculae becomes progressively steeper with increasing [Ca
2+
]. The active 
force-SL relationship was determined in five [Ca
2+
] ranging from 1.9 μM to 50 μM between 
the threshold and saturating concentration; (B): Relationship between force generation 
and [Ca
2+
]i at increasing SL from 1.65 μm to 2.15 μm. Increases in SL induce increases in 
the maximum Ca
2+
-activated force as well as in the Ca
2+
 sensitivity. The latter is 
manifested by the rising dashed line which indicates the decreasing [Ca
2+
] at 
half-maximum force production with increased SL. 
 
1.5.2 Concepts regarding LDA 
 
1.5.2.1 Two Phases 
As the cellular basis of the Frank-Starling law of the heart, LDA describes an intrinsic 
property of the sarcomere in response to a change in length. Incidentally, 
investigations by sinusoidal SL alteration in skinned isolated cardiac muscle during 
activation have revealed two distinct phases of the SL-modulation of force 
development: an immediate twitch force response, which is largely due to the change 




response that develops over the course of several minutes, which may results from 
alterations in the amount of Ca2+ released from SR (Allen and Kentish, 1985; Konhilas 
et al., 2002a). Later investigations by Campbell et al. (1993) in rabbit myocardium 
have suggested that the time constant for the latter phase (~100ms) was well 
correlated with the kinetics of cross-bridge cycling, suggesting the time course of LDA 
is relatively slow, accounting for ~25% of the time frame in one complete heartbeat. 
However, more recent studies by Mateja and de Tombe (2012) suggested that LDA 
describes the series of sarcomere lengthening-induced events that occur prior to the 
myofilament activation. Thus the latter delayed phase of force response, which may 
involve both LDA and its subsequent downstream processes including variations in 
the cycling of cross-bridges, is not a consistent indicator for the rate at which LDA 
develops. To measure the rate of LDA, Mateja and de Tombe (2012) compared the 
contraction kinetics (relaxation and activation) and force development in isolated 
guinea-pig myocardium at sub-maximal activation between steady-state SL and those 
after rapid ramp changes to the same SL before activation. Results showed that for 
the rapid ramp SL changes as fast as 5ms, neither contraction kinetics nor the 
sub-maximal force development was affected by the contraction modes (steady-state 
or rapid SL ramps), indicating almost instantaneous transduction of the signal from 
sarcomere lengthening to modulating the Ca2+ sensitivity in LDA (within 5ms), 
possibly due to the length-induced structural rearrangements of the sarcomeric 
proteins. 
 
1.5.2.2 LDA in Skeletal Muscle vs Cardiac Muscle 
Generally, LDA is a phenomenon applicable to all striated muscle, yet it is much more 
prominent in cardiac than skeletal muscle (Babu et al., 1988; Fabiato and Fabiato, 
1975). Investigations by Konhilas et al. (2001) concluded the magnitude of SL 
modulated Ca2+ sensitivity change followed the order cardiac muscle> fast skeletal 
muscle (psoas)> slow skeletal muscle (soleus) in skinned rat muscle preparations. As 
described in 1.2.1, the major proteins that make up the sarcomere are important 
determinants in regulating sarcomeric function. Despite the fact that all striated 
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muscle have identical type of sarcomeric proteins, the specific isoforms expression of 
these proteins varies between muscle types, which may explain the different 
magnitude of LDA.  
As the Ca2+ binding subunit in Tn complex, TnC contains two types of Ca2+ 
binding sites: high affinity and low affinity. Both skeletal and cardiac TnCs have two 
high affinity Ca2+ binding sites, which are always occupied with Ca2+ and function as a 
structural component in anchoring TnC with the rest of Tn complex (Pan and Solaro, 
1987). The activation of myofilament is triggered by the transient increase in [Ca2+]i 
which binds to the low affinity binding sites of TnC. Studies showed skeletal muscle 
TnC provides two low affinity binding sites, whilst cTnC only has one (Holroyde et al., 
1980; Potter and Gergely, 1975). In the absence of Ca2+, the inhibitory region of TnI 
holds Tm in a position that covers the binding sites for myosin heads on actin, 
preventing the actomyosin interactions. Upon the binding of Ca2+ to the low affinity 
site(s) on TnC, a hydrophobic patch exposes in TnC to interact with TnI, thus 
removing the steric block for Tm on actin filament. However, the affinity of TnC/TnI 
interactions following Ca2+ binding is much greater in skeletal muscle than in cardiac 
muscle (Kobayashi et al., 2008; Kobayashi and Solaro, 2005). Also, the 
conformational changes in the N-lobe of TnC upon activation are substantially larger 
in skeletal muscle (Sun et al., 2006; Sun et al., 2009). These two phenomena may be 
related with the sub-maximal activation of cardiac muscle by Ca2+ binding, thus 
explain the more prominent regulation of myofilament activation by length observed in 
cardiac muscle compared to skeletal muscle (Konhilas et al., 2001). 
Another study with regards to the impact of different isoforms expression of 
sarcomeric proteins on different magnitude of LDA in skeletal and cardiac muscle 
comes from the replacement of native cTnI with slow skeletal muscle TnI (ssTnI) in 
transgenic mice (Konhilas et al., 2003). The substitution with ssTnI in cardiac muscle 
reduced the SL-dependent difference in Ca2+ sensitivity, as expected for the blunted 
LDA observed in skeletal muscle, implying the critical role of TnI in determining the 
different impact of SL on skeletal and cardiac Ca2+ sensitivity. Despite the several 
deviations between cTnI and ssTnI isoforms, it was suggested that the key region 
52 
  
underlies the signal transduction of sarcomere lengthening, and contributes to the 
various LDA in different muscle types may be located in the inhibitory domain of cTnI 
(de Tombe et al., 2010; Smith et al., 2003).  
Additionally, as described in Section 1.3.2, the relationship between force and 
free [Ca2+] is very steep in both skeletal and cardiac muscle, suggesting highly 
cooperative Ca2+ regulation of myofilament activation. Although the mechanism 
underlying this cooperativity differs from the positive feedback of myosin binding to 
the intrinsic property of thin filament, different isoforms of sarcomeric proteins in the 
different muscle types are surely not making the same contribution to the cooperativity, 
which presumably affects the modulation of Ca2+ sensitivity in response to SL change 
(Fuchs and Martyn, 2005; Gordon et al., 2001; Moss et al., 2004; Sun et al., 2009).  
 
1.5.3 Current Hypotheses 
 
As the cellular basis of the Frank-Starling relationship, the importance of LDA has 
been appreciated for a very long time, yet there is still no clear answer as for how the 
information concerning SL transmits to both the force production and the Ca2+ 
sensitivity. In the earlier investigations, the major determinants of LDA were divided 
into ‘physical’ factors and ‘activation’ factors (Allen and Kentish, 1985; Jewell, 1977). 
Physical factors mainly involve those transferring the sarcomere lengthening signal 
through spatial changes in the thick and thin filaments, such as filament overlap and 
interfilament spacing; whilst activation factors are the subsequent alterations in the 
signalling pathway following SL change, including cross-bridges cycling, Ca2+ binding 
to cTnC and protein-protein interactions. To investigate the molecular mechanisms 
underlying the signal pathway from sarcomere lengthening to increase the maximum 
force and the Ca2+ sensitivity is the main propose of this study. Current hypothesis 
include the role of the Ca2+-binding protein cTnC, force-generating cross-bridges and 
cooperativity in terms of the activation factors; also, the effect of changes in filament 





Contraction of the heart muscle is triggered by a rise in intracellular calcium ions, 
which bind to troponin on the actin-containing thin filaments, leading to structural 
changes in the thin filament that allows myosin heads to bind and generate force. As 
the Ca2+-binding subunit, the cardiac troponin C (cTnC) has been proposed to play an 
important role in the regulation of Ca2+ sensitivity. cTnC has three Ca2+ binding sites: 
two high affinity Ca2+/Mg2+ binding sites in the C-lobe of cTnC, and only one low 
affinity Ca2+ binding site in the N-lobe (Holroyde et al., 1980). Under physiological 
conditions, the high affinity sites are constantly occupied by Mg2+ or Ca2+ depending 
on the intracellular [Ca2+], thus the Ca2+ regulation of the cardiac contractility is mostly 
achieved by binding to the low affinity site on the N-lobe of cTnC, i.e. the regulatory 
head, which is considered to be the physiological Ca2+-sensor. (Pan and Solaro, 1987; 
Takeda et al., 2003). 
As described above, with the increasing SL, LDA has two outcomes: the 
increasing maximum force and the increasing Ca2+ sensitivity. Studies have shown 
that in association with the increasing Ca2+ sensitivity, there was an increasing Ca2+ 
binding affinity for the N-lobe of cTnC in response to SL elongation (Hofmann and 
Fuchs, 1987a; Hofmann and Fuchs, 1988; Wang and Fuchs, 1995). As the Ca2+ 
binding protein, the potential role of cTnC in LDA was initially hypothesised. 
Investigations by Babu et al. (1988) replaced the native cTnC with skeletal TnC in 
skinned cardiac muscle. Substitution greatly compromised the enhancing Ca2+ 
sensitivity at longer SL, indicating the specific isoform of cTnC was able to regulate 
the Ca2+ sensitivity in LDA. However, further investigations using transgenic mice that 
express skeletal TnC instead of cTnC in cardiac muscle did not alter the 
SL-dependent difference in Ca2+ sensitivity compared to normal mice containing cTnC, 
vice versa (McDonald et al., 1995; Moss et al., 1991). Also, investigations using cTnC 
mutants L29Q and L48Q indicated the mutations on the Ca2+ sensor not only altered 
the Ca2+ sensitivity, but also affected the SL-dependent change in Ca2+ sensitivity 
(Korte et al., 2012; Li et al., 2013).Thus, the role of cTnC in transmitting the SL 
changing signal to regulate the Ca2+ sensitivity remains controversial. 
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On the other hand, in vitro studies have shown that Ca2+ binding opens the 
N-lobe of cTnC, exposes a hydrophobic patch that binds the switch peptide of cTnI, 
which leads to a further opening of the N-lobe (Li et al., 1999; Sia et al., 1997) 
(detailed description in Section 1.2.2). These global rearrangements in the troponin 
complex result in an azimuthal motion of the tropomyosin around the thin filament that 
exposes the myosin binding sites on actin monomers, which allows the interaction 
between actin and myosin, and drives force generation and muscle contraction. Our 
group’s previous investigations have shown that the force generation in cardiac 
muscle contraction was coupled to the structural change of cTnC upon Ca2+ activation. 
Therefore, to investigate the possibility of cTnC in sensing the SL change to modulate 
maximum force and Ca2+ sensitivity is the first aspect in this study of the molecular 
basis of the Frank-Starling relationship (Chapter 4). 
 
1.5.3.2 Force-generating Cross-bridges 
The cellular basis of the Frank-Starling relationship between ventricular filling and 
pressure is the SL-dependent modulation of force production at a given [Ca2+]i. It was 
suggested that this SL-dependent force regulation largely depends on alterations in 
the number of the force-generating cross-bridges with varied SL (Allen and Kentish, 
1985). Within the time course of one heartbeat, the formation of cross-bridges are 
determined by the degree of ventricular filling during diastole, and transferred from 
either blocked or weak binding non-force generating state to strong binding 
force-generating state during systole, results in the modulation of ventricular pressure 
development at end-systole.  
In order to investigate the role of force-generating cross-bridges in the other 
outcome of LDA — the SL-dependent Ca2+ sensitivity, researchers have been 
focusing on the connection between strong-binding cross-bridges and Ca2+ sensitivity 
in cardiac muscle contraction. Over the years, the concept of cross-bridges switching 
on the regulatory system has been widely accepted, in which tropomyosin is held in a 
‘on’ position by strong binding myosin heads, resulting in a higher Ca2+ affinity for 
troponin in adjacent RUs. Experiments using a phosphate analog vanadate to inhibit 
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the strong binding of myosin to actin have suggested that, the strong binding of 
cross-bridges promoted further binding of Ca2+ to cTnC, in association with enhanced 
structural change in cTnC upon activation (Hofmann and Fuchs, 1987b; Martyn et al., 
2001; Wang and Fuchs, 1994). 
Recent studies also reported that the strong binding of myosin heads contributed 
partly in the structural changes of cTnC, and enhanced the Ca2+ affinity to cTnC as a 
consequence (Rieck et al., 2013; Zhou et al., 2012). It was suggested that the 
formation of force-generating cross-bridges stabilised the conformation change in 
cTnC by keeping the inhibitory regions of cTnI off actin, thus favouring the attachment 
of the switch peptide of cTnI to cTnC. The association of the switch peptide to the 
Ca2+-induced hydrophobic patch in cTnC has been known to increase the Ca2+-cTnC 
affinity substantially (Johnson et al., 1980). Thus, it is reasonable to assume the 
strong binding of myosin heads is involved in stabilizing the structural changes in 
cTnC, thus increasing the Ca2+ sensitivity upon activation.  
The role of the force-generating cross-bridges in LDA has been investigated 
using experiments with modified actin-myosin interactions. Interventions which slow 
the rate of cross-bridges cycling and enhance the number of strong-binding 
cross-bridges, such as NEM-S1 (myosin subfragment-1 (S1) that was reacted with 
N-ethylmaleimide (NEM)), MgADP, reduced MgATP, increased both the maximum 
force and the Ca2+ sensitivity at short SL, yet reduced or even eliminated the 
SL-dependent difference in Ca2+ sensitivity (Adhikari et al., 2004; Fitzsimons and 
Moss, 1998; Fukuda et al., 2000). These results suggested at shorter SL before 
interventions, the formation of strong binding cross-bridges was less than at longer SL. 
The interventions enhanced the population of strong binding cross-bridges to a similar 
level as that formed at longer SL, which in turn reduced the Ca2+ sensitivity difference 
between short and long SL. Therefore, the SL-dependent variation in the number of 
the force-generating cross-bridges may be responsible for the length modulation of 
both maximum force and Ca2+ sensitivity. 
However, all these investigations have been taken in rigor-like conditions. 
According to Sun et al. (2009), the impact of the rigor-binding myosin heads was 
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distinct from that of the active-cycling myosin heads under physiological conditions. 
Thus, in order to re-evaluate the role of force-generating cross-bridges in the two 
outcomes of LDA, our next focus moved onto the thick filament, investigating the 
effect of cross-bridges in the SL-dependent maximum force and Ca2+ sensitivity by 
inhibiting the formation of them using a myosin binding inhibitor — blebbistatin 
(Chapter 5).  
 
1.5.3.3 Cooperativity 
As described in Section 1.3.2, the steepness of the force-[Ca2+]i relationship is much 
greater than would be expected from the equilibrium Ca2+ binding to the single binding 
site on cTnC, indicating highly cooperative Ca2+ regulation (Shiner and Solaro, 1984). 
Over the years, the mechanisms underlying this cooperativity vary: it might be 
modulated by strong myosin heads binding, or it might be the intrinsic property of the 
thin filament. The former possibility has been considered more likely at first due to the 
widely accepted concept of myosin heads binding switching on the regulatory system. 
Thus, in the investigations slowing the cycling kinetics and enhancing the population 
of strong binding cross-bridges (applying NEM-S1, adding MgADP, or reducing 
MgATP), it was assumed that the increasing Ca2+ sensitivity at longer SL might result 
from a cooperative rising in the number of the force-generating cross-bridges at 
longer SL.    
However, studies in our laboratory (Sun et al., 2009) have shown that the 
force-generating cross-bridges can only switch on thin filaments in rigor-like 
conditions (low [MgATP]), not under physiological conditions. Inhibition of active force 
by blebbistatin did not affect the steepness of the force-[Ca2+]I relationship, indicating 
the highly cooperative Ca2+-activation was not due to the positive feedback from 
myosin heads binding, but an intrinsic property of the thin filaments. In physiological 
conditions, the information of Ca2+ binding to one RU spreads to adjacent RUs via 
coupling between Tm molecules, promoting further binding of Ca2+ and formation of 
cross-bridges in those adjacent units. Investigations by Farman et al. (2010) indicated 
that the coupling between adjacent units increased with SL, such that less Ca2+ 
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binding was required to achieve activation at longer SL. Thus, at longer SL, upon the 
same amount of Ca2+ binding, the Ca2+ cooperativity was enhanced to transit more of 
the neighbouring RUs from the “blocked” state to the “closed” state via stronger 
coupling, which increased Ca2+ sensitivity. Interestingly, in an earlier study by  
Dobesh et al. (2002), the SL-dependent increase in Ca2+ sensitivity was not 
accompanied by an increase in cooperativity. Thus, the role of cooperativity in 
transmitting the signal from sarcomere lengthening to affect the Ca2+ sensitivity 
remains controversial and subject to further investigation.  
 
1.5.3.4 Double Overlap Hypothesis 
The impact of SL change on the number of force-generating cross-bridges was 
initially hypothesized to be due to the SL-induced change in filament overlap. The 
length of a sarcomere is defined by the distance between two Z-lines and ranges from 
1.7 μm to 2.3 μm in human heart under physiological conditions, corresponding to the 
ascending limb of the length-tension curve. Over the SL range 1.7 to 2.1 μm, the 
combined length of the thin filaments extended from each side of the sarcomere is 
longer than SL, suggesting double overlap of the oppositely polarized actin filaments. 
The double overlap was assumed to interference with the normal interactions 
between actin and myosin heads, thus reduce the formation of force-generating 
cross-bridges at given [Ca2+], leading to down-regulation of the Ca2+ sensitivity 
(Gordon et al., 1966; Hofmann and Fuchs, 1988).  
However, studies in terms of the geometry of double overlap suggested that 
within the SL range 1.7 μm to 2.3 μm, the SL shorten-induced variation in the amount 
of double overlap is very small, involving a maximum of less than 25% of the 
cross-bridges that switches from the single overlap zone to the double overlap zone, 
which may account for the modest reduction in force development (Gordon et al., 
1966). Yet the force-length relationship is too steeply and too variably dependent on 
[Ca2+] to be fully explained by such a mechanism. Moreover, Fabiato and Fabiato 
(1978) reported increased Ca2+ sensitivity on the descending limb of the cardiac 
length-tension curve, where both the amount of double overlap and the potential for 
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cross-bridge formations are diminished, suggesting the filament overlap-induced 
change in the number of cross-bridges is not sufficient to make a contribution to the 
SL-dependent change in either force generation or Ca2+ sensitivity. 
 
1.5.3.5 Interfilament Spacing Hypothesis 
Another popular hypothesis of the LDA proposes that it is the corresponding change 
in the radial distance between the thick and thin filament (the interfilament spacing, IS) 
that determines the impact of SL in LDA — the interfilament spacing theory. As shown 
by X-ray diffraction studies (Millman, 1998; Rome, 1972), the intact myofilament 
sarcomere is an isovolumic system that is able to maintain close to constant volume 
upon SL variation. Changes in lattice spacing are inversely related to changes in SL in 
isolated cardiac muscle (Irving et al., 2000). Thus, an increase in SL is expected to 
lead to a corresponding reduction in the lattice spacing between thick and thin 
filaments (Figure 1.5.3). The closer proximity between myosin heads and actin 
enhances the formation of cross-bridges and thereby enhances force development at 
a given concentration of Ca2+ (Fuchs and Smith, 2001; Godt and Maughan, 1981; 
McDonald and Moss, 1995).  
Although the constant volume behaviour is not exhibited in skinned muscle 
preparations due to the loss of osmotic constraint by cell membrane, the amounts of 
reduction in the IS upon the same sarcomere lengthening are very similar between 
intact and skinned preparations, indicating changes in IS inversely related to changes 
in SL regardless of the preparations (Irving et al., 2000). The correlation between SL 
and IS is mostly mediated by titin (Figure 1.5.3). The interactions with both thick and 
thin filaments allow titin to produce a radial force which pulls the myofilaments 
together upon SL increasing (Cazorla et al., 1999; Cazorla et al., 2001; Fukuda and 




Figure 1.5.3: Schematic illustration of the reduction in interfilament spacing (IS) upon SL 
elongation. From upper to lower: increasing SL results in a closer proximity of the thick 
and thin filaments within the sarcomere, allowing a more favourable disposition of myosin 
heads to interact with actin. The correlation between SL and IS is mostly mediated by the 
extensible region of titin. Figure adapted from Tskhovrebova and Trinick (2003). 
 
To evaluate the interfilament spacing hypothesis, osmotic compression of the 
myofilaments by high molecular weight molecule — dextran, which cannot enter the 
myofilament lattice structure, was used to mimic the SL-induced reduction in IS 
without changing SL. 
At first, fibre width was measured as an indicator of the changes in IS. Studies by 
McDonald and Moss (1995) showed compression of the rat cardiomyocytes using 2.5% 
dextran at SL 1.85 μm led to an increase in Ca2+ sensitivity which matched that 
induced by increasing SL to 2.25 μm, indicating that the effect of SL elongation on 
Ca2+ sensitivity could be largely accounted for by mimicking the SL-induced changes 
in IS. Wang and Fuchs (1995) demonstrated similar conclusions using 5% dextran to 
compress bovine cardiac muscle bundle. At SL 1.7 μm, upon compression, there was 
an increase in Ca2+ sensitivity coupled with a reduction in fibre width, which were both 
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equivalent to those produced by increasing SL to 2.3 μm. In the subsequent 
investigations by Fuchs and Wang (1996), demembranated bovine cardiac muscle 
bundles at SL ranging from 1.7 μm to 2.3 μm were exposed to varied concentrations 
of dextran (0-5%). Applying certain amount of dextran to maintain a relatively constant 
interfilament spacing among all the SLs essentially eliminated the length dependent 
change in Ca2+ sensitivity. Their results showed that changes in the Ca2+ sensitivity 
have closer correlation with changes in the IS than changes in the SL, agrees with the 
IS theory.    
However, the evidence presented above came entirely from the experiments in 
which the extent of osmotic compression on interfilament spacing was estimated from 
the reduction in fiber width, based on the assumption that the changes in fibre width 
are proportional to the changes in lattice spacing. X-ray diffraction measurements 
have confirmed this assumption in skinned rabbit psoas muscle fibres. However, 
Kawai et al. (1993) argued that the close proportionality between muscle width and 
interfilament spacing might not apply to other muscle types which have a high 
mitochondrial content (cardiac and slow skeletal muscle). More recent investigations 
challenged this proportionality between fibre width and IS by direct measurement of 
the IS using X-ray diffraction. Konhilas et al. (2002b) reported that dextran treatment 
compressed the fibre width to a greater extent than IS, implying measurement of fibre 
width is not a consistent indicator of changes in interfilament spacing, questioning the 
supporting conclusions of the hypothesis obtained previously. 
Since then, researchers have been trying to seek for a more accurate relationship 
between the actual IS and the Ca2+ sensitivity to prove the IS hypothesis. Konhilas et 
al. (2002b) measured the IS and the Ca2+ sensitivity in rat cardiac trabeculae under 
varying degrees of osmotic compression (0, 3% or 6% dextran) at three SLs — 1.95 
μm, 2.15 μm and 2.25 μm. They found that the addition of 3% dextran remarkably 
increased Ca2+ sensitivity by a similar amount at all three SLs. However, further 
compression with 6% dextran did not show an additional significant effect on Ca2+ 
sensitivity. Although the outcome of 3% dextran compression was consistent with the 
interfilament spacing hypothesis, a further reduction in lattice spacing without a further 
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increase in Ca2+ sensitivity could not be fully explained by such a theory, indicating the 
possibility of a saturated state in the impact of osmotic compression on Ca2+ sensitivity. 
It was suggested that lattice compression with more than 5% dextran might have no 
effect on Ca2+ sensitivity and over-compression with more than 10% dextran might 
even reduce the myofilament Ca2+ sensitivity (Ford et al., 1991; Wang and Fuchs, 
1995; Zhao et al., 1993). As reported by Adhikari and Fajer (1996), a possible 
explanation for the saturation of osmotic compression was that, due to the distance 
between thick and thin filaments were too close by over-compression, normal 
cross-bridge motion was likely to be interrupted, resulting in a reduction in the number 
of strong binding cross-bridges and the Ca2+ sensitivity.  
Their research also showed that the SL-induced increase in Ca2+ sensitivity was 
not affected by either 3% or 6% dextran treatment, whereas the reductions in 
interfilament spacing corresponding to SL elongation were significantly decreased 
upon the compression with 3% or 6% dextran. Moreover, moderate compression with 
1% dextran, which decreased the lattice spacing equivalent to that induced by SL 
stretching from 2.02 μm to 2.19 μm in uncompressed trabeculae, did not show an 
increase in Ca2+ sensitivity, in contrast to the significant increase reported in SL 
elongation. These results suggested that the alteration in lattice spacing may not 
always be the primary mechanism that underlies SL’s effect in Ca2+ sensitivity. 
However, later investigations by Martyn et al. (2004) held different point of view in 
terms of the null effect of 1% dextran on Ca2+ sensitivity. They argued that the change 
in lattice spacing with 1% dextran compression (measured by X-ray diffraction) was 
too minor to be detected, thus it produced no change in Ca2+ sensitivity. The 
discrepancy between the two studies is not clear, although it may be related to the 
different temperatures used in each measurement (5°C in Martyn et al. (2004) vs 
room temperature in Konhilas et al. (2002b)). 
Above investigations have shown variable relationships between changes in IS 
and changes in Ca2+ sensitivity, depending on the degree of osmotic compression and 
the SL. There may be other mechanisms in LDA that can operate independent of 




1.5.3.6 Other Hypotheses 
In addition, it has been hypothesised that the giant elastic protein titin may be the 
primary length-sensing element in the myofilament sarcomere which underlies the 
LDA. Indeed, several studies have revealed a correlation between the amount of 
titin-based passive tension and the amount of LDA, indicating a possible role of titin in 
correlating its passive tension production with the signal transmission of SL change in 
LDA. Also, investigations in which the native cTnI was replaced by the slow skeletal 
isoform (ssTnI), which lacks one protein kinase A (PKA) target site, have provided 
insights of the role of cTnI, together with the phosphorylation of cTnI in the regulation 
of LDA. 
 
1.6 Aims and Strategy of the Project 
 
The aim of the project is to understand the molecular mechanisms underlying the 
Frank-Starling relationship in the heart, which is to a large extent determined by the 
molecular mechanisms of the LDA in the cardiomyocytes. Despite extensive research 
efforts over many years, there is no certain answer yet. In response to the increasing 
SL, the outcome of LDA has two aspects: the increasing maximum force and the 
increasing Ca2+ sensitivity. So this project mainly focused on the molecular 
mechanisms underlying the signal pathway from sarcomere lengthening to increase 
the maximum force and Ca2+ sensitivity. We investigated whether the two outcomes of 
LDA are correlated with each other and from the same mechanism.  
The technique that was used in this project — Fluorescence for In Situ Structure 
(FISS), offers a powerful new approach to test these hypotheses. This approach 
examines the dynamic conformations of proteins in real time in a working muscle cell 
using fluorescence polarization measurements and correlates the structure of 
sarcomeric proteins (in this case, the Ca2+ binding protein-cTnC) with their functions in 
the regulation of cardiac muscle activation. With FISS, the force development and the 
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in situ structural changes in cTnC upon Ca2+ binding can be determined 
simultaneously under various experimental conditions during the physiological 
activation of the heart in the cardiomyocyte environment. More importantly, it enables 
us to evaluate Ca2+ sensitivity and cooperativity under complete force inhibition by 
following the structural changes in Tn. 
The native cTnC residues in demembranated trabeculae from rat ventricle were 
replaced by cTnC mutants with bifunctional rhodamine (BR) probes attached along 
either the C-helix of cTnC in the regulatory head, or the E- helix of cTnC in the IT arm, 
to determine the in situ orientation of the two major domains of the Tn complex. The 
dependence of isometric force and cTnC helix orientation changes on [Ca2+] were 
fitted to the Hill equation:  
                        
where nH measures the cooperativity of Ca
2+ activation, and pCa50 represents Ca
2+ 
sensitivity.  
To perform our investigations in terms of the molecular basis underlying the 
SL-dependent Ca2+ sensitivity using the fluorescence polarization technique, a new 
experimental set-up was required to obtain the polarized fluorescence intensities 
emitted from the BR probes. Building the set-up was the very first step in this project. 
Detailed information concerning FISS and the experimental set-up is in Chapters 2 
and 3, respectively. 
The investigations in this study (Chapters 4~6) can be summarised below: 
1. Firstly, we tested the role of the Ca2+ binding protein cTnC on the thin filament, 
which has been recognised as an important mediator of the Ca2+ sensitivity. We 
investigated whether cTnCis primarily responsible for regulating the maximum force 
and the Ca2+ sensitivity with increased SL.  
2. Secondly, it was suggested that the increasing maximum force production is the 
result of more force-generating cross-bridges formed at longer SL. But the effect of 
cross-bridges on the Ca2+ sensitivity at longer SL still remains controversial. So we 
then examined the role of the force-generating cross-bridges in the SL-dependent 
Ca2+ sensitivity by inhibiting the formation of them using blebbistatin. 
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3. Last, we examined one of the most popular hypothesis of LDA — the interfilament 
spacing theory. It assumes that the critical length-sensing function may be relying on 
the spatial factor, which is the radial distance between the thick and thin filaments in 
the sarcomere (the interfilament spacing).  
The results will help us understand the molecular mechanisms underlying the 
Frank-Starling relationship in the heart, and lead to more effective drug designs and 












































2.1 Chemicals and Solutions 
 
For the chemicals and solutions used in the preparation of rat cardiac trabeculae, see 
Section 2.2 for details. Composition of the solutions used in experiments is listed in 
Table 2.1. Activation of trabeculae was performed in activating solution after a 2-min 
bathing in pre-activating solution where no calcium was added and only 0.2 mM of 
EGTA was present. The immersion in pre-activating solution allowed most of the 
EGTA to diffuse out of the fibre prior to activation.  
The concentrations are shown in mM. Ionic strength was adjusted to 200mM with 
potassium propionate (KPr). pH of all solutions have been adjusted to 7.1 at room 
temperature (~20°C). 0.1% protease inhibitor cocktail (Sigma, P8340) was added into 
all solutions to prevent proteolytic cleavage of proteins in the fibre. The purity of EGTA 
was 98.5% according to the manufacturer’s analysis. The concentration of free Ca2+ 
was calculated using the program Maxchelator: Ca-Mg-ATP-EGTA Calculator v1.0 
(http://www.stanford.edu/~cpatton/downloads.htm), and expressed on a logarithmic 
scale, as pCa = -log10[Ca
2+] (Table 2.2). The calculated free [Ca2+] was in the range 
pCa 9.0 to pCa 4.5 (1 nM to 33 μM). It could be obtained by mixing relaxing (pCa 9.0) 
and activating (pCa 4.5) solutions according to the calculated ratios showed in Table 
2.2.  
When required, 25 μM blebbistatin (Sigma, B0560) was added from a 25 mM 
stock solution in DMSO, and 1% or 4% (w/v) Dextran (Sigma, 31392) was added to 










Table 2.1: Composition of experimental solutions (in mM) used in fluorescence 
polarization measurements. Ionic strength was adjusted to 200 mM with potassium 
propionate; pH was 7.1 at 20 °C. Na2CrP, disodium creatine phosphate; KPr, potassium 
propionate; Na2ATP, disodium adenosine-5’-triphosphate; K2EGTA, dipotassium ethylene 
glycol tetra acetic acid; DTT, 2’,2’-Dithiothreitol. 
 (mM) Imidazole Na2CrP KPr Na2ATP MgCl2 CaCl2 K2EGTA DTT 
Relaxing 25 15 78.4 5.65 6.8 0 10 1 
Pre-activating 25 15 108.2 5.65 6.3 0 0.2 1 
Activating 25 15 58.7 5.65 6.3 10 10 1 
 
Table 2.2: Composition of pCa solutions — Ratio of activating solution. For the desired 
pCa (free [Ca
2+
]) from 9.0 to 4.5 (1 nM to 33 μM), the total [Ca2+] (calculated using 
“Maxchelator” program with 10 mM EGTA) indicates the fraction of activating solution in 
each pCa solution, the last two columns showed the composition of pCa solutions.  
pCa Free [Ca
2+
] (M) Total [Ca
2+
] (M) pCa 4.5 (ml) pCa 9.0 (ml) 
9.0 1.00E-09 3.50E-05 0.00 10.00 
7.0 1.00E-07 2.55E-03 2.55 7.45 
6.7 2.00E-07 4.04E-03 4.04 5.96 
6.4 3.98E-07 5.72E-03 5.72 4.28 
6.2 6.30E-07 6.77E-03 6.77 3.23 
6.0 1.00E-06 7.80E-03 7.80 2.20 
5.8 1.60E-06 8.40E-03 8.40 1.60 
5.6 2.50E-06 8.85E-03 8.85 1.15 
5.5 3.20E-06 9.04E-03 9.04 0.96 
5.4 4.00E-06 9.20E-03 9.20 0.80 
5.2 6.30E-06 9.44E-03 9.44 0.56 
5.0 1.00E-05 9.60E-03 9.60 0.40 




2.2 Fluorescence for In Situ Structure (FISS)  
 
Contraction of cardiac muscle is triggered by the reversible binding of Ca2+ to the 
N-terminal regulatory lobe of cTnC, initiating conformational changes in the filament 
proteins which allow the interactions between thick and thin filaments to form 
cross-bridges and generate force (Gordon et al., 2000; Tobacman, 1996). Although 
the structures of most major proteins in the sarcomere have been characterized by 
crystallography or NMR spectroscopy at near-atomic level, their conformational 
changes and cellular functions under physiological conditions are difficult to study 
(Sun et al., 2009). The heterogeneity of biochemical states and the flexibility of protein 
conformations in vitro have been contributed to this difficulty. The dynamic 
interactions between macromolecular complexes which may influence protein 
conformations cannot be reproduced in vitro. Therefore in this project, a technique 
called Fluorescence for In Situ Structure (FISS) was used to measure orientation 
changes in protein domains during physiological activation of the heart muscle cells in 
the cellular environment, in which the native structural relationships and interactions 
between sarcomeric proteins in the regulatory system are preserved.  
This approach examines the dynamic conformations of proteins in real time in a 
working muscle cell using fluorescence polarization measurements. Fluorescence 
polarization techniques have been widely used to study both cardiac and skeletal 
muscle contractility (Ferguson et al., 2003; Julien et al., 2007; Knowles et al., 2012; 
Sun et al., 2006; Sun et al., 2009). It requires double cysteine residues introduced into 
a protein domain at sites chosen from its static structure to cross-link with the 
bifunctional rhodamine (BR) dye (Ferguson et al., 2003; Sun et al., 2009). The 
bifunctional rhodamine reagent (Bis-iodoacetamidorhodamine, BR-I2) contains a 
central rhodamine fluorophore flanked by two flexible linkers, each terminating in an 
iodoacetamido group (Corrie et al., 1998). When these groups react with the two 
suitably placed cysteine residues, the average orientation of the probe dipole, which is 
aligned with the long axis of the three coplanar rings of the fluorophore, is expected to 
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be parallel to a line joining the cysteines (Corrie et al., 1999). The BR-labelled protein 
is then exchanged into its native environment, where the fluorescence polarization 
data from the BR probe can be used to determine the orientaion of the probe dipole, 
and thereby, determine the conformational changes of the chosen protein domain. 
This method correlates the structure of sarcomeric proteins with their functions in the 
regulation of cardiac muscle activation. Specifically, it has been applied to investigate 
the Ca2+ dependent structural changes of troponin C that are involved in muscle 
regulation (Ferguson et al., 2003; Sun et al., 2006; Sun et al., 2009). A schematic 
overview of this method is shown in Figure 2.1. 
 
Figure 2.1: Schematic of the general work-flow of FISS. A full description is in the text. 
Site-specific introduction of double cysteines allows the bifunctional rhodamine dye to 
cross-link with their β-carbons. Therefore, the probe dipole is parallel to the line joining the 
two cysteines, thus to the α-helix of the protein to which it was attached. After exchange 
the BR-labelled protein into muscle fibre, the orientation of the dipole can be determined 
by polarized fluorescence. With data from more than one probe, the orientation of the 
main domains in desire protein can be determined in situ. 
 
In this project, to study the Ca2+ dependent structural changes in cTnC, the 
bifunctional fluorescent probes were attached along either the C-helix, adjacent to the 
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regulatory Ca2+ binding site, or the E-helix, in the IT arm of the troponin complex 
(Figure 2.2). The labelling sites were chosen using the high resolution structures of 
isolated troponin components and engineered by expressing human cardiac TnC 
(hcTnC) mutants with double cysteine residues at the chosen sites (details in Section 
2.3) (Takeda et al., 2003).Thus the two probes used here report conformational 
changes in the two major domains of the troponin core complex in the cellular 
environment — the N terminal regulatory lobe and the IT arm.  
 
 
Figure 2.2: Bifunctional Rhodamine labelling of cTnC. (A) Structure of the bifunctional 
rhodamine reagent (BR-I2). (B) Structure of the core domain of cardiac troponin complex 
in the Ca
2+
-saturated form (Takeda et al., 2003) (PDB 1J1D), containing cTnC in red, part 
of cTnI in blue and cTnT in gold, showing the two pairs of cysteine residues: 55 and 62 
along the C-helix in the regulatory head of Tn, or 95 and 102 along the E-helix in the IT 







2.3 Preparation of Demembranated Cardiac Trabeculae 
 
2.3.1 Dissection and Permeabilizing Cardiac Trabeculae from Rat 
 
Wistar rats (male, 200-250g) were stunned and culled by cervical dislocation 
(Schedule 1 humane killing procedure in accordance with UK Animal Scientific 
Procedure Act, 1986). The hearts were removed immediately and rinsed free of blood 
in Krebs-Henseleit solution (Sigma, K3753) containing: NaCl 118 mM, NaHCO3 24.8 
mM, Na2HPO4 1.18 mM, MgSO4 1.18 mM, KCl 4.75 mM, CaCl2 2.54 mM, glucose 10 
mM; bubbled with 95% O2–5% CO2; pH7.4 at 20°C. Suitable trabeculae (see Figure 
2.3) (free running, unbranched, diameter ≤ 250 μm) were dissected from both the left 
and right ventricles in Krebs solution containing 25 mM 2,3-butanedione-monoxime 
(to inhibit spontaneous contraction). Isolated trabeculae were then permeabilized in 
relaxing solution (Table 2.1) containing 1% Triton X-100 for 60 min on ice and stored 
in relaxing solution containing 50% (v/v) glycerol at -20 °C for experiments, or 
incubated in exchange solution containing 0.5 mg/ml BR-hcTnC mutants (see Section 
2.3.3 for details) on ice overnight. Prepared trabeculae were used within three days of 
dissection.  
Figure 2.3: Cardiac Trabeculae. (A) Photomicrograph of a Bouin’s-fixed picrosirius 
red–stained rat right ventricle. The two narrow arrows point to thin, free–running 
trabeculae (similar to the specimen used for fluorescence polarization experiments). (B) 
Confocal image of the cross–sectional area of fixed, picrosirius red (PSR)–stained 
trabecula showing its cellular organization. Pictures were taken from Goo et al. (2009). 
  
 
 A B 
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2.3.2 Preparation of BR-labelled hcTnC mutants 
 
In order to attach bifunctional rhodamine probe along a helix on hcTnC, a pair of 
cysteine residues was introduced into the chosen site. The double cysteine mutants 
E55C/ D62C and E95C/ R102C of hcTnC in the Pet3a expression vector were 
obtained by site-directed mutagenesis and expressed in E. coli. (Sun et al. (2009). 
Residues 55 and 62 are on the C-helix in the regulatory lobe of TnC and residues 95 
and 102 on the E-helix of TnC in the IT arm. The native cysteines C35 and C84 were 
replaced by serines. The hcTnC mutants were expressed, purified and labelled by the 
protocol from Ferguson et al. (2003). The cysteines were cross-linked with BR probe 
to form 1:1 BR:TnC conjugates TnC-BR55-62 and TnC-BR95-102. The BR probe was 
synthesized and provided by Corrie et al. (1999). The conjugates were then purified to 
more than 95% homogeneity by reverse-phase HPLC, and the confirmation of the 
labelling stoichiometry and specificity was performed by electrospray mass 
spectrometry. All the BR-cTnCs have the expected molecular weights; the measured 
mass of TnC-BR55-62 was 18858.5 ± 0.9Da (calculated mass of 18858.6Da) and that of 
TnC-BR95-102 was 18817.9 ± 0.8Da (calculated mass 18817.3Da). Labelled hcTnCs 
were then aliquoted and stored at -80°C in exchange buffer (10 mM Tris pH 7.5, 100 
mM NaCl, 1 mM MgCl2). Both TnC-BR55-62 and TnC-BR95-102 (1.8 mg/ml) have been 
previously produced in the lab and were available for this study. It has been shown 
that neither the mutagenesis nor the subsequent labelling is likely to affect the 
structure of the labelled domains of cTnC (Ferguson et al., 2003), although the 
presence of BR probe on either the C- or E-helix reduces the Ca2+ affinity of the 
regulatory site with no significant effect on the cooperativity of Ca2+ regulation (Sun et 
al., 2009). 
 
2.3.3 Exchange of BR-hcTnCs into Permeabilized Rat Cardiac Trabeculae 
 
Each BR-hcTnC was separately exchanged for the native cTnC of the permeabilized 
trabeculae from rat ventricle, using a passive exchange protocol. Previous 
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experiments in the lab were using trifluoperazine (TFP) protocol (20-25 cycles of 
incubation) to extract about two thirds of the native cTnC from trabeculae (Sun et al., 
2009). Although passive exchange does not involve cTnC extraction, it has been 
shown to achieve the same degree of exchange. For example, substitution of whole 
troponin (Brenner et al., 1999; Kohler et al., 2003; She et al., 2000; Sumandea et al., 
2003; Tachampa et al., 2007) or cTnC (Farman et al., 2010) at room temperature for 
two hours achieved ~95% replacement. In addition, TFP protocol is not specific to 
cTnC extraction — it has also been used in studies that extract regulatory light chain 
(RLC) and essential light chain (ELC). Thus, TFP protocol is likely to remove more 
than just cTnC from trabecula. In order to avoid the downsides of TFP extraction, 
passive exchange was used in all experiments presented in this project.   
After permeabilization, the trabeculae were incubated in 100µl relaxing solution 
containing 0.5 mg/ml TnC-BR55-62 or TnC-BR95-102 overnight on ice, to passively 
exchange the native cTnC for BR-hcTnCs. Subsequent preparation of the fibre (i.e. 
attachment of T-clips) and in situ fluorescence polarization measurements were 
performed the following day. The extent of reconstitution using the above exchange 
protocol was calculated by immunoblot analysis with a monoclonal anti-cTnC antibody. 
It was estimated that the percentage of BR-labelled cTnCs with respect to total cTnCs 
was about 77 ± 2% (± SEM, n = 3). This procedure was performed by Dr. Ivanka 
Sevrieva in the lab. Maximum Ca2+-activated force in exchanged trabeculae was 
about 95 ± 10% (± SEM, n = 10) compared with that in un-exchanged trabeculae from 
separate batch of trabeculae, indicating the incorporation of BR-labelled cTnC 
produced no significant effect on cTnC function (unpaired t-test, p = 0.477).  
 
2.3.4 Polarized Fluorescence Measurements 
 
Permeabilized trabeculae were mounted via the attachment of two aluminium T-clips, 
between a force transducer (SI-KG7, World Precision Instruments, INC., USA) and a 
fixed hook in a 70 µl glass trough containing relaxing solution (details of troughs in 
Section 3.2.3). Trabeculae were bathed in relaxing solution containing 50% (v/v) 
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glycerol on ice during the attachment of T-clips. The experimental temperature was 
20-22°C (room temperature).  
The BR dye on the fibre was illuminated by 532 nm incident light polarized either 
parallel or perpendicular to the fibre axis. The illuminating beam was either below the 
fibre (X-illuminating pathway) or from behind (Y-illuminating pathway). The emitted 
fluorescence was collected in line with the illuminating pathway and separated into 
parallel and perpendicular components. The measured intensities were then used to 
calculate three independent orientation order parameters: <P2>, <P4> and <P2d>, 
which describe the distribution of the angle between probe dipole and fibre axis over 
slower timescales (Dale et al., 1999). The orientation of the probe dipole, as the 
orientation of the helix to which it was attached, was estimated for a folded Gaussian 
orientation distribution model (see Section 2.4 for details). The polarized fluorescence 
measurements were undertaken using a self-built experimental set-up, a schematic 
diagram of which is shown in Figure 2.4. A full description for the design and building 
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Figure 2.4: Schematic diagram of the fluorescence polarization set-up. A full description 
of the set-up is in the text. Trabecula was mounted in the glass trough with its long axis 
parallel with the transmission direction of initial incident light. Pale and dark green arrows 
respectively represent the light from X- and Y-illumination pathway, and orange light is the 
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2.4 Interpretation of FISS Measurements 
 
2.4.1 Analysis of Fluorescence Intensity Data 
 
The orientation of the BR fluorescence dipole, and thus of the cTnC helix to which it 
was attached, was determined from the polarized fluorescence intensities. Eight 









yIll from Y-pathway (see Figure 2.5 for 
pictorial description).  
 
Figure 2.5: The propagation of the excitation and emission pathway. Incident light 
polarized either parallel or perpendicular to the fibre axis illuminates trabecula from X- and 
Y-illumination pathway. The angle between probe dipole and trabecular axis is probe 
angle θ. The emitted fluorescence light from the probe is collected in-line with 
X-illumination pathway, and separated into parallel and perpendicular polarized 
components.  
 
The first (mI) and second subscript (In) denote the excitation and emission 
polarization respectively, where ll and ┴ represent the parallel and perpendicular 
polarization with respect to the trabecular axis, whilst x and y indicate the different 
77 
  
illumination pathway. However, in this study, Y-illumination pathway was used only in 
the measurements of SL (details in Section 2.5.1), although it was designed for the 
second illumination (more details of the experimental apparatus in Chapter 3), and the 
difference between the measured fluorescence intensities from X- and Y- illumination 
can be used to determine the fast motion of the probe (see Section 2.4.2 for details). 
The measured fluorescence intensities are affected by the differential 
transmittance of parallel and perpendicular components in excitation and emission 
light. In order to eliminate these effects, a rhodamine slide — made by embedding a 
sample of iodoacetamidotetramethylrhodamine (IATR) in epoxy resin on a glass slide 
under a cover slip — was used to obtain correction for the excitation (xg = ┴/║) and 
emission (xk = ┴/║) transmission factors in X-pathway (since it was the only pathway 
used in this project to take the fluorescence polarization measurements). Since for an 




xIll, the X-pathway correction factors 
could be calculated using the measured intensities of the rhodamine slide: 













































In the polarized fluorescence measurements of the trabeculae, the corrected 

















The corrected intensities from the fibre were then used to obtain polarization 
ratios, which provide the orientation distribution information of the probe dipole 
without influenced by brightness of the illumination, size of the fibre, extent of labelling 
or protein exchange and efficiency of fluorescence collection etc.  












In principle, if the parallel and perpendicular components of the excitation and 
emission light were equally transmitted, and the rhodamine was completely isotropic 
and immobile with absorption and emission dipoles collinear, the xP║ calculated from 
the corrected intensities of the rhodamine slide would be 0.50. However, the 
polarization ratio obtained in the X-illumination pathway was 0.43 in this study, the 
deviation from 0.50 could be the result of incomplete immobilization of the IATR in the 
epoxy or instrumental imperfections.  
Even though cross-linked with two residues, the BR probes are not completely 
immobilized on the protein. This may due to the wobble of BR probes with respect to 
the trabeculae or to the dynamic native environment of the fibre itself. If probes 
change orientation on a rapid timescale (nanosecond) compared to the fluorescence 
lifetime, the orientation of the dipole can be different between the absorption moment 
and emission moment. Fluorescence polarization ratios are very sensitive to the 
motion of the fluorophores, and this motion decreases the observed polarization ratios. 
Therefore, it is necessary to understand the extent of the fast probe mobility and 
distinguish it from the orientation change of the protein to which it is attached. By 
assuming the rapid probe motion is cylindrically symmetrical about the average 
orientation, like wobbling in a cone, the extent of this wobbling can be characterized 
by the semi-cone angle δ or the order parameter <P2d> (the amplitude of the fast 
motion, defined in Section 2.4.2), and calculated from the difference between the 
fluorescence intensities obtained from X- and Y-illumination pathways. Nonetheless, 
angle δ and <P2d> are constant values for a given probe (δ ≈ 20°, <P2d> ≈ 0.8), thus 
the measurements from Y-illumiantion pathway was not necessary for this purpose 
(Dale et al., 1999; Irving, 1996). 
      
2.4.2 Orientation Distribution of the Probe 
 
Shown in Figure 2.5, the angle between the probe dipole and the trabecular axis (θ) 
was used to describe the probe orientation with respect to the fibre axis during 
different experimental conditions. Due to the cylindrically symmetrical property of the 
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trabeculae, the top and bottom of the cylinder were impossible to differentiate, thereby, 
θ was the only angle we obtained for a given probe. Moreover, even though the probe 
labelling sites on cTnC were precisely designed to crosslink between two specific 
atoms, the orientation of each probe is not likely to be at exactly the same angle. Due 
to the intrinsic disorder of the probes, and/or since the cTnC molecules are probably 
not all in precisely the same conformation, and are likely to adopt two or more different 
conformations simultaneously, the orientation of the probe and the protein domain 
must be described as a distribution of angles rather than a single angle. The 
distribution of all probe angles on the trabeculae, mathematically written as f(θ), was 
used to indicate the possibility of finding a probe at angle θ. 
Legendre showed that any angular distribution f(θ) can be represented by the 
summation of a set of functions, now called Legendre polynomials — Pj(cosθ): 
f(θ) =                  
where j is an integer showing the rank of the polynomials. Pj(cosθ) denotes a standard 
set of functions with the terms of cosθ, cos2θ, cos3θ, and so on in response to rank j. 
<Pj> is the order parameter and is the average value of Pj(cosθ) over the normalized 
distribution f(θ). With fluorescence from a cylindrically symmetrical system like a 
muscle fibre, only the two first even-ranked order parameters: second-rank <P2> and 
fourth-rank <P4> can be obtained to describe the shape of the angular distribution of 
BR probes. The corresponding second and fourth Legendre polynomials: 




Thus, <P2> and <P4> represent the average of the corresponding Legendre 
polynomial functions over the probe orientation distribution. They imply the similarity 
of shapes between the general dipole distribution and these two even-rank polynomial 
functions (see Figure 2.6). The values of them depend on both the average 
orientation and dispersion of the probe population with respect to the fibre axis, and 
they are always between +1 and -0.5. Furthermore, they are both 0 when the probe 
orientations are isotropic. As shown in Figure 2.6, a positive <P2> indicates a parallel 
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preference of the average probe orientation relative to the fibre axis, whilst a negative 
<P2> shows a perpendicular preference. Therefore, an increase or decrease of <P2> 
indicates the axial angle θ has become more parallel or more perpendicular. Likewise, 
the value of <P4> works in a similar way, except it gives higher resolution information - 
a positive <P4> shows a more preferable probe orientations around 0° or 90° rather 
than those near 50°. 
 
Figure 2.6: Second and forth rank Legendre polynomials. θ is the angle between probe 
dipole and trabecular axis. SInce a trabecula is cylindrically symmetrical around its axis, 
the limitation of θ is considered ranging from 0° to 90°. The second and forth rank 
Legendre polynomials are: P2 (cosθ) = 0.5(3cos
2θ - 1) (in red) and P4 (cosθ) = (35cos
4θ - 
30cos
2θ + 3)/8 (in green). 
 
The fast probe motion mentioned above is an inevitable artefact that affects the 
values of the measured polarized intensities. This mobility of the probe can be 
accessed using another independent second-rank order parameter, <P2d>, referred to 
as the <P2> for fast motion, indicating the amplitude of the rapid probe motion. It is a 
property of the BR probes attached to a specific site on a protein (Dale et al., 1999). 
Therefore in this study, <P2d> was considered constant for each probe (C- or E-helix 
probe), and both of them were obtained from our group’s previous publications (Sun 
et al., 2009). Assuming the fluorophore moves within a symmetrical cylinder around 
its axis like wobbling in a cone on the timescale of fluorescence lifetime (ca 4ns), the 
semi angle of this cone (δ) can be used to describe the average amplitude of this 
θ 
Order Parameters 
  <P2> 
  <P4> 
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wobbling and determine the value of <P2d>: 
<P2d> = cosδ (1 + cosδ)/2 
The value of <P2d> ranges from 0 to 1.0, indicating two extreme conditions of the 
probe, unlimited rapid wobble as well as completely immobile. 
As the effect of the fast probe motion has been factored out by <P2d>, <P2> and 
<P4> can describe the average orientation distribution of angle θ between fluorophore 
dipole and trabecular axis independently. Also, they are linearly related with the probe 
populations within muscle cell (Sun et al., 2006). If a fraction f of probes have the 
orientation shown by order parameter <P2a>, and a fraction (1-f) of probes have 
another orientation with order parameter <P2b>, then the measured <P2> is simply f 
<P2a> + (1-f) <P2b>. 
Dale et al. (1999) showed that there was no specific form for either the orientation 
distribution or rapid motion of the probe, however some reasonable assumptions 
about the characteristics of the local probe motion has been taken into account to 
obtain these order parameters:  
1. The orientation distribution of the BR probe dipole is cylindrically symmetrical 
to the trabecular axis. 
2. The orientation distributions of the excitation and emission dipole moments 
are collinear. 
3. The probe moves within a symmetrical cylinder around its axis like wobbling in 
a cone, and this motion is fast (sub-nanosecond) compared with the timescale 
of fluorescence lifetime (nanosecond). 
4. The probe orientation is fixed within the protein, and the motions of a protein 
are trifling on the time scale of fluorescence lifetime. 
In this study, the polarized fluorescence intensities measured with our 
experimental set-up (described in Chapter 3) were used to calculate these Legendre 
polynomial order parameters according to the equations described by Dale et al. 
(Dale et al., 1999). The value of <P2d> in this project has been determined by our 
group’s previous publication — for C-helix probe <P2d> = 0.8625, for E-helix probe 
<P2d> = 0.9025 (Sun et al., 2009), therefore some modifications have been made to 
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the original equations to calculate <P2> and <P4> from polarized intensities recorded 
using only X-illumination pathway, the modified equations were provided by Dr. Luca 
Fusi (King’s College London) and Dr. Elisabetta Brunello (University of Florence). 
<P2> = Sd/<P2d> 
<P4> = 5 (G0+G2)/(3<P2d>
2)-2/3 
where Sd is the second-rank order parameter for the axial angle θ between probe 
dipole and fibre axis, whilst G is the correlation function for θ. They can be determined 
from the four corrected polarized fluorescence intensities obtained from the 





Sd = 1-3(I/2- ll
xIll/2-┴
xIll)/I 
















Notice that the normalized changes in <P2> and <P4> had the same Ca
2+ 
dependence in all conditions studied in this project, and detail results are presented 
only for <P2>, which can be measured with greater signal-to-noise ratio (Sun et al., 
2006). 
 
2.4.3 Modelling the orientation distribution of cTnC C- and E-helix 
 
Due to the dynamic property of the protein orientation in a symmetrical system like 
trabeculae, every cTnC in the fibre is not expected to adopt exactly the same angle 
relative to the fibre axis. Therefore, the orientation distribution of the probe dipole with 
respect to the fibre axis was estimated from <P2> and <P4> by fitting model orientation 
distributions with a Gaussian shape (Ferguson et al., 2003). 
Assuming f(θ) has a Gaussian shape with a mean peak angle θg and a standard 
deviation σ about the distribution of probe orientations, i.e. f(θ) = exp. –(θ-θg)
2/2σ2, 
where θ is the axial angle between probe dipole and trabecular axis. Unlike the 
previous models — “truncated Gaussians” which chop off the Gaussian shape at θ = 0° 
and 90° (Corrie et al., 1999; Ferguson et al., 2003; Hopkins et al., 2002), the present 
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model — “folded Gaussians” was not truncated at 0° or 90° since there is no physical 
reason to exclude the negative and > 90° axial angles. The cylindrical symmetry of the 
trabecular system, the bipolar organization of sarcomeres and the dipole nature of the 
probes allow the Gaussian distributions outside the set limit 0° < θ < 90° to be folded 
back into this region. The mean angle of the folded Gaussian distribution is θf, and it is 
not equal to θg (Julien et al., 2007). 
 
2.5 Experimental Protocols  
 
2.5.1 Sarcomere Length Measurements  
 
Sarcomere Length (SL) measurements were performed using the Y-illumination 
pathway of the experimental set-up (mentioned in Section 2.3.4 with full description in 
Chapter 3). The same laser was used as the light source for both the fluorescence 
polarization and SL measurements. SL was estimated from the position of the 
first-order laser diffraction pattern, and can be calculated according to the formula: 
SL = λ/sin(arctan(d/h)) 
where λ represents the wavelength of illumination source in μm, d is the distance 
between the 1st order diffraction and the 0th order in cm, and h equals to the distance 
between the trabeculae and the screen where the image of the diffraction pattern is 
presented in cm. 
With the trabeculae illuminated from behind by Y-illumination pathway, the 
sarcomere diffraction pattern was projected onto a “screen” mounted in front of the 
trabeculae. The screen used to show the diffraction pattern was made by paper card, 
with the 0th order marked in the middle. The position of the 1st order diffraction pattern 
corresponding to the SL from 1.9 μm to 2.5 μm at 0.1 μm intervals was calculated 
using the formula above, and marked on the screen. The image of the diffraction 
pattern on the screen was then used to set the desired SL (1.9 μm and 2.3 μm in this 
project). Additionally, when trabeculae showed faint or disordered diffraction pattern, a 
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blocker was inserted in the illumination path before the screen to reduce the intensity 
of the 0th pattern on the screen to make the 1st order diffraction more visible. 
 
2.5.2 Steady-state Measurements 
 
Steady-state polarization measurements were performed on trabeculae with 
BR-labelled cTnC by immersing muscle fibres in different solutions or at different SLs. 
As described in Section 2.3.4, the permeabilized trabecula with BR-labelled cTnC was 
transferred into a 70 μl glass trough and immersed in relaxing solution. Fibre was 
mounted via two aluminium T-clips between a force transducer and a fixed hook 
(schematic picture in Figure 3.2). SL was measured by laser diffraction pattern as 
explained in last Section, and fibre length was adjusted to SL 1.9 μm by hook 
separation before first activation. Fibre diameter was measured on the graduated 
scale of a 64x objective (Stemi SV 8, Zeiss, Germany) and ocular microscope. 
Force was measured and recorded by force transducer and, simultaneously, 
polarization fluorescence intensities were measured by illuminating trabeculae 
vertically from below with polarized laser light as described in Section 2.3.4. The 
processing and interpretation of the polarized fluorescence intensities were described 
in Section 2.4. 
The trabecula was activated at SL 1.9µm in activating solution preceded by 2 min 
incubation in pre‐activating solution at room temperature. It was necessary to induce 
fast Ca2+ diffusion into fibres. Maximal isometric force and fluorescence intensities 
were measured and recorded after steady-state force was established (<30s). The 
fibre was then transferred to relaxing solution followed by stretching the SL to 2.3 μm, 
and activated again. Force per cross-sectional area of the trabecula was calculated by 
dividing the obtained force (in mN) with the fibre cross-section area (in mm2), 
assuming that the trabecula has an elliptical shape, whereby the width-to-depth ratio 
of the fibre (varied from 1~2) was measured before mounting. The fibre was discarded 
if it had a slow force development or low force generation (<20mN/mm2). Polarized 
fluorescence intensities were used to obtain the order parameters and the Gaussian 
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orientation distributions of the probe dipole with respect to the fibre axis. 
When applicable, 1% or 4% Dextran was added into relaxing, pre-activating and 
activating solutions to investigate the effect of osmotic compression on trabecular 
force development (details see Chapter 6). 
 
2.5.3 Ca2+ Titration Measurements 
 
In order to determine whether different experimental conditions (i.e. changing 
SL, inhibiting active force, and osmotic compression of fibre diameter) altered 
the ability of cTnC to regulate contraction, the dependence of force and cTnC 
structure change (denoted by <P2> or θf, see Section 2.4 for details) on free 
[Ca2+] was measured using Ca2+ titration measurements. All measurements 
were taken in the same trough — the activating trough to avoid variance of the 
trough, whilst the remaining troughs were used to switch solutions. 
Similar to the steady-state measurements mentioned in previous section, each 
trabecula was first activated at SL 1.9µm in activating solution preceded by 2 min 
incubation in pre‐activating solution to calculate the force per cross-sectional area, 
followed by a continuous activation of the fibre by step increments of [Ca2+] from pCa 
9.0 to pCa 4.5. The trabecula was then washed in relaxing solution, adjusted to SL 2.3 
μm or changed to other experimental conditions, and activated again. The pCa 
solutions (listed in Table 2.2) were mixed up from the stock solutions on the day of 
experiment. Isometric force and fluorescence intensities were measured and 
recorded after steady-state force was established at each pCa. Typically, 
measurements were taken at least twice at each [Ca2+] and averaged. Maximum 
activated force was recorded before and after each series of activations. If the 
maximum force decreased by ≥ 20% at the end of the Ca2+ titration experiment, the 
data were not used. 
When applicable, 25 μM blebbistatin or 1% or 4% dextran was added into all 
solutions (including relaxing, pre-activating, activating and all pCa solutions). 
Trabeculae were incubated in the relaxing solution containing blebbistatin or dextran 
86 
  
for 10min to 30min to allow the reagent to diffuse into the fibre, the titration 
experiments were then repeated in the presence of blebbistatin or dextran (details in 
Chapters 5 and 6). 
The force and cTnC structure changes (represented by <P2> or θf) from each 
titration experiment were fitted to the Hill equation using non-linear least-squares 
regression: 
                        
where pCa is the negative log10 of the free Ca
2+ concentration — pCa = -log10[Ca
2+], 
pCa50 is the pCa corresponding to half-maximum force production or cTnC structure 
changes, and nH is the Hill coefficient representing the cooperativity of the Ca
2+ 
regulated muscle contraction (Ferguson et al., 2003). All values presented in this 
study are given as mean ± SEM except where noted, with n representing the number 






























In order to investigate the sarcomere length regulation of cardiac contractility, i.e. the 
Ca2+ dependence of troponin conformational change in response to sarcomere length 
change,  an in situ fluorescence polarization approach, FISS, has been used in this 
project. FISS provides an effective way to measure the motions of cTn with respect to 
fibre axis during the contraction in single cardiac trabecula (details see Section 2.2). 
Bifunctional rhodamine probes were introduced into the regulatory head of cTn, 
cross-linking cysteines in the C-helix of cTnC, and into the IT arm, cross-linking 
cysteines in the E-helix of cTnC (Figure 2.2). The polarized fluorescence from the BR 
probes were then used to measure the orientation change of each helix when Ca2+ 
binds to the regulatory sites and/or when SL changes. Building a new experimental 
set-up for FISS measurement was the first step in this project. 
The basic design of the experimental apparatus was to excite BR probes with 
polarized incident light through two alternative excitation pathways — X- and 
Y-illumination. The emitted fluorescence was then separated into parallel and 
perpendicular components with respect to the muscle fibre axis by beam-splitters and 
the intensities were collected and measured by two photomultipliers. This newly built 
optical set-up was similar to that described by Hopkins et al. (1998) which consists of 
two orthogonal illumination pathways to obtain additional information about the probe 
orientational distribution.  
It has been reported that the BR probe, even though attached with two points 
along a helix, is not completely rigid on the protein. It typically exhibits rapid 
orientational motion (“wobble”) with respect to the protein backbone. The timescale of 
the motion is fast (sub-nanosecond) compared with the fluorescence lifetime of 
rhodamine (~ 5-nanosecond). Therefore probe dipole orientation could be different 
between the moments of absorption and emission. Assuming the probe motion is 
cylindrically symmetrical about its average position, like wobbling in a cone, the extent 
of wobbling can be described by the semi angle δ of the cone (Irving, 1996) (see 
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Section 2.4.1 for details). To estimate the extent of this probe motion, i.e. the 
estimation of δ, polarized fluorescence intensities were measured using excitation 
light propagating perpendicular to the emission axis — Y-illumination pathway in 
addition to the one in-line with the emission axis — X-illumination pathway. The 
addition of a second illumination pathway allows the measurement of fluorescence 
intensities with different angle between the excitation and emission pathway. The 
estimation assumes that the probe has equal possibility to sample any angular 
position within the cone defined by the semi cone angle δ during the ~ 5-ns lifetime of 
rhodamine and that the protein domain to which it is attached has relatively slower 
inter-domain motion than the probe (Hopkins et al., 1998). 
Additionally, the new set-up was different to the fluorescence polarization 
microscope described by Brack et al. (2004) which had two orthogonal emission 
pathways instead of two illumination pathways to collect the parallel and 
perpendicular polarization simultaneously. The new set-up has been proved to give 
the same information as the previous one, but less expensive and difficult in terms of 
set-up building and maintenance (further discussed in Section 3.4). Figure 3.1 shows 
both the schematic representation and photograph of the new fluorescence 
polarization set-up. It consists of two parts: excitation optics, which allow the 
generation and modulation of linearly polarized laser light, and collecting optics, which 
allow the recording of the emitted polarized fluorescence. 
The acquired polarized fluorescence intensities were then used to obtain order 
parameters of the probe dipoles using the equations from Dale et al. (1999) to 
describe the orientation changes of the two major domains of the troponin core 
complex — the regulatory lobe and the IT arm, with respect to the actin axis on Ca2+ 














Figure 3.1: Fluorescence polarization set-up designed and built for the project. (A): 
Schematic diagram of the set-up. Excitation optics (Green) allow 532 nm laser light to 
illuminate the fluorophores on the BR-labelled fibre from below (X-illumination, solid) or 
from behind (Y-illumination, dashed). Dashed mirrors are inserted in the pathway for 
Y-illumination. The muscle fibre was mounted between a force transducer (right) and a 
fixed hook (left) under a binocular microscope. Collection optics (orange) collect the 
emitted fluorescence in-line with X-illumination, parallel and perpendicular components 
were separated by beam-splitters and each component was measured with the 
photomultiplier. (B): Photograph of the set-up showing the actual geometry. A full 
description of the set-up is in the text.  
 
3.2 Design and Building the Experimental Set-up 
 
3.2.1 Excitation Optics 
 
A continuous diode pumped solid state laser light (class G4, power 75 mW, model 
G4-60, Elforlight, UK) with the wavelength of 532 nm was used to illuminate the 
fluorophores in the trabeculae. It was initially polarized parallel to the fibre axis. Two 
heatsinks (Thermal Resistance 1.3°C/W, RS components, UK) were mounted 
underneath the laser head to remove waste heat (maximum 15W). To avoid reaching 
the photomultiplier tube saturation limit, the intensity of laser beam was attenuated by 
a set of absorptive filters and the gain factor of the photomultiplier was adjusted 
accordingly (explained in Section 3.2.2). Absorptive filters were mounted on a 
manually rotated filter wheel which provides a selection from six filters with the optical 
density (O.D.) value ranging from 0.2 to 4.0. Additionally, a second absorptive filter 
(O.D. = 2.0) was inserted in the pathway after the wheel when needed. For a typical 
BR-cTnC exchanged trabecula used in the project, an O.D. value of 2.0-3.0 was 
sufficient for achieving strong output fluorescence intensities without saturating the 
photosensors. The O.D. value of the filters is the negative of the common logarithm of 
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the transmission coefficient (O.D. = -log10(I1/I0), where I1 is the intensity of transmitted 
radiation and I0 is the intensity of the incident radiation) and it describes the reduction 
of intensity by reflecting or absorbing a portion of the radiation. A manually controlled, 
electronic shutter was inserted after the filters. It was opened only during data 
recording to minimise photobleaching. 
The polarization of the laser light was modulated by a Pockels Cell optical 
modulator (model M370, Conoptics, Danbury, CT, USA), which modulates the 
direction of polarization between parallel and perpendicular with respect to the 
trabecular axis through voltage control. The Pockels cell contains a static polarizer 
and a birefringent crystal. It was positioned in the pathway so the laser beam was 
centred on the input and the exit crystal faces to assure no deviation from its previous 
path.  The principal axis of the Pockels cell polarizer was aligned with the initial 
polarization of the laser light. Therefore, there was neither polarization change (i.e. 
parallel to the fibre axis) nor any retardation in the laser beam while no voltage signal 
was applied. Voltage control of the Pockels cell was manipulated using a computer 
software program Labview 2011 (National Instruments, Texas, USA) to generate a 
square wave analog output voltage signal to the birefringent crystal (details of 
Labview programs in Section 3.2.4). When switched between -1V to +1V at 100 kHz, 
the voltage signal altered the optical properties of the crystal. The crystal then acted 
as a half-wave plate to switch the polarization of the resultant light between parallel 
and perpendicular relative to the fibre axis. Precise linear alignment of the laser light 
and the Pockels cell was critical for the fully functioning of the set-up, failure to do so 
would lead to the incomplete separation of parallel and perpendicular polarizations by 
the beam-splitter prisms in the collecting path (defined in Section 3.2.2). 
The illumination pathway was divided into two orthogonal directions, i.e. X- and 
Y-illumination pathways. The transformation between each pathway was achieved by 
a flip mount (FM 90, Thorlabs, UK) which held a silver right angle prism mirror (5mm, 
Thorlabs, UK). The mirror was inserted for the Y-illumination pathway and removed 
for the X-illumination pathway (Figure 3.1). An isolated trabecula was then illuminated 
with a laser beam size approximately 300*60 µm either from below (X-illumination) or 
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from behind (Y-illumination), as shown in Figure 3.2. The addition of Y-pathway was 
necessary in the determination of rapid probe motion (i.e. the semi cone angle δ or 
<P2d>). However, for a given probe, no significant changes in <P2d> were observed 
during isometric contraction as suggested in previous studies (Ferguson et al., 2003). 
For the two probes used in this project, <P2d> has already been determined from our 
group’s previous work — for the C-helix probe, <P2d> = 0.8625; for the E-helix probe, 
<P2d> = 0.9025, suggesting the amplitude of such a motion is small (Sun et al., 2009). 
Provided the knowledge of <P2d>, polarized intensities were only recorded with 
X-illumination pathway, although Y-pathway was fully functional and used for SL 
measurement and future experiment. 
 
 
Figure 3.2: Schematic representation of illumination pathways. Cardiac trabecula was 
mounted in the glass trough via the connection between force transducer and fixed hook. 
A: Viewed from the front of the set-up, showing the X-pathway illuminated the fibre from 
below. B: Viewed from the side of the set-up, showing fibre was illuminated from two 
orthogonal directions. 
 
3.2.2 Collecting Optics  
  
After the BR fluorophores in the trabecula were excited by the polarized laser light 
from below (X-illumination), the emitted fluorescence was propagated vertically and 




was collected directly on top of the fibre in-line with the exciting light via a 10x 
objective (0.3 N.A., 16 mm working distance, Nikon). A dichroic mirror (565 nm, Long 
pass, Chroma technology, USA) was then inserted in the collecting pathway to divert 
a fraction of the emission light (wavelength under 565nm) to produce an image of the 
fibre on a screen for accurate alignment and positioning. Whilst the light transmitted 
through the dichroic mirror (> 565nm) passed a rhodamine emission filter (605-70 nm 
bandpass, Chroma technology, USA) above to selectively transmit the rhodamine 
fluorescence. Above the rhodamine filter, three broadband polarizing cube 
beam-splitters (25.4mm, 420-680 nm, Newport Corporation, UK), each fitted inside a 
4-port prism cage cube mount (30mm cage system cube, Thorlabs, UK), were used to 
separate the emitted fluorescence into parallel and perpendicular polarized 
components.  
After the emission beam entered the first cube prism, it was split into P-polarized 
light (transmitted) and S-polarized light (reflected). P light was polarized parallel to the 
incident plane (the plane spanned by the surface normal and the propagation vector 
of the incoming radiation) whilst S light was perpendicular, as shown in Figure 3.3. 
Ideally, the incident light would be split into two orthogonal, linearly and fully polarized 
outgoing beams. However, for the beam-splitter, only the transmitted component (P 
light) is fully polarized, the reflected one (S light) contains a mixture of polarization 
states. At least two beam-splitters were therefore necessary for the complete 
separation of the two components — a second cube mounted on the side of the first 
one was to purify the reflected S light (perpendicular) to a similar ratio as the 
transmitted P light (parallel). The third cube beam-splitter mounted above the first one 
in this set-up was inserted for the equivalent and accuracy of the experiments (Figure 
3.1). 
A convex lens (focal length 50mm, N-BK7 Bi-Convex Lens, Thorlabs, UK) was 
placed 5cm in front of each photomultiplier (PM) tube (H5784-20, Hamamatsu, Japan). 
It was used to focus the emission fluorescence of both components to a small dot on 
the PM window to minimize the artefact of small movements in the fluorescence 
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pathway. It was necessary since different regions of the PM window had different 
sensitivity — it’s decreasing towards the edge of the PM window.  
The fluorescence intensities of each component were then detected by the two PM 
tubes. Photomultipliers converted the electrical current signal of the polarized 
fluorescence into a voltage signal for analysis and processing with Labview (details in 
Section 3.2.4). Three independent order parameters <P2>, <P4> and <P2d> were then 
calculated from the measured intensities, representing the distribution of the 
orientational changes of the BR probes. 
Figure 3.3: Beam-splitter separates incident light into two orthogonal polarizations 
simultaneously — P-polarized light (transmitted) and S-polarized light (reflected). Only P 
light is fully polarized, whilst S light contains a mixture of polarization states. For fully 
separation of the two components, three beam-splitters were used in the project. 
 
3.2.3 The Microscope Stage 
 
As shown in Figure 3.4, the central part of the set-up where the muscle fibre was 
mounted is the microscope stage. It holds five glass troughs, a force transducer and a 
fixed holder. Changing of solutions during measurement was achieved by rotating 
















Figure 3.4: Photographs of the microscope stage. (A):  Five glass troughs on a copper 
plate were used to hold experimental solutions. Manually rotate trough stage to switch 
solutions. Fixed holder and force transducer were mounted on stages that can be 
adjusted by xyz translation stages. (B): The muscle fibre was mounted in one of the 


















3.2.3.1 Muscle fibre mounting  
After incorporating BR labelled hcTnC mutants into the permeabilized ventricular 
trabeculae (details in Section 2.3.3), aluminium T-clips were attached to both ends in 
relaxing solution (Table 2.1) containing 50% (v/v) glycerol on a cooling stage under a 
50x binocular microscope (Stemi SV 6, Zeiss, Germany). The dimension of the fibre 
was measured prior to the mounting. Trabeculae are not typically cylindrical, therefore 
the width and depth of the fibre were measured and used to calculate the fibre’s 
width/depth ratio.  
As described in Section 2.5.2, the fibre was then transferred into one of the five 
glass troughs– the loading trough on a manually rotated stage (details see next 
section). The trabecula was mounted via the connection between T-clips and hooks in 
relaxing solution. The trabecula was attached to a fixed hook at one end and to a 
strain gauge force transducer (250Hz resonance frequency, SI-KG7, World Precision 
Instruments, INC., USA) at the other end (Figure 3.2). In order to align the fibre, the 
microscope stage, the fixed hook and the force transducer can be adjusted 
individually in x, y, z directions by translation stages. 
Hooks were prepared by bending the sharp tip of JH pin to approximate 50°-60° 
with respect to the pin axis, then inserting the other end of the bended pin into a 30 
gauge needle (0.3x13mm, microlance 3, Becton Dickinson), which served as the lever 
of the hook. The two hooks were carefully aligned under a 64x binocular microscope 
(Stemi SV 8, Zeiss, Germany) to make sure the fibre axis was perpendicular to the 
optical axes. Separation of the hooks was used to set the sarcomere length of the 
fibre. The sarcomere length was measured by laser diffraction pattern, as explained in 
Section 2.5.1. In this study, the initial sarcomere length of the fibre was set to 1.9µm 
as it was just above the slack length of the fibre in relaxation. The width of the fibre 
was then read on the graduated scale of the 64x microscope, together with the 







The microscope stage contains five glass troughs on a copper plate, each holds 
different experimental solutions. The fibre was immersed into a solution by manually 
rotating the plate. Each of the five troughs has glass base and walls with the same 
size (7*4 mm) and was marked according to their usage – holding relaxing, 
pre-activating and activating solution. Each trough had a space of 2.5 mm between 
each wall to immerse the fibre (trough volume 70µl); whilst the loading trough has a 
distance of 3mm, more space makes handling fibre easier during mounting.  
For changing the solution, the plate was lowered, rotated and raised to immerse 
the stationary fibre in a different trough containing the required solution. The trabecula 
was in air for less than 2s. When measurements were taken, a glass cover slip was 
placed on top of the trough so the top surface was optically flat. During experiments, 
an electronic suction (12V) was used to clean the trough. 
 
3.2.3.3 Force Transducer 
The isolated trabecula was mounted in the trough via the connection between T-clips 
and two hooks. One of the hooks was attached to a strain gauge force transducer by a 
heat shrink tubing (3:1 shrink ratio, HIS-3, HellermannTyton, UK). During experiments, 
the force development of the fibre was measured by a force transducer. The SI-KG7 
force transducer used in this set-up is shown in Figure 3.5. An amplifier 
(SI-BAM21-LC, World Precision Instruments, INC., USA) was connected to the force 
transducer to output analog voltage signal to communicate with Labview (see next 
section for details). The output signal was proportional to the force that applied to the 
force transducer. It was buffered and multiplied by a factor of 1, 2, 5 or 10 to provide a 
better resolution for a minimal change in applied force, depending on the front panel 
gain switch setting. In this study, the x10 setting was often used since the tension 
signals were usually small. The force transducer was regularly calibrated before 




Figure 3.5: Direction of force detecting in SI-KG7 force transducer (orange arrows). For 
measurement of muscle fibre force development in this project, force transducer was 
mounted vertically with sensing direction horizontal (parallel with fibre axis). 
 
3.2.4 Data Generation and Acquisition – Labview Programs 
 
Computer software programs using Labview 2011 were written in-house to control the 
data acquisition (DAQ) board PCI-6251 (National Instruments, Texas, USA) which 
was installed in the computer to communicate with the Pockels Cell, photomultipliers 
and force transducer. A 68-pin shielded desktop connector block (SCB-68, National 
Instruments, USA) was used to provide analog input and output channels to connect 
the DAQ device and the instruments. Output channel ao 0 was used to generate 
analog voltage signals to switch the polarization direction of the incident light by the 
Pockels Cell. Input channels ai 0, ai 1 and ai 2 were used to acquire force and 
fluorescence intensities simultaneously from the force transducer and two 
photomultipliers, respectively.  
 
3.2.4.1 Pockels Cell Calibration 
To obtain a complete separation of the parallel and perpendicular polarized excitation 
light, the calibration of Pockels cell was performed on a daily basis. A ramp voltage 
signal ranging from -1 V to +1 V with a precision of 0.002V was generated using 
LabView to drive the Pockels cell, thus 1000 data points were generated to alter the 
polarization of the excitation light. Acquisition of intensities from the two 
photomultipliers was performed at the same time. The sampling rate of each channel 
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(number of data points collected per second per channel) was 100 kHz. The 
maximum and minimum intensities collected from both photomultipliers, together with 
the corresponding voltage signals generated to drive the Pockels cell, were measured 
and recorded. The voltages at which the photomultipliers detected the maximum 
parallel intensity and minimum perpendicular intensity were averaged (recorded as Vll) 
and considered to provide a maximum extinction ratio Illmax:I┴min for the parallel 
excitation light. Similarly, V┴ (the averaged voltage at which the photomultipliers 
detected the maximum parallel intensity and minimum perpendicular intensity) was 
recorded to obtain the maximum extinction ratio I┴max:Illmin in perpendicular 
excitation polarization. The Vll and V┴ were then used to form a square wave signal to 
drive the Pockels cell, enabling the switching between parallel and perpendicular 
polarizations of the excitation light.  
 
3.2.4.2 General Measurements 
After the determination of Vll and V┴, another Labview program produced a 200 Hz 
square wave voltage signal to the birefringent crystal of the Pockels cell to alter its 
optical properties. For the first half of a square wave cycle, the voltage input to the 
Pockels cell was Vll and the polarization of the excitation light was parallel relative to 
the fibre axis; and for the second half of the cycle, the input voltage was V┴, switching 
the polarization to perpendicular.  
Meanwhile, the polarized fluorescence intensity data were simultaneously 
collected from the two photomultipliers — the parallel photomultiplier (PMTll) for the 
emitted fluorescence polarized parallel to the fibre axis and the perpendicular 
photomultiplier (PMT┴) for the perpendicular polarization. The fluorescence from each 
photomultiplier was separated into two groups according to the polarization of the 
excitation light — the parallel and perpendicular excitation. The extractions were then 
averaged to obtain the fluorescence intensities: ll
xIll and ┴
xIll from the parallel 
photomultiplier, and ll
xI┴ and ┴
xI┴ from the perpendicular photomultiplier. The first (mI) 
and second subscript (In) denote the excitation and emission polarization respectively. 
The background signals were obtained prior to the measurements with the 
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illumination pathway blocked by a shutter (mentioned in Section 3.2.1). After 
subtracting the background signal and applying the correction factors explained in 
Section 2.4.1, the corrected fluorescence intensities were used to calculate order 
parameters to determine the orientation distribution of the BR probes (details in 
Section 2.4). 
Additionally, force development data was collected from the force transducer 
through channel ai 0 continuously for 0.5s in the same program. The average value — 
Mean Tension, together with the fluorescence intensities were shown in the front 
panel of the program. The program front panel and the description of the workflow are 
































AI 1        AI 2 
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Figure 3.6: Labview program for force and fluorescence intensity measurements. (A): 
Front panel of the program. Firstly, input Vll and V┴ values for the square wave generation, 
then choose the illumination pathways and measure background signal (Dark currency), 
followed by opening the shutter, measuring fluorescence intensities (mFn) and calculating 
the corrected intensities (mIn). Mean tension measured from force transducer is recorded 
simultaneously with the fluorescence intensities. All values are shown in the front panel. 
(B): Workflow of the program. Channel ao 0 generates a square wave voltage signal 
ranging from Vll to V┴, whilst fluorescence intensity signals output from channel ai 1 (PMTll) 
and ai 2 (PMT┴) are extracted into four groups of signals according to the polarization of 









F┴ from perpendicular photomultiplier.  
 
3.2.4.3 Force Measurements 
An additional program for the continuous detection of force development was written 
using only the force transducer-connected channel ai 0. There was no time limitation 
in the program. It was used to record the force trace of muscle activation in 
steady-state measurements (Figure 3.7). The calibration of the force transducer was 
regularly performed using this program (details in next section).  
 
Figure 3.7: Force trace recording of typical trabecula activation at pCa 4.5 using Labview 
program. Force is presented as the output voltage (V) from force transducer, further 




3.3 Force Transducer Calibration 
 
Before taking measurements, the force transducer and its amplifier were calibrated by 
applying different known mass weights to correlate the loaded force with its voltage 
output. In order to perform the calibration, the force transducer was unmounted from 
the stage (Figure 3.2), and mounted temporally on another stage to hold the force 
transducer in a position that allowed the lever and the hook to be vertically downward 
(Figure 3.8). In this way, when the weights were hung on the hook, the force sensing 
direction was the same as that in the steady-state measurements.  
                Force Transducer 
     Force Sensing Direction 
 
 
Figure 3.8: Mounting of force transducer for calibration. The force transducer was 
unmounted from its original stage on the set-up (with force sensing horizontal) and 
mounted on a temporary stage, which senses force vertically. Green arrows show the 
direction of force sensing. Five weights were used for calibration. Output voltage was 
recorded after the weight became motionless.  
 
The force transducer was calibrated for all four gain switches (x1, x2, x5 and x10). 
At each factor, a baseline reference point was set when the force transducer was 
un-loaded. Five weights with different mass (listed in Table 3.1) were suspended on 
the hook respectively. After the suspended weight became motionless, output voltage 
was measured and recorded using Labview program mentioned in 3.2.4.2. Each 
amplification factor was tested with the five mass three times to eliminate the error, 
the averaged output voltages were listed in Table 3.1. A linear relationship between 
force and output voltage was then established in each gain factor for calculation of 
force development (Figure 3.9).  
Temporary Stage 
Hook 
Known Mass Weight 
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Table 3.1: Force transducer calibration with five mass weights at gain factors x1, x2, x5 
and x10. Force was calculated by F = ma (mass times acceleration 9.8m/s
2
). Baseline 
point at each amplification factor was obtained before the weight was added. The output 
voltages of x2, x5 and x10 factors are approximately two, five and ten times of the value 
recorded in the x1 gain switch.   
 
Figure 3.9: The correlation between weights and output voltages for each amplification 
factor of the force transducer. Data were averaged from three repetitions at each 
amplification factor. The value of the slope (mN/V) was used for calculation of force 
development. In the study, x10 was most often used as the force signals from cardiac 














0 0 0 0 0 0 0 
1 95 0.931 0.294 0.589 1.452 2.903 
2 190 1.862 0.593 1.179 2.910 5.816 
3 272 2.666 0.843 1.682 4.153 8.288 
4 351 3.440 1.093 2.185 5.391 9.273 




3.4 Performance of the Experimental Set-Up 
 
3.4.1 Alignment of the Optical Pathway 
 
The alignment of the optical pathway and polarization axis was critical for the 
performance of the experimental set-up in FISS measurements. Imperfect alignment 
would result in light deviation, incomplete separation of the parallel and perpendicular 
excitations, unequal detection of the polarized fluorescence intensities etc.  
First, the laser beam was aligned horizontally with the initial polarization parallel 
to the fibre axis. The Pockels cell was positioned into the pathway to make sure there 
was no deviation of the laser light. The principal axis of the Pockels cell polarizer was 
aligned with the initial polarization of the laser light. Thus no polarization was switched 
in the laser light when no voltage applied to the Pockels cell. The optical devices were 
then inserted into the illumination and emission pathways one by one to assure the 
light that passed through was not deviated. 
The microscope stage where the muscle fibre was mounted was able to be 
moved in xyz directions using translation stages. Thus the fibre could be positioned 
and aligned to allow the excitation light to illuminate it from below, whilst the emission 
light to reach the objectives and other collecting optics in the centre. All the optics and 
PM tubes in the emission pathway were mounted on a stage and could be adjusted as 
one unit for accurate positioning. Once the alignment was completed, any movement 
in the illumination or emission pathway (except for the microscope stage) would 
require a precise re-alignment of the whole system. To test the performance of the 
set-up after alignment, calibration of the Pockels cell and optical pathway were 








3.4.2 Calibration of the Pockels Cell  
 
To ensure complete separation of the parallel and perpendicular excitations, the 
Pockels cell calibration was performed regularly. Using the Labview program 
described in Section 3.2.4.1, a ramp voltage signal ranging from -1 V to +1 V was 
delivered to the Pockels cell to obtain the voltages at which the maximum and 
minimum parallel and perpendicular fluorescence intensities were recorded. The 
Pockels cell ratio (Illmax:Illmin, I┴max:I┴min) varied between parallel and perpendicular 
components — about 180:1 in the parallel PM tube and 65:1 in the perpendicular. The 
reason for this differentiation was likely due to the alignment of the pathway after 
splitting the fluorescence was not equally precise. On the older set-up described by 
Brack et al. (2004), the typical Pockels cell ratio was 40:1. Therefore both ratios 
obtained here indicated a well aligned Pockels cell to achieve the maximum 
separation of the parallel and perpendicular excitations. 
Due to the factory setting for the Pockels cell, the input voltage signals below -0.6 
V or above + 0.6V were cut-off, although the whole range of -1 V to +1 V signal was 
generated by DAQ device. Therefore, the fluorescence intensity output from each 
photomultiplier was not a complete sine wave (Figure 3.10), although it did not affect 




Figure 3.10: Calibration of the Pockels cell. (A): voltage signals output from DAQ device 
(black) verses what Pockels cell received (red). The input -1 V~+1 V ramp signal was cut 
off due to  the factory setting of the Pockels cell to -0.6 V~+0.6 V. (B): The fluorescence 
intensity curves output from PMTll (black) and PMT┴ (red), corresponding to the 
incomplete signal (x-axis) of the Pockels cell. Although both curves are not complete, 
maximum and minimum intensities from each photomultiplier could be obtained at the 











3.4.3 Calibration of the Optical Pathway  
 
A daily calibration of the optical pathway was performed to correct for the differential 
transmittance of the exciting and emission light and the differences in photomultiplier 
sensitivity. A rhodamine slide (used to get the correction factors, explained in Section 
2.4) was used to measure the polarized fluorescence intensities to obtain the 
polarization ratio — xPll. Polarization ratio would be 0.50 if the set-up had equal 
transmittance for parallel and perpendicular excitation and emission light, and the 
rhodamine on the slide was completely isotropic and immobile. 
Using the Labview program described in 3.2.4.2, Vll and V┴ (determined from 
Pockels cell calibration), a square wave signal was delivered to perform polarization 
switch in the excitation light, and four fluorescence intensities were measured from 
illuminating the rhodamine slide. The polarization ratio from the rhodamine slide on 
the new set-up was 0.430. The lower signal in the ratio compared with that from the 
older set-up described by Brack et al. was possibly due to instrumental imperfections, 
incomplete immobilisation or anisotropic orientation of the rhodamine, or imperfect 
alignment of the pathway. However, the polarization ratio was similar to that obtained 
by group members from another set-up (0.446). Additionally, the order parameter <P2> 
obtained from muscle fibre experiments on the new set-up were in good agreement 
with our group’s previous data on other set-up (Sevrieva, 2014), indicating the new 
set-up was in a condition to provide reliable results in the measurements, and that the 
Pockels cell ratio was sufficient to separate the parallel and perpendicular excitations. 
After the removal of the rhodamine slide, the background calibration was also 
performed mainly to examine the transparency of the optical pathway, i.e. whether 
there was stain on the trough or whether the mirror was clean etc. The ideal intensity 










The new set-up was built differently from the older one in the group described by 
Brack et al. (2004), which had two orthogonal emission pathways: X-emission — 
in-line with the illumination pathway, and Y-emission — at 90° with the excitation light.  
As described in Section 3.1, the reason of adding Y-pathway was to estimate the 
amplitude of the fast probe motion (δ or <P2d>) experimentally (Hopkins et al., 1998). 
For a cylindrically symmetric model like cardiac trabecula, the measured fluorescence 
polarization intensities that have at least one parallel polarization (llIll, llI┴ and ┴Ill) are 
identical for X- and Y-pathway, the only difference is ┴I┴. As shown in Figure 2.5, 
among the eight intensities that can be obtained from X- and Y-illumination pathway, 
only ┴
yI┴ has the excitation and emission polarization in orthogonal direction. 
According to the equations by Irving (1996), ┴
xI┴ and ┴
yI┴ are independent intensities. 
The difference between these two can be used to estimate the semi-angle of the 
probe wobble — δ. Therefore, to describe the fast probe motion, fluorescence 
intensity measurements need to be taken with different angles between the excitation 
and emission pathway. Either Y-illumination or Y-emission can provide this 
information. 
Compared with the addition of Y-emission pathway, Y-illumination was preferred 
in the new set-up for two main reasons. Firstly, it was more durable, efficient and 
affordable. Instead of mounting another collecting optics, Y-illumination was 
comprised by a series of right angle mirrors. Secondly, even though in this project it 
was not necessary to determine the value of <P2d> (obtained from our group’s 
previous publication), Y-illumination was also used as the light source for SL 
measurement using first-order diffraction pattern. Since switching between the X- and 
Y-illumination pathways was performed by a manually controlled mirror bearer, the 
measurements from both pathways could not be taken simultaneously. Therefore 












Effects of Sarcomere Length on 







Contraction of heart muscle is triggered by a rise in intracellular calcium ions. Ca2+ 
binding to cTnC leads to a series of structural rearrangements in the thin filament that 
allows myosin heads to bind and generate force. Our group’s previous investigations 
(Sun et al., 2009) on the molecular mechanism of Ca2+ regulation have reported that 
the Ca2+ activation-induced structural changes in the C- and E-helix of cTnC have the 
same Ca2+ dependence as force production, indicating the force production was 
linearly related to the structural change in cTnC upon activation. The C- and E-helices 
of cTnC are located in the regulatory head and the IT arm of the cTn complex, 
respectively. Thus the combination of the orientation changes from both helices 
represents the structural change in cTn complex upon Ca2+ binding (Sun et al., 2009). 
The similar force-[Ca2+] and troponin structural change-[Ca2+] relationships indicated 
similar Ca2+ sensitivity for both force and cTnC structural change in Ca2+ activation.  
  As the Ca2+ binding protein, cTnC has long been considered a significant 
modulator of the Ca2+ sensitivity. Therefore, the coupling between force production 
and cTnC structural change, together with that between the Ca2+ sensitivity for force 
and cTnC structural change might imply the impact of cTnC in cardiac muscle 
regulation. 
As the cellular basis of the Frank-Starling relationship, both maximum force 
production and the Ca2+ sensitivity for force increase with increased SL. Thus, it is 
reasonable to assume that these two outcomes of LDA are regulated by the 
SL-dependent changes in cTnC.  
Therefore, in this study, we first investigated the possibility of cTnC in sensing the 
SL change to modulate maximum force and the Ca2+ sensitivity. Here, we used a 
polarized fluorescence technique called FISS (Section 2.2) on an experimental set-up 
(Chapter 3) that was built for the project to study the role of the thin filament protein 
cTnC in LDA. The advantage of this method is that it allows simultaneous 
measurements of force and cTnC structural change in the native environment of a 
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working heart muscle cell on the timescale of a heartbeat. The investigations were 
performed through the continuous activation of the cardiac trabeculae by step-wise 
increased [Ca2+] at two different SLs — 1.9 and 2.3 μm.  
 
4.2 Effect of SL on Force Development 
 
4.2.1 Effect of SL on Resting and Maximum Ca2+-activated Force 
 
The effect of SL on force development was investigated by steady-state force 
measurements in permeabilized cardiac trabeculae from rat ventricle at SLs ranging 
from 1.9 μm to 2.3 μm. The SLs were chosen according to the working length in the 
ascending limb of the cardiac length-tension curve (see Section 1.5.1). SL 1.9 μm and 
2.3 μm represent lengths just above slack and optimally stretched, respectively. The 
SL was carefully set by adjusting the separation between two hooks according to laser 
diffraction pattern (Section 2.5.1). At each SL, force was measured and recorded after 
it was steadily established at relaxation and maximal Ca2+ activation. Thus, both 
resting tension (passive tension) and maximum Ca2+-activated force were obtained at 
each SL. Maximum Ca2+-activated force was defined as the difference between 
maximum force level and resting tension, indicating the actual force development 
upon Ca2+-activation. SL was measured before and after each activation to ensure the 
resting tension and maximum activated force were obtained at the same SL. Force 
per cross-sectional area (mN/mm2) was calculated to minimise the individual variation 
(i.e. fibre size and shape). For comparison, both resting and maximum Ca2+-activated 
force at different SLs were normalized to the maximum activated force produced at 
initial SL (1.9 μm) in each trabecula. The averaged data were used to plot force-SL 















Figure 4.1: Effect of SL on force development. Relative force is the difference between 
measured force and resting tension, represents the active force (the maximum 
Ca
2+
-activated force in this case) developed upon Ca
2+
-activation. (A): unexchanged 
trabeculae, n = 6, force was normalised to the maximum force produced at 1.9 μm. Blue 
squares represent resting tension, purple squares are relative force. Force development 
of unexchanged fibre was measured and recorded from SL 1.9 μm to 2.3 μm at 0.1 μm 
intervals. (B): BR-cTnC exchanged trabeculae, n = 8, data were pooled from both C- and 
E-helix probes exchanged preparations (data from each helix probe were not significantly 
different, details see Table 4.2). Force was normalised to the relative force produced at 
1.9 μm. Blue squares denote resting tension, purple squares are relative force.  
 
(B)                           
(A)                           
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To determine the influence of cTnC reconstitution, steady-state force 
measurements were performed on both unexchanged and BR-cTnC exchanged 
trabeculae. For unexchanged trabeculae, measurements were taken at SL 1.9 μm to 
2.3 μm at 0.1 μm intervals. As shown in Figure 4.1 (A), both resting and maximum 
Ca2+-activated tensions are linearly proportional to the SL within the physiological 
working range of cardiac sarcomeres. At SL 2.3 μm, maximum Ca2+-activated force 
increased 35 ± 7% (± SEM, n = 6) compared to that at 1.9 μm, whilst resting tension 
increased to 29 ± 3% (± SEM, n = 6) of the active force level at 1.9 μm (see Table 4.1 
A). The increasing resting tension upon stretching may be due to the regulation of the 
giant protein titin (Granzier and Irving, 1995; Wu et al., 2000). 
Unlike unexchanged trabeculae, the steady-state force measurements on the 
exchanged fibres, where the native cTnCs were reconstituted with BR-labelled 
hcTnC-C or –E, were performed at SL 1.9 μm, 2.1 μm and 2.3 μm (Figure 4.1 (B)). 
Similarly, both resting tension and relative force increased linearly in response to SL 
stretching, with a total increasing of 31 ± 4% (± SEM, n = 8) in resting tension and 41 
± 2% (± SEM, n = 8) in relative force from SL 1.9 μm to 2.3 μm (see Table 4.1 B). 
These values were not significantly different from those in unexchanged fibres, 
indicating the incorporation of BR-labelled cTnCs does not affect the SL dependent 
force increase. The force-SL relations in Figure 4.1 (B) was plotted using data from 
both C- and E-helix probes; the separate data are shown in Table 4.2. At SL 2.3 μm, 
resting tension increased 29 ± 5% (± SEM, n = 6) for the C-helix probe and 36 ± 3% (± 
SEM, n = 2) for the E-helix probe, whilst maximum Ca2+-activated force showed an 
increase of 40 ± 2% (± SEM, n = 6) and 47 ± 2% (± SEM, n = 2) for the C- and E-helix 
probes, respectively. Results from BR-cTnC-C and -E did not show significant 
difference compared either with each other or with measurements in unexchanged 
trabeculae, indicating the SL dependence of force is not affected by either BR-cTnCs 






Table 4.1: Steady-state force measurement parameters for (A): unexchanged trabeculae, 
n = 6; (B): BR-cTnC exchanged trabeculae, n = 8 (n = 6 for BR-cTnC-C and n = 2 for 
BR-cTnC-E). Measurements in exchanged fibres were performed at 1.9, 2.1 and 2.3 μm. 
Active force describes the maximum Ca
2+
-activated force produced in addition to the 
resting tension at each SL. Both resting and active tensions were normalized to the 
maximum Ca
2+
-activated force produced at SL 1.9 μm for each trabecula. Both force per 
cross-sectional area and normalization were presented. Mean ± SEM. Comparison: 
paired two-tailed student t-test (force at 1.9 μm vs at 2.3 μm) (statistical significance 
*p<0.05). Unpaired t-test between unexchanged and exchanged data was not significant 
(not shown). 
Unexchanged 
fibre (n = 6)  
Resting Tension  Active Force 
SL(μm) mN/mm
2
 Normalised   mN/mm
2
 Normalised  
1.9  0 0 29.3 ± 5.3 1.00 ± 0.00 
2.0  0.9 ± 0.3 0.04 ± 0.01 31.5 ± 6.1 1.06 ± 0.03 
2.1  2.9 ± 0.7 0.10 ± 0.01 34.1 ± 6.7 1.15 ± 0.04 
2.2  7.2 ± 3.3 0.24 ± 0.07 34.4 ± 6.3 1.18 ± 0.05 
2.3  8.6 ± 1.6 0.29 ± 0.03 40.8 ± 7.6 1.35 ± 0.07 
Δ 29 ± 3%* 35 ± 7%* 
#





, n = 8)  
Resting Tension  Active Force  
SL (μm) N/mm
2
 Normalised   mN/mm
2
 Normalised   
1.9 0 0 25.5 ± 2.3 1.0 ± 0.0 
2.1 2.1 ± 0.3 0.1 ± 0.0 32.3 ± 3.5 1.3 ± 0.1 
2.3 7.9 ± 1.4 0.3 ± 0.0 35.9 ± 3.1 1.4 ± 0.0 





Table 4.2: Steady-state force measurement parameters for (A): C-helix and (B): E-helix 
BR-probes. Active force describes the maximum Ca
2+
-activated force generated in 
addition to the resting tension at each SL. Force was normalized to the maximum 
Ca
2+
-activated force produced at SL 1.9 μm for each trabecula. Both force per 
cross-sectional area and normalization were presented. Mean ± SEM. Comparison: 
paired two-tailed student t-test (*p<0.05). 






1.9 0 0 26.7 ± 2.9 1.0 ± 0.0 
2.1 1.9 ± 0.4 0.1 ± 0.0 35.0 ± 4.1 1.3 ± 0.1 
2.3 8.0 ± 1.9 0.3 ± 0.0 37.2 ± 3.9 1.4 ± 0.0 











E-helix (n = 2)  Resting Tension  Active Force  
SL (μm) mN/mm
2
 Normalised   mN/mm
2
 Normalised  
1.9 0 0 21.7 ± 1.9 1.0 ± 0.0 
2.1 2.4 ± 0.6 0.1 ± 0.0 24.3 ± 1.2 1.1 ± 0.0 
2.3 7.8 ± 0.1 0.4 ± 0.0 31.8 ± 3.1 1.5 ± 0.0 





Together with the data from unexchanged fibres, results showed linear 
relationship between SL and force development in cardiac muscle. In response to SL 
elongation from 1.9 μm to 2.3 μm, the maximum Ca2+-activated force increased ~40% 
of that at 1.9 μm (P0), whilst passive tension increased by ~30% P0. Incorporation of 
BR-labeled cTnCs had no effect on this relationship. This was in good agreement with 
the previous studies on LDA (Dobesh et al., 2002; Kentish et al., 1986; Martyn and 
Gordon, 2001) 
Additionally, force traces from a steady-state measurement of force development 
at SL 1.9 μm and 2.3 μm are shown in Figure 4.2. Figure was directly exported from 
Labview program where the force signal was detected from the force transducer, thus 
represented by voltage values. Resting tension was recorded in relaxing solution 
before activation. Stretching SL from 1.9 μm to 2.3 μm increased resting tension from 
0.120 V to 0.230 V, which can be converted to an increase from 2.2 mN/mm2 to 4.3 
mN/mm2 (cross-sectional area 17275 μm2) according to the calibration of the force 
transducer x10 gain prior to the measurements (details in Section 3.3). Maximum 
Ca2+-activated force was calculated as the difference between the maximum 
measured force and the resting tension. The maximum Ca2+-activated force of the 
representative fibre in Figure 4.2 increased about 28% (from 1.13 V to 1.455 V, equals 
to 21.0 mN/mm2 to 27.0 mN/mm2) upon SL increasing from 1.9 μm to 2.3 μm. The 
increasing was slightly smaller compared to the results above and it was likely due to 
fibre variation.  
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Figure 4.2: Force traces from the steady-state measurement of a representative fibre at 
SL 1.9 μm and 2.3 μm. Trabecula reconstituted with BR-cTnC-C was activated at SL 1.9 
μm and 2.3 μm. Trace recording started after setting SL and finished after maximal 
activation. Resting tension was developed by stretching the fibre, and maximum 
Ca
2+
-activated force (active tension in the figure) was indicated by the difference between 
maximum force level and resting tension (green arrow). Force traces were directly 
exported from Labview program, thus force signal was described as voltage signal. Force 
values in mN/mm
2
 can be found in the text. 
 
4.2.2 Effect of SL on the Ca2+ Dependence of Force Development 
 
To determine the effect of SL variation on the Ca2+ dependence of force development, 
Ca2+ titration experiments were performed in skinned trabeculae at the two SLs 
described above — 1.9 μm and 2.3 μm. Permeabilization allows the control of free 
1.9 μm             
2.3 μm          
(s)             
 
(s)             
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[Ca2+] using EGTA buffers. Free [Ca2+] was expressed on a logarithmic scale, as pCa 
= -log10[Ca
2+]. Trabecula reconstituted with either BR-cTnC-C or BR-cTnC-E was 
continuously activated by a stepwise increase in [Ca2+] (from pCa 9.0 to maximum 
activated at pCa 4.5) at SL 1.9 μm (as the control group) and 2.3 μm, respectively. 
The SL was carefully set according to diffraction pattern and was checked before and 
after each series of continuous activation. At each SL, Ca2+-activated force was 
measured after steady-state was established at each pCa, and plotted as a function of 
free [Ca2+]. Ca2+-activated force was calculated as the force production above the 
resting tension. It was then normalized to the maximum Ca2+-activated force at each 
SL to reduce the biological variation (i.e. shape, size of the fibre) between trabeculae. 
Maximum Ca2+-activated force was recorded at maximal Ca2+ activation (pCa 4.5) at 
each SL. Data from individual fibres at each SL were fitted by modified Hill 
relationship — Y = 1/(1+10nH(pCa-pCa50)), where pCa50 (corresponding to the pCa at half 
maximum force) describes the Ca2+ sensitivity and Hill coefficient-nH (the steepness of 
the force-pCa relationship) describes the cooperativity of Ca2+ regulation. The 
average parameters are summarized in Table 4.3.  
After stretching SL from 1.9 μm to 2.3 μm, maximum force increased 31 ± 6% (± 
SEM, n = 5) and 24 ± 3% (± SEM, n = 5), respectively, for trabeculae reconstituted 
with BR-cTnC-C and BR-cTnC-E (Table 4.3), inducing a leftward shift of the force-pCa 
curve (Figure 4.3). This is consistent with the previous studies, for example, Dobesh 
et al. (2002), which reported an average increase of 9% of the maximum 
Ca2+-activated force in response to per 0.1 μm SL elongation within the physiological 
range. Results were also in agreement with the maximum force measurements 
described in Section 4.2.1, suggesting the development of maximum activated force 
is proportional to SL in cardiac muscle, although the SL dependent force increases in 
titration experiments were smaller than that in Fmax measurements (~30% in Ca2+ 
titration vs ~40% in Fmax measurements). This may be the result of some minor 















Table 4.3: Hill parameters for the effect of SL on the Ca
2+
 dependence of force 
development. (A). C-helix probe experiments; (B). E-helix probe experiments. Mean ± 
SEM of the parameters obtained by fitting parameters for each trabecula at each SL. Fmax 
indicates the force per cross-sectional area of the maximum Ca
2+
-activated force. Δ 
describes the difference between two SLs. Comparison: paired two-tailed student t-test 




Mean ± SEM  1.9 μm 2.3 μm Δ 
Fmax (mN/mm
2
) 24 ± 1  32 ± 2  31 ± 6%* 
pCa
50
 5.37 ± 0.04 5.50 ± 0.03  0.12 ± 0.01***  
n
H  4.01 ± 0.19 4.29 ± 0.24   0.27 ± 0.08*  
n  5  
 
E-helix 
Mean ± SEM  1.9 μm 2.3 μm Δ 
Fmax (mN/mm
2
) 22 ± 5  27 ± 6  24 ± 3%*  
pCa
50
 5.37 ± 0.02 5.49 ± 0.03  0.11 ± 0.02**  
n
H  4.05 ± 0.24 4.45 ± 0.26  0.40 ± 0.07**  
n  5  
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Figure 4.3: Effect of SL on the Ca
2+
-dependence of force development. Force was plotted 
as a function of pCa at SL 1.9 μm (red solid squares) and 2.3 μm (blue solid squares) for 
(A). C-helix probe; (B). E-helix probe. Red and blue lines indicate the fittings by Hill 
equation at SL 1.9 μm and 2.3 μm, respectively. Error bars denote S.E.M. Trabeculae 
number n = 5 for both C- and E-helix probes (Hill parameters are provided in Table 4.3). 
 
Increasing SL in fibres reconstituted with BR-cTnC-C resulted in a leftward shift 
of the force-calcium relationship (Figure 4.3 A), indicated by an increasing in pCa50 
(the pCa at half-maximum force) from 5.37 ± 0.04 to 5.50 ± 0.03 (± SEM, n = 5). The 
steepness of the Ca2+ dependence (nH), increased by 0.27 ± 0.08 (± SEM, n = 5) 
when the SL was increased (Table 4.3 A). However, the increase in nH was quite small 
when compared with the highly cooperative Ca2+ regulation, denoted by a Hill 
coefficient close to 4. 
(A) 
C-helix     
(B) 
E-helix     
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A similar situation was also observed for BR-cTnC-E. Increasing SL from 1.9 μm 
to 2.3 μm induced a leftward shift of the force-pCa curve (Figure 4.3 B), indicated by a 
significant increase in pCa50 from 5.37 ± 0.02 to 5.49 ± 0.03 (± SEM, n = 5) (Table 4.3 
B). The cooperativity of the Ca2+-dependent change in force (nH) was increased by 
0.40 ± 0.07 (± SEM, n = 5) at longer SL (Table 4.3 B). 
Taken together, as SL was increased, both the maximum Ca2+-activated force 
and the Ca2+ sensitivity for force were increased. The increase in Ca2+ sensitivity upon 
SL stretching was similar for both labelled helices (~0.11pCa units, Table 4.3), 
indicating a similar length dependent behaviour in the force-[Ca2+] relationship in the 
two major domains of cTn complex. 
 
4.3 Effect of SL on cTnC orientation 
 
4.3.1 Effect of SL on In Situ Orientation of cTnC 
 
Investigations were then focused on the physiological Ca2+-sensor — cTnC.  
Measurements were taken simultaneously in the same set of ventricular trabeculae as 
that in force-[Ca2+] measurements, where the native cTnC was reconstituted with 
BR-labelled hcTnC-C or hcTnC-E. The native structural relationships between the full 
complement of proteins in the regulatory system are preserved (Sun et al., 2009). The 
orientation of the BR probes, thus of the C- or E-helix of cTnC to which it was attached, 
was determined by polarised fluorescence (see Section 2.2). As mentioned in Chapter 
2, the C- and E- helix probes were used to report changes in the orientation of the two 
major domains of the troponin core complex in the regulation of Ca2+-dependent 
activation — the regulatory head and the IT arm. 
The in situ orientation changes of the C- and E-helix of cTnC were determined 
during relaxation (pCa 9.0) and maximal Ca2+ activation (pCa 4.5) at SL 1.9 μm and 
2.3 μm, respectively. The Ca2+-induced orientation changes in cTnC are thought to be 
primarily associated with the movement of B and C helices away from the N, A and D 
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helices in response to the Ca2+binding and the switch peptide of cTnI binding to the 
N-lobe of cTnC (Sun et al., 2006; Sun et al., 2009). The order parameters <P2> and 
<P4> were calculated from the fluorescence polarization to describe the orientation 
distribution of the BR dipoles with respect to the fibre axis. A Gaussian model was 
used to acquire the peak angle θf and standard deviation σg of these dipole orientation 
distributions (Julien et al., 2007) (data reported in Table 4.4. For details about order 
parameters and Gaussian model, see Section 2.4). 
At SL 1.9 μm, the C-helix had a more parallel orientation with respect to the fibre 
axis at relaxation (θf = 51.9 ± 0.4°, ± SEM, n = 5) compared with at maximum 
activation (θf = 55.5 ± 0.2°), corresponding to the <P2> values 0.104 ± 0.004 and 
0.028 ± 0.004 at relaxation and maximum activation (Table 4.4 A). Stretching to a 
longer SL at 2.3 μm slightly reduced C-helix’s axial angle θf during both relaxation 
(~51.9° at 1.9 μm vs ~51.3° at 2.3 μm) and activation (~55.5° at 1.9 μm vs ~55.0° at 
2.3 μm) by shifting towards more parallel conformations, although the shifting of the 
relaxing orientation was not statistically significant. Yet the overall orientation changes 
of the C-helix from pCa 9.0 to pCa 4.5 were not significantly affected by SL alteration, 
indicated either by Δ<P2> (0.076 ± 0.006 at SL 1.9 μm, 0.075 ± 0.006 at 2.3 μm) or Δθf 
(3.6° ± 0.2° at both SLs). Figure 4.4 A gives a more direct comparison of the in situ 
orientation of the C-helix during relaxation and maximum activation at both SLs. 
Although these orientation changes were small, they were highly reproducible. 
Additionally, there was no significant change in the probe dispersion σg upon either 




Table 4.4: Parameters for the effect of SL on cTnC in situ orientation change. A. C-helix probe experiments; B. E-helix probe experiments. Order 
parameters <P2> and <P4> were obtained during relaxation and maximum activation. θf and σg indicate the peak angle and standard deviation of the 
Gaussian orientation distribution of the probe angle with respect to the fibre axis, respectively (indicated in the text and Section 2.4). Mean ± SEM. Δ is 
the difference of each parameter between pCa9.0 and pCa4.5. n = 5 for both BR-cTnC-C and -E. Comparison: paired two-tailed student t-test between 
SL 1.9 and 2.3 μm (statistical significance * p<0.05, ** p<0.01).  
C-helix  




























pCa 9.0 0.104 ± 0.004 -0.132 ± 0.028  51.9 ± 0.4 18.8 ± 1.4 0.111 ± 0.006  -0.168 ± 0.025  51.3 ± 0.3  16.8 ± 1.2 
pCa 4.5  0.028 ± 0.004 -0.145 ± 0.022  55.5 ± 0.2 17.7 ± 1.2 0.036 ± 0.003*  -0.158 ± 0.028 55.0 ± 0.2*  17.1 ± 1.5 
Δ  0.076 ± 0.006 0.013 ± 0.019 -3.6 ± 0.2   0.075 ± 0.006 -0.010 ± 0.006 -3.6 ± 0.2   
n  5  
E-helix  


























pCa 9.0  0.259 ± 0.008 -0.155 ± 0.046  44.4±0.4 15.9 ± 2.1 0.277 ± 0.009*  -0.207 ± 0.034*  43.8 ± 0.3*  13.1 ± 1.6*  
pCa 4.5  0.182 ± 0.007 -0.205 ± 0.038  47.9±0.3 14.7 ± 1.8 0.208 ± 0.008**  -0.232 ± 0.028 46.8 ± 0.3**  13.2 ± 1.3   
Δ  0.077 ± 0.010 0.050 ± 0.010 -3.6±0.5   0.069 ± 0.005 0.025 ± 0.008 -3.0 ± 0.2   










The orientation of the E-helix had a more parallel preference compared with the 
C-helix (Table 4.4 B). Similarly, at SL 1.9 μm, maximum activation shifted E-helix 
towards a slightly more perpendicular conformation: decreasing <P2> by 0.077 ± 
0.010 (± SEM, n = 5), or increasing θf by 3.6 ± 0.5° (± SEM, n = 5). However, 
increasing SL to 2.3 μm induced a small but significant increase in <P2> values at 
both pCa 9.0 (from ~0.259 to ~0.277) and pCa 4.5 (from ~0.182 to ~0.208), indicating 
a more parallel conformation of the E-helix at longer SL at both relaxed and activated 
state. Interestingly, the net angular change from relaxation to maximum activation at 
each SL (Δ<P2> or Δθf, see Table 4.4 B and Figure 4.4 B) was very similar (Table 4.4 
A). It was not affected by SL either, as in the case of the C-helix probe. The standard 
deviation of the E-helix probe σg decreased slightly at pCa 9.0 after stretching, but did 
not show significant change at pCa 4.5. The slightly bigger standard error in <P2> 
values for the E-helix probe was likely due to a greater fibre to fibre variation in the 
<P2> of BR-cTnC-E, thus a bigger spread in the mean, while Δ<P2> remained 
relatively constant. 
Although increasing SL caused small changes in the orientation of both C- and 
E-helix of cTnC at either relaxation or maximum activation state, the results above 
reported no significant impact of SL alteration on the amplitude of cTnC orientation 
change upon Ca2+ activation. The results indicate that as one of the two outcomes of 
LDA, the SL-dependent increase of maximum force is not likely due to more cTnC 
structural change upon Ca2+ activation.    
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Figure 4.4: Effect of SL change on cTnC in situ orientation. Bar Charts show <P2> upon 
activation and SL alteration. (A): C-helix probe; (B): E-helix probe. Green and red bars in 
each set represent <P2> value at relaxation (pCa 9.0) and maximum activation (pCa 4.5), 
respectively. First set in each graph is at SL 1.9 μm, second at 2.3 μm. Error bars denote 
SEM. n = 5 for each probe. Statistical significance of differences between values from two 
SLs for each probe was assessed using paired two-tailed student t-test: *p< 0.05, 
**p<0.01 (<P2> values are presented in Table 4.4). 
 
4.3.2 Effect of SL on the Ca2+ Dependence of cTnC Orientation 
 
In order to determine the effect of SL on the Ca2+ dependence of cTnC orientation 





C-helix     
(B) 







simultaneously with isometric force development in the Ca2+ titration experiments 
described in Section 4.2.2. The SL was set to 1.9 μm and 2.3 μm for the continuous 
activation in each permeabilized trabecula. In situ orientation was determined from 
the fluorescence polarization of the BR dipole attached along C- or E-helix of cTnC 
using FISS, and was described by the order parameter <P2>, which gives the same 
relationship to [Ca2+] as that of the mean axial angle θf (Figure 4.5). <P2> from each 
titration was recorded and plotted as a function of free [Ca2+], which was represented 
by pCa (-log10[Ca
2+]). <P2>-pCa relationship was fit by Hill equation for each fibre at 
each SL, the curve was set through the maximum and minimum of <P2> values, while 
pCa50 and nH were acquired from the average of each individual fitting (reported in 
Table 4.5).  
 
Figure 4.5: The Ca
2+
-dependent C-helix orientation change at SL 1.9 μm, showing the 
consistency of θf (left axis, cross in the circle) and <P2> (right axis, red circles) in terms of 
representing the in situ orientation changes in cTnC. Black and red lines are the Hill fit of 
pCa-θf and pCa-<P2> curve respectively. Error bars are omitted here for clarity. n = 5. 
 
The stretching of the SL in skinned trabeculae reconstituted with BR-cTnC-C 
from 1.9 μm to 2.3 μm induced a shift of the <P2>-pCa curve (Figure 4.6 A). As 
described above, although stretching to a longer SL slightly increased <P2> value at 
pCa 4.5, the overall orientation change of the C-helix was not significantly affected by 
SL increasing, indicated by the similar amplitude of the <P2>-pCa relationship at both 
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SLs (Δ<P2 > ~0.076 at 1.9 μm vs ~0.075 at 2.3 μm, Table 4.4 A and Table 4.5 A). 
When SL increased from 1.9 μm to 2.3 μm, the Ca2+ sensitivity for C-helix orientation 
change increased from pCa50 5.37 ± 0.02 to 5.48 ± 0.01, showing a ΔpCa50 of 0.11 ± 
0.02 (± SEM, n = 5), which is similar to what was observed for the force development 
(ΔpCa50 = 0.12 ± 0.01, ± SEM, n = 5, see Table 4.3 A). Although there was a tendency 
to increase the cooperativity of the Ca2+-dependent C-helix orientation change upon 
stretching (ΔnH = 0.10 ± 0.19, ± SEM), it was not statistically significant as that in the 
force-pCa relationship (ΔnH = 0.27 ± 0.08, ± SEM) (Table 4.3 A and Table 4.5 A). The 
<P2>-pCa relationship was less steep than what was observed for the force-pCa 
relationship at both SLs. The reduction in nH for <P2> was found in the E-helix probe 
experiments as well. Detailed comparison of force-pCa and <P2>-pCa relationship for 
the E-helix probe is presented in next section. 
Unlike BR-cTnC-C, the <P2>-pCa relationship for BR-cTnC-E had a small 
additional component in the subthreshold of pCa, which was similar in both SLs 
(Figure 4.6 B) (for details in terms of the additional orientation component of the 
E-helix, see next Section 4.3.3). The major component of the E-helix orientation 
change upon pCa<6.0 was fitted to the Hill equation. Increasing SL to 2.3 μm showed 
an increase in the <P2> values over the whole range of pCa (Figure 4.6 B). Although 
there was an increase in <P2> at both pCa 9.0 and 4.5, SL elongation had no 
significant effect on the amplitude of E-helix’s orientation change during activation 
(Δ<P2> ~0.077 at 1.9 μm vs ~0.069 at 2.3 μm, see Table 4.4 B and 4.5 B). As 
anticipated, stretching SL increased the Ca2+ sensitivity for E-helix orientation change 
by increasing pCa50 from 5.34 ± 0.02 to 5.45 ± 0.02, with a overall ΔpCa50 of 0.11 ± 
0.03 (± SEM, n = 5) (Table 4.5 B). The increase in Ca2+ sensitivity corresponds well to 
that observed for force development in the same set of trabeculae (Table 4.3 B), and 
to that for the C-helix probe experiments (Table 4.5 A). However, the increased SL 
appeared to show a tendency towards reduced cooperativity for the Ca2+-dependent 
change in the E-helix orientation (ΔnH = -0.36 ± 0.41, ± SEM, n = 5), opposite to the 
increasing Hill coefficient for the C-helix probe, although these changes of nH in 
response to stretching observed in the <P2>-pCa relationship for both C- and E-helix 
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probes were not statistically significant (Table 4.5).  
 
Table 4.5: Hill parameters for the effect of SL on the Ca
2+
 dependence of cTnC orientation 
change. (A): C-helix probe experiments; (B): E-helix probe experiments. Parameters were 
obtained by fitting data for each trabecula at each SL. Δ<P2> represents the orientation 
change from relaxation to maximum activation. Mean ± SEM. n = 5 for both BR-cTnC-C 
and –E exchanged trabeculae. Δ indicates the difference in each parameter from SL 1.9 to 
2.3 μm. Comparison: paired two-tailed student t-test between two SLs (statistical 
significance * p<0.05, ** p<0.01). 
C-helix  
  








> pCa 4.5 0.028 ± 0.004 0.036 ± 0.003*    
Δ<P
2
>  0.076 ± 0.006 0.075 ± 0.006   
pCa
50 
 5.37 ± 0.02 5.48 ± 0.01**  0.11 ± 0.02**  
n
H 









> pCa 9.0 0.259 ± 0.008 0.277 ± 0.009*    
<P
2
> pCa 4.5 0.182 ± 0.007 0.208 ± 0.008**    
Δ<P
2
> 0.077 ± 0.010 0.069 ± 0.005   
pCa
50
 5.34 ± 0.02 5.45 ± 0.02*  0.11 ± 0.03*  
n
H 



















Figure 4.6: Effect of SL change on the Ca
2+
 dependence of cTnC orientation change. <P2> 
values were plotted as functions of pCa at SL 1.9 μm (red circles) and 2.3 μm (blue 
circles), respectively. (A): C-helix probe; and (B): E-helix probe. Red and blue lines 
indicate the fitting by Hill equation for 1.9 μm and 2.3 μm, respectively. Error bars denote 
SEM. Trabeculae number n = 5 for each helix probe. (Hill parameters are provided in 
Table 4.5). 
 
4.3.3 Ca2+ Regulation of Force and cTnC Orientation 
 
As mentioned above, the Ca2+-dependence of force and cTnC orientation were 
investigated simultaneously in the same set of trabeculae using Ca2+ titration 
experiments, where the force development, together with the orientation change in 
either helices were measured and plotted as functions of pCa. As shown in Figure 4.7, 
(A) 
C-helix     
(B) 
E-helix        
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force and <P2> from averaging individual fibre were fitted to Hill equation. Since <P2> 
is inversely related to force, in order to compare the force development and 
orientation change from the same trabeculae, <P2>-pCa was plotted inversely and the 
scale was adjusted accordingly in the second graph of each group in Figure 4.7 and 
all <P2>-pCa curves in this thesis. Force was normalised to the one produced at 
maximal Ca2+-activation, whilst the <P2>-pCa curve was set through the maximum 
and minimum of <P2> values. pCa50 and nH were determined from the mean of each 
individual fitting.  
As mentioned in last section, for BR-cTnC-E, unlike the Ca2+-dependent force 
development, the orientation change had an additional component in the lower range 
of [Ca2+], i.e. pCa 9.0 to pCa 6.0, where the changes in <P2> was at opposite direction 
compared with in the higher [Ca2+] (pCa 6.0 to pCa 4.5) (Figure 4.7). The additional 
orientation component has been previously observed for the E-helix probe and 
mono-functional probes on Cys-84 of cTnC (Bell et al., 2006; Sun et al., 2009). Of the 
three Ca2+ binding sites on cTnC, two high affinity sites (Ca2+/Mg2+) are in the C-lobe 
of cTnC, whilst one low affinity site is in the N-lobe and specific for Ca2+ (details in 
Section 1.2.2.3).  Possibly, the additional component is associated with Ca2+ binding 
to the Ca2+/Mg2+ sites in the C-lobe near the E-helix. According to the Ca2+ binding 
affinities for the cTnC sites calculated by Kobayashi and Solaro (2005), the majority of 
Ca2+-Mg2+ exchange (~85%) at high affinity sites occurs between pCa 9.0 and pCa 
7.0 (Bell et al., 2006), which could be partly responsible for the offset between the 
Ca2+ dependence of the E-helix orientation change and force development.  
The similar shape of force-pCa and <P2>-pCa curves in each group suggests 
similar Ca2+ sensitivity (pCa50) and cooperativity (nH) in the Ca
2+ dependence of force 
development and cTnC orientation change, indicating that the orientation change in 
cTnC upon Ca2+ binding, together with the subsequent force development, have 
essentially the same Ca2+ dependence. SL variation did not affect this similarity 
between force and cTnC. Thus, there is a simple relationship between cTnC 
orientation change and force development — with the increasing [Ca2+], force is 
linearly related to the Ca2+-induced orientation changes in cTnC at each SL. This is in 
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agreement with previous investigations (Sun et al., 2009), suggesting that force 
development is proportional to the fraction of cTnC molecules in the Ca2+-binding 
state. However, the SL-dependent increase in maximum force was not accompanied 
by the increasing amplitude of cTnC structural change upon activation. More 
importantly, the results showed similar increase in the Ca2+ sensitivity for both force 
and cTnC structural change in response to SL elongation, suggesting the 
SL-dependent increase in the Ca2+ sensitivity for force is very likely modulated by 














Figure 4.7: The Ca
2+
 dependence of force and structural changes in cTnC at two SLs. 
Force (solid black squares) and orientation changes (solid purple circles) for the C- or 
E-helix probe from the same set of trabeculae (n = 5 for both probes) were plotted as 
functions of pCa at two SLs — 1.9 μm and 2.3 μm. Black and purple lines are fits of the 
Hill equation to force and <P2> respectively. Relative force was normalised to the 
maximum Ca
2+
-activated force at each SL in each fibre. Error bars denote S.E.M. for n = 5 
trabeculae for each helix probe. In the 2
nd
 figure of each group, <P2> values were plotted 
inversely and the scale was adjusted accordingly so the <P2>-pCa relationship follows the 
force-pCa relationship very closely. Error bars are omitted in the 2
nd




















4.4.1 Role of cTnC in LDA 
 
In this chapter, we investigated the role of the Ca2+ binding protein cTnC in the two 
outcomes of LDA — the SL-dependent maximum force and Ca2+ sensitivity. 
Increasing SL from 1.9 μm to 2.3 μm caused ~40% increase in the maximum 
Ca2+-activated force in skinned cardiac trabeculae. No significant difference was 
observed in the SL-dependent force increase between BR-cTnC exchanged and 
unexchanged fibres (Table 4.1), nor between BR-cTnC-C and BR-cTnC-E exchanged 
trabeculae (Table 4.2). The resting tension increased ~30% upon SL increasing from 
1.9 μm to 2.3 μm, which was largely regulated by the elastic titin. Titin spans the full 
half of the sarcomere and it has interactions with both the thick and thin filaments. The 
increased resting tension suggests the increased titin strain might be correlated with 
positioning cross-bridges, so as to increase the probability of myosin heads binding at 
longer SL, thus increase the maximum Ca2+-activated force.  
However, the ~40% maximum force increase at SL 2.3 μm was not accompanied 
by the increasing amplitude of cTnC structural change upon activation. Structural 
changes in cTnC upon Ca2+ activation were reported by BR probes on the C- and 
E-helix of cTnC, corresponding to the changes in the angle θf between each helix and 
the trabecular axis. Although increasing SL showed small effect on the orientation of 
each helix with respect to the fibre axis, the net orientation change upon maximum 
activation (represented by either Δ<P2> or Δθf) was independent of SL change, 
suggesting the SL-dependent increase in the maximum activated force was not due to 
the increased structural changes in cTnC. However, the small effect on the orientation 
of each helix upon SL stretching may imply the possibility of a reorientation of cTnC 
on the thin filament, inducing a closer proximity with the switch peptide of cTnI. In this 
way, the increasing cTnC/cTnI interactions at longer SL may result in an increasing 
Ca2+ sensitivity. The amplitude of each helix’s orientation change upon activation was 
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~3.6° at both SL 1.9 and 2.3 μm (Table 4.4). It was smaller than previously reported 
(~5°) (Sun et al., 2009), possibly due to the difference in the exchange and titration 
protocols between studies.  
As mentioned above, the additional component of E-helix orientation change 
observed in the subthreshold range of [Ca2+] at both SLs may be associated with Ca2+ 
binding to the Ca2+/Mg2+ site in the C-lobe of cTnC near the E-helix. This independent 
motion of the C-lobe of cTnC at lower [Ca2+] altered the relative conformation between 
the two lobes of cTnC. It may be related to the system preparing for the interactions 
between cTnC and cTnI prior to the Ca2+ binding to the N-lobe and the subsequent 
Ca2+-induced structural change in troponin.  
Titration experiments on the Ca2+ dependence of force and cTnC structural 
change showed an almost identical leftward shift of the force-pCa and <P2>-pCa 
curves upon SL changing from 1.9 μm to 2.3 μm, indicative of a similar SL-dependent 
change in pCa50 (Ca
2+ sensitivity) and nH (Ca
2+ cooperativity) of force and orientation 
change for both C- and E-helix probes. Increasing SL increased the Ca2+ sensitivity 
for force and both C- and E-helix orientation change by a similar amount of 0.11 pCa 
units (Table 4.3 & Table 4.5). Thus, it is reasonable to conclude that the mechanism 
underlying the SL-dependent Ca2+ sensitivity for force and cTnC structural change is 
the same.  
Additionally, current experiments showed that the steepness (nH) of the force-pCa 
relationship had a small increase in response to SL increasing, whereas that of the 
cTnC structural change-pCa relationship did not change significantly. As described 
before, the cooperativity of Ca2+ regulation is not driven by the feedback of 
cross-bridge attachment, rather, it is more likely to be the intrinsic property of the thin 
filament itself. Ca2+ binding cooperatively induces Tm movement in adjacent RUs, 
leads to the structural change of neighbouring cTnC, and exposes more sites for 
myosin heads to bind and generate force.  
Based on this theory, Farman et al. (2010) reported that it was the number of the 
RUs able to bind Ca2+ that most affects LDA. Their findings indicated the coupling 
between neighbouring RUs upon Ca2+ binding was enhanced at longer SL, thus 
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allowing the impact of Ca2+ binding to propagate further along the thin filament with 
the assistance by weak binding cross-bridges, which ultimately transmit to the strong 
binding and generate force. Presumably, the influence of SL would have the same 
effect on the Ca2+ cooperativity of force production and cTnC structural change by 
stronger coupling of the adjacent RUs. However, titin may also play a role in the 
SL-dependent regulation of cooperativity. As increasing SL strains the titin molecule, 
the straining may affect the relative conformation between myosin heads and actin 
monomers which favours the weakly attached heads. It has been suggested that the 
fully open conformation of cTnC was stabilized by strong-binding cross-bridges. In 
this case, the opening in cTnC will not be as substantial as that induced by the 
cooperative coupling of RU. The effect of cooperativity to couple the structural change 
of cTnC in adjacent RUs may not be as efficient as to couple the formation of 
cross-bridges in neighbouring sites. Yet the weak binding cross-bridges are capable 
of further shifting towards the strongly bound force-generating conformation. Thereby, 
no significant increase was observed in the cooperativity for cTnC structural change 
upon SL increasing, by contrast to the small increase in that for force. 
Therefore, the results in this chapter showed that, even though with the 
increasing [Ca2+], force generation was still coupled to cTnC structural change at each 
SL, the SL-dependent increase in maximum force was not accompanied by the similar 
increase in the amplitude of cTnC structural change upon Ca2+ activation. However, 
the SL-dependent increase in the Ca2+ sensitivity was very similar for both force 
production and cTnC structural change, suggesting the two outcomes of LDA 
(increasing maximum force and Ca2+ sensitivity) are not both related with cTnC. While 
the SL-dependent Ca2+ sensitivity for force is very likely modulated through the Ca2+ 
sensitivity for cTnC structural change by cTnC, the SL-dependent maximum force is 
not. It was suggested that this SL-dependent increase in the maximum force was the 
result of an increasing number of force-generating cross-bridges formed at longer SL 
(Allen and Kentish, 1985; Wannenburg et al., 2000; Wannenburg et al., 1997), which 




4.4.2 Comparison with Previous Studies 
 
As the cellular basis of the Frank-Starling relationship, LDA describes the effects of 
sarcomere lengthening on both the maximum force production and the Ca2+ sensitivity 
on the level of cardiomyocytes. In this study, we found ~40% increase in the maximum 
force in response to SL increasing from 1.9 to 2.3 μm. The result was in good 
agreement with the previous studies, which concluded that: at a given [Ca2+], SL 
increasing was accompanied by significant increase in the force development; and it 
was the SL-dependent increase in the maximum force production that contributes to 
the rising ventricular pressure in the heart. For instance, the investigation by Kentish 
et al. (1986) has shown that the average maximum force increased ~87% as SL 
increased from 1.65 to 2.15 μm in skinned cardiac trabeculae experiments. Dobesh et 
al. (2002) reported the averaged maximum force development increased ~9% for 
each 0.1 μm increase in SL. The various amounts of force increase among different 
studies may be due to different experiment protocols applied in each study: force 
production at different SLs was determined from different groups of trabeculae in 
Kentish et al. (1986), whereas determined from the same group of trabeculae in 
Dobesh et al. (2002) and our study. 
    However, we found this SL-dependent increase in the maximum force was not 
accompanied by the similar increase in the amplitude of cTnC structural change upon 
activation, at variance with the previous conclusions that both force and 
activation-dependent changes in cTnC structure were influenced by SL (Martyn and 
Gordon, 2001). The results indicate that there may not be a certain relationship 
between force development and structural change in cTnC upon activation at different 
SLs. The SL-dependent maximum force increase is more likely to due to increasing 
number of force-generating cross-bridges than increasing extent of cTnC 
conformation change at longer SL. 
A total angular change of only ~3.6° in each helix upon maximum Ca2+-activation 
was reported in this study. This seems to be at variance with the measurements 
previously done on isolated cTnC, which demonstrated a change of 12° in the 
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opening of the N-lobe on Ca2+ binding alone, and 34° after the subsequent binding of 
the cTnI switch peptide (Li et al., 1999; Sia et al., 1997). However, the two probes 
used here did not necessarily measure the extent of N-lobe opening. The small 
angular change with respect to the fibre axis does not exclude the possibility of an 
azimuthal motion around the axis, which may result in a substantial opening in the 
N-lobe. To characterise this, further investigation using probes on other sites of cTnC 
are needed.  
The similar Ca2+ sensitivity for force production and cTnC structural change at 
either SL1.9 or 2.3 μm was consistent with our group’s previous experiments (Sun et 
al., 2009), in which the [Ca2+] for half maximum force production and half cTnC 
structural change at SL 2.1 μm was not significantly different. The similarity was not 
affected by SL. The Ca2+ sensitivity for both force and cTnC structural change 
increased similar amounts as SL increased from 1.9 to 2.3 μm. Thus, with the 
increasing SL, the increased Ca2+ sensitivity for force, as one of the two outcomes of 
LDA, was linearly related to the increasing Ca2+ sensitivity for cTnC structural change. 
In conclusion, the present results are to a large extent consistent with the 
previous studies of LDA. We have shown a ~40% increase in the maximum 
Ca2+-activated force upon SL increasing from 1.9 μm to 2.3 μm, together with ~0.11 
pCa units increase in the Ca2+ sensitivity for both force and cTnC structural change. 
The present results also showed that the SL-dependent increase in the maximum 
force was not due to the increase in the extent of cTnC structural change upon 
activation. Yet, the SL-dependent Ca2+ sensitivity was very likely to due to the 
modulation of the Ca2+ sensitivity for cTnC structural change in the thin filament. 
Further investigations in terms of the effect of thick filament in LDA by inhibiting the 













Role of Force-generating 






5.1 Introduction  
 
Previous studies have shown that the SL-dependent modulation of maximum force 
production largely depends on alterations in the number of force-generating 
cross-bridges with varied SL (Allen and Kentish, 1985). The role of cross-bridges in 
the other outcome of LDA — the SL-dependent Ca2+ sensitivity, on the other hand, 
has been of particular interest for researchers lately, yet still remains controversial. 
Therefore, our next focus moved onto the thick filament, investigating the role of 
force-generating cross-bridges in the SL-dependent Ca2+ sensitivity, determining 
whether the two outcomes of LDA are regulated by the same mechanism through 
cross-bridges. 
  In our group’s previous study (Sun et al., 2009), the formation of force-generating 
cross-bridges was inhibited using a myosin binding inhibitor — blebbistatin. The 
results have shown that the widely-accepted concept of myosin binding switching on 
the thin filaments (keeping Tm in the clear position, thus favouring a Tn conformation 
with higher Ca2+ affinity) only occurred in rigor-like conditions. Under physiological 
conditions, the thin filament activation is driven by Ca2+ binding-induced cTn structural 
change, which leads to Tm movement and cross-bridges formation. Also, inhibition of 
active force by blebbistatin slightly reduced the Ca2+ sensitivity, with no significant 
effect in the cooperativity of cTnC structural change and force production upon 
activation. These results suggested that the highly cooperative Ca2+ regulation of 
cardiac muscle contraction is not due to the force-generating cross-bridges, but an 
intrinsic property of the thin filaments — the coupling between Tm molecules in 
adjacent RUs along the thin filament. Thus, it showed that myosin binding does not 
contribute significantly in the Ca2+ regulation of cardiac contractility.  
  The conclusions were at variance with the previous ones, which suggested that 
force-generating cross-bridges play a dominant role in cooperatively regulating the 
Ca2+-cTnC affinity through controlling the amount of cTnC structural change upon 
activation (Hofmann and Fuchs, 1987a; Martyn et al., 2001; Wang and Fuchs, 1994). 
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The discrepancies could be due to the different inhibitors applied in these studies: the 
25 μM blebbistatin used in our group’s study is a more specific inhibitor than the 
millimolar vanadate used in the previous studies (Hofmann and Fuchs, 1987a; Martyn 
et al., 2001; Wang and Fuchs, 1994). Blebbistatin binds to the actin-binding cleft of 
myosin with high affinity, preventing the strong binding of myosin heads to actin 
(Allingham et al., 2005; Straight et al., 2003), inhibiting the ATPase activity of 
actin-myosin interactions (Kovacs et al., 2004), thus inhibiting the active force 
development in cardiac muscle contraction (Dou et al., 2007; Farman et al., 2008) 
(Figure 5.1). Vanadate, on the other hand, has been reported to have non-specific 
effect on other sarcomeric proteins: it extracts TnC from skeletal muscle (Agianian et 
al., 2004; Allhouse et al., 1999), and extracts both cTnC and cTnI from cardiac muscle 
(Strauss et al., 1992). Thus, conclusions drawn from the previous studies using 
vanadate may not have been entirely due to the inhibition of myosin binding. 
  Therefore, in this chapter, in order to investigate the role of force-generating 
cross-bridges in the two outcomes of LDA, especially the SL-dependent Ca2+ 
sensitivity, we examined the Ca2+ dependence of cTnC structural change at two SLs 
— 1.9 and 2.3 μm after inhibiting active force by 25 μM blebbistatin. 
 
Figure 5.1: (A): Chemical structure of the myosin binding inhibitor — blebbistatin; (B): 
Protein structure of the location of blebbistatin in cardiac myosin. Figure has been taken 





5.2 Effect of Force Inhibition on cTnC Orientation 
 
In order to determine the role of force-generating cross-bridges on the orientation 
change of cTnC upon Ca2+ activation, skinned trabeculae exchanged with either 
BR-cTnC-C or BR-cTnC-E were bathed in experimental solutions with 25 μM 
blebbistatin to prevent the strong binding of myosin heads to actin. In this chapter, 
together with the Ca2+ dependence of cTnC structural change, the in situ orientation of 
cTnC at two extreme states — relaxation and maximum activation were acquired from 
the same set of Ca2+ titration experiment described in Section 2.5.3. Trabeculae were 
continuously activated from pCa 9.0 to 4.5 at SL 1.9 μm at first (as the control group). 
Followed by 30mins of incubation in relaxing solution containing 25 μM blebbistatin, 
the same fibre was then undergone a second round of Ca2+ titration in the presence of 
blebbistatin. Incubation allows the diffusion of blebbistatin into fibre. After incubation, 
the maximum activated force was reduced by 94 ± 1% (± SEM, n = 7) for BR-cTnC-C 
and by 95 ± 1% (± SEM, n = 8) for BR-cTnC-E compared to that in the absence of 
blebbistatin. As described in Chapter 4, the orientation changes of cTnC were 
determined from the fluorescence polarization of the BR dipole attached along C- or 
E-helix of cTnC using FISS, and was described by order parameters <P2> and <P4>. 
A Gaussian model was used to acquire the mean axial angle θf and standard 
deviation σg of these dipole orientation distributions (data reported in Table 5.1). 
<P2>-pCa relationship was fit by Hill equation for each fibre with and without 
blebbistatin. The curve was set through the maximum and minimum of <P2> values.  
 
5.2.1 Effect of Force Inhibition on the In Situ Orientation of cTnC 
 
In agreement with the results from last chapter (Table 4.4), upon maximum activation, 
both the C- and E-helices of cTnC were slightly shifted towards more perpendicular 
conformations with respect to the trabecular axis at SL 1.9 μm. The orientation 
change was indicated by a decrease in <P2> value (Δ<P2>) of 0.076 ± 0.003 (± SEM, 
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n = 7) for the C-helix probe and 0.089 ± 0.006 (± SEM, n = 8) for the E-helix probe. 
These reductions in <P2> values were consistent with the small increases in θf of 3.8 ± 
0.2° (± SEM, n = 7) and 4.6 ± 0.4° (± SEM, n = 8) for the C- and E-helix probe, 
respectively (Table 5.1).  
Inhibition of active force showed some non-significant effect on the orientation of 
the C-helix at either pCa 9.0 or pCa 4.5. The net angular change from relaxation to 
maximum activation was depressed after the addition of blebbistatin, indicated by a 
decrease in either Δ<P2> from 0.076 ± 0.003 to 0.066 ± 0.004, or Δθf from 3.8 ± 0.2° to 
3.3 ± 0.2° (± SEM, n = 7) (Table 5.1 A). The ~0.5° reduction in the total orientation 
change of the C-helix upon Ca2+-activation after force inhibition was small but 
statistically significant, suggesting the strong-binding of myosin heads enhances the 
orientation change of the C-helix upon Ca2+-activation. Additionally, the standard 
deviation of the Gaussian distribution σg for the C-helix probe showed no significant 
change either upon activation or in the presence of blebbistatin (Table 5.1 A).  
Unlike the C-helix, the orientation of the E-helix has been reported to be more 
sensitive to the feedback from myosin heads binding (Sun et al., 2009). The 
conformation of the E-helix at both relaxation and maximum activation was perturbed 
by active force inhibition. As presented in Table 5.1 B, blebbistatin increased <P2> 
significantly at both pCa 9.0 and pCa 4.5 causing a decrease in θf from ~44° to ~43° 
at relaxing and from ~49° to ~47° at activating state. These results showed that the 
inhibition of myosin heads binding induced a shift in the E-helix towards a more 
parallel conformation with respect to fibre axis. The decrease in θf for the E-helix 
probe was consistent with the previous study by Sun et al. (2009). As in the case of 
the C-helix probe, the overall orientation change for the E-helix upon Ca2+-activation 
was hindered by the presence of blebbistatin as well: Δ<P2> was reduced from 0.089 
± 0.006 to 0.075 ± 0.004 (± SEM, n = 8), whilst Δθf decreased by about 0.8° to 3.8 ± 
0.2°(± SEM, n = 8). Likewise, there was no significant change in the E-helix probe 




Table 5.1: Parameters for the effect of force-generating cross-bridges on cTnC in situ orientation change. (A): C-helix probe experiments; (B): E-helix 
probe experiments. Order parameters <P2> and <P4> were obtained at pCa 9.0 and 4.5 using FISS. θf and σg respectively indicate the peak angle and 
standard deviation of the Gaussian orientation distribution of the probe angle with respect to the fibre axis (indicated in the text and Section 2.4). Mean 
± SEM. Δ is the difference of each parameter between pCa9.0 and pCa4.5. n is the number of trabeculae in experiments. Comparison: paired two-tailed 
student t-test between no blebbistatin and 25 μM blebbistatin (statistical significance * p<0.05, ** p<0.01, ***p<0.001, ****p<0.0001). 
  
 C-helix  


























pCa9.0  0.086 ± 0.002 -0.140 ± 0.018  52.7 ± 0.2 18.3 ± 0.9 0.081 ± 0.005 -0.147 ± 0.015 52.9 ± 0.3 17.9 ± 0.8  
pCa4.5  0.010 ± 0.002 -0.138 ± 0.020 56.5 ± 0.3 17.9 ± 1.1 0.014 ± 0.002 -0.135 ± 0.015 56.2 ± 0.2 18.0 ± 0.8 
Δ  0.076 ± 0.003 -0.002 ± 0.006 -3.8 ± 0.2   0.066 ± 0.004**  -0.011 ± 0.005 -3.3 ± 0.2*    
n  7  
   
E-helix  


























pCa9.0  0.258 ± 0.009 -0.073 ± 0.013  44.1 ± 0.5 20.0 ± 0.6 0.280 ± 0.010***  -0.080 ± 0.011  43.1 ± 0.5***  19.0 ± 0.5  
pCa4.5  0.169 ± 0.007 -0.116 ± 0.010  48.7 ± 0.3 19.0 ± 0.5 0.205 ± 0.006****  -0.126 ± 0.012  46.9 ± 0.3****  18.1 ± 0.6  
Δ  0.089 ± 0.006 0.043 ± 0.010 -4.6 ± 0.4   0.075 ± 0.004**  0.046 ± 0.009 -3.8 ± 0.2**    






Thus, the results indicate that inhibiting the formation of force-generating 
cross-bridges significantly affects the net angular change in both helices of cTnC 
upon activation. In good agreement with the studies reported by Sevrieva (2014), 
these results highlight the important role of cross-bridges in stabilising the 
conformational change of cTnC. Investigations by Zhou et al. (2012) have shown the 
strong binding of myosin heads stabilised the association of the switch peptide of cTnI 
to the hydrophobic patch on cTnC by keeping the inhibitory region off of actin via 
pushing Tm, thus shifting the equilibrium towards an open conformation for the N-lobe 
of cTnC. Detailed data are summarised in Table 5.1. Figure 5.2 gives a more direct 
comparison of the in situ orientation transitions of the C and E-helix of cTnC from 
relaxation to maximal activation in the absence and presence of blebbistatin.  
 
 
Figure 5.2: Effect of active force inhibition on cTnC in situ orientation. (A): C-helix probe; 
(B): E-helix probe. Green and red bar in each set represent <P2> value at relaxation (pCa 
9.0) and maximum activation (pCa 4.5), respectively. First set in each graph is before the 
addition of blebbistatin, second is in the presence of blebbistatin. SL has been set to 1.9 
μm in this experiment. Error bars denote SEM. n = 7 for BR-cTnC-C and n = 8 for 
BR-cTnC-E. Statistical significance of differences between the <P2> values in the 
absence and presence of blebbistatin for each helix probe was assessed using paired 
two-tailed student t-test: ***p< 0.001, ****p<0.0001 (<P2> values in Table 5.1). 
 
C-helix                             E-helix 





5.2.2 Effect of Force Inhibition on the Ca2+ Dependence of cTnC 
Orientation 
 
The Ca2+ dependence of cTnC orientation change was examined using the titration 
experiments. As shown in Figure 5.3 A, active force inhibition had a tendency of 
reducing <P2> value at the lower range of [Ca
2+] (pCa 9.0 to pCa 5.5), reflected in a 
small increasing in axial angle θf, whilst shifted the <P2>-pCa curve slightly towards 
relaxed value at higher [Ca2+] (pCa 5.4 to pCa 4.5). The difference in <P2> value in the 
presence of blebbistatin was minimised towards the middle [Ca2+] of the titration. As 
described in the last section (Section 5.2.1), the overall amplitude of the <P2>-pCa 
curve for the C-helix probe was diminished in the presence of blebbistatin (Table 5.1 A 
and Table 5.2 A). Additionally, blebbistatin reduced the Ca2+ sensitivity for the C-helix 
orientation change by decreasing pCa50 from 5.40 ± 0.01 to 5.35 ± 0.01, showing a 
ΔpCa50 of -0.06 ± 0.02 pCa units (± SEM, n = 7). There was a minor, but not 
statistically significant, propensity of reducing the cooperativity of the Ca2+-dependent 
C-helix orientation change in the presence of blebbistatin. A similar situation was 
observed in the previous studies by Sun et al. (2009), and in the later investigations 
on BR-cTnC-E.  
As explained in last chapter, there were similar additional components in the 
<P2>-pCa relationship for BR-cTnC-E in both the absence and presence of 
blebbistatin at subthreshold pCa as well (Figure 5.3 B). The major component of the 







Figure 5.3: Effect of force inhibition on the Ca
2+
 dependence of cTnC orientation change. 
<P2> values were plotted as functions of pCa before the addition of blebbistatin (red 
circles) and in the presence of blebbistatin (red triangles) for A. C-helix; and B. E-helix 
probe. Red indicates the SL in this experiment has been set to 1.9 μm. Solid and dotted 
lines respectively indicate the fitting by Hill equation for 1.9 μm and 1.9 μm+25 μM 
blebbistatin. Since the cause of the additional component for BR-cTnC-E has not been 
identified, <P2>-pCa curves for the E-helix probe were fitted by fixing the minimum <P2> to 
the lowest value. Error bars denote SEM. Trabeculae number n = 7 for the C-helix probe 
and n = 8 for the E-helix probe. (Hill parameters are provided in Table 5.2). 
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Table 5.2: Hill parameters for the effect of force inhibition on the Ca
2+
 dependence of 
cTnC orientation change. A. BR-cTnC-C; B. BR-cTnC-E. Parameters were obtained by 
individually fitting data for each trabecula in the absence and presence of blebbistatin. 
Δ<P2> represents the overall orientation change from relaxation to maximum activation. 
Mean ± SEM. n is the number of trabeculae used in experiments. Δ indicates the 
difference in each parameter after adding 25 μM blebbistatin. Comparison:  paired 
two-tailed student t-test before and after adding blebbistatin (statistical significance 








> pCa9.0 0.086 ± 0.002 0.081 ± 0.005   
<P
2
> pCa4.5 0.010 ± 0.002 0.014 ± 0.002   
Δ<P
2
>  0.076 ± 0.003 0.066 ± 0.004**    
pCa
50 
 5.40 ± 0.01 5.35 ± 0.01*   -0.06 ± 0.02*  
n
H 
 2.96 ± 0.27 2.74 ± 0.33  -0.22 ± 0.19 










> pCa9.0 0.258 ± 0.009 0.280 ± 0.010***    
<P
2
> pCa4.5 0.169 ± 0.007 0.205 ± 0.006****    
Δ<P
2
> 0.089 ± 0.006 0.075 ± 0.004**    
pCa
50
 5.36 ± 0.02 5.29 ± 0.03***  -0.07 ± 0.01***  
n
H 
 3.77 ± 0.30 2.96 ± 0.27   -0.81 ± 0.43 
n 8  
(B) 
(B) 









The effect of active force inhibition was more pronounced on the orientation of the 
E-helix. Blebbistatin increased <P2> significantly over the whole range of pCa, and the 
increase became more dramatic near the maximum activation (<P2> increased from 
0.258 ± 0.009 to 0.280 ± 0.010 at pCa 9.0 and from 0.169 ± 0.007 to 0.205 ± 0.006 at 
pCa 4.5, ± SEM, n = 8) (Table 5.2 B). The <P2>-pCa curve shifted downward in the 
presence of blebbistatin, corresponding to a reduction in the axial angle θf by 1°~2° 
over the whole pCa, consistent with the previous studies by Sun et al. (2009). As 
shown in Figure 5.3 B, the amplitude of the <P2>-pCa curve was decreased by the 
addition of blebbistatin, as in the case of the C-helix probe, suggesting the important 
effect of myosin heads binding on the Ca2+-dependent cTnC structural change. 
Additionally, the Ca2+ sensitivity (pCa50) for the E-helix orientation change reduced a 
similar amount after force inhibition as that of the C-helix probe — ΔpCa50 = -0.07 ± 
0.01 for BR-cTnC-E (± SEM, n = 8), and ΔpCa50 = -0.06 ± 0.02 for BR-cTnC-C (± SEM, 
n = 7). Similarly, a small and non-significant reduction in the steepness of the 
<P2>-pCa relationship in the presence of blebbistatin was obtained in the E-helix 
probe as well. 
The present results showed a decrease in the Ca2+ sensitivity for structural 
change when the strong binding of myosin heads was disrupted. This is in agreement 
with the conclusion that the formation of force-generating cross-bridges would 
enhance the Ca2+ sensitivity of thin filaments (Gordon and Ridgway, 1993; Pan and 
Solaro, 1987). Although the molecular mechanisms are not yet fully understood, an 
important role of cross-bridges in driving the movement of tropomyosin into the “open 
state” by stabilising the Ca2+-sensitizing cTnI/cTnC interaction has been proposed to 
be involved in this effect (Zhou et al., 2000; Zhou et al., 2012). In agreement with the 
investigations by Sun et al. (2009), there was no significant change (only a minor 
tendency towards a reduction, see Table 5.2) in the steepness of <P2>-pCa 
relationships in both helices. These results indicate that the force-generating 
cross-bridges are not responsible for the cooperativity of the Ca2+-dependent cTnC 
structural change, suggesting a dominant role of troponin in switching on the thin 




5.3 Effect of Force Inhibition on LDA 
 
In order to determine the role of force-generating cross-bridges in LDA, a third round 
of Ca2+ titration was performed at SL 2.3 μm in the presence of blebbistatin. 
Measurements were taken in the same set of trabeculae as described in previous 
section, where the native cTnC was exchanged with either BR-cTnC-C or BR-cTnC-E. 
25 μM blebbistatin was added in all experimental solutions throughout the titrations to 
prevent the strong binding of myosin heads to actin. After the 30mins incubation within 
relaxing solution containing blebbistatin, trabecula was activated continuously from 
pCa 9.0 to 4.5 in the presence of blebbistatin at SL 1.9 μm (as the control group), 
followed by another set of Ca2+ titration at SL 2.3 μm, to investigate the impact of 
active force inhibition on the SL dependent changes in cTnC. SL was set before each 
titration by laser diffraction, and was checked after each series of activation to avoid 
inadequate measurement due to the deterioration of the diffraction pattern at high 
[Ca2+].  
Overall, three rounds of titration experiments were taken in the permeabilized 
trabeculae used in this chapter — at SL 1.9 μm without blebbistatin, the addition of 
blebbistatin at SL 1.9 μm, and at SL 2.3 μm in the presence of blebbistatin. Although 
multiple activations would cause irreversible damage to the fibre, the inhibition of 
active force by blebbistatin from the second round of titration should minimise this 
effect.  
 
5.3.1 Role of Force-generating Cross-bridges in SL’s Effect on cTnC In 
Situ Orientation 
 
In the presence of blebbistatin, at both SL 1.9 and 2.3 μm, maximum Ca2+-activation 
shifted the C-helix towards a more perpendicular conformation with respect to the 
fibre axis, indicated by a decrease in <P2> (Δ<P2>) by 0.066 ± 0.004 at 1.9 μm and 
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0.059 ± 0.002 (± SEM, n = 7) at 2.3 μm. The reduction in <P2> equals to a rise in the 
axial angle θf from 52.9 ± 0.3° to 56.2 ± 0.2° (Δθf = 3.3° ± 0.2°) at 1.9 μm and from 
52.8 ± 0.2° to 55.7 ± 0.1° (Δθf = 2.9 ± 0.1°) at 2.3 μm. As shown in Table 5.3 A, while 
increasing SL from 1.9 μm to 2.3 μm in the presence of blebbistatin did not 
significantly affect C-helix’s orientation at pCa 9.0, it affected the orientation at pCa 
4.5 by shifting towards the relaxing value. That is, at maximum activation, <P2> was 
increased from 0.014 ± 0.002 to 0.022 ± 0.003 (± SEM, n = 7) in response to SL 
increasing, corresponding to a small decrease in θf by ~0.5°. The present results were 
similar compared to the earlier investigations in the effect of SL on the C-helix 
orientation without blebbistatin (Table 4.4 A). However, the amplitude of orientation 
change from relaxation to maximum activation for the C-helix probe was significantly 
depressed at SL 2.3 μm after the inhibition of active force, indicated either by Δ<P2> 
(from 0.066 ± 0.004 at 1.9 μm to 0.059 ± 0.002 at 2.3 μm) or Δθf (from 3.3 ± 0.2° to 2.9 
± 0.1°) (± SEM, n = 7). Interestingly, as observed in the measurements without 
blebbistatin, SL change alone did not affect the overall orientation change of the 
C-helix upon Ca2+-activation (Table 4.4 A). Current results therefore indicated that the 
smaller conformational change in the regulatory head of cTn upon maximum 
activation at longer SL was likely to be the result of inhibiting the formation of 
force-generating cross-bridges. Thus, it is reasonable to conclude that certain change 
in strong-binding myosin heads occurs with SL variation, which interferes with the 
Ca2+-induced structural change in cTnC. Additionally, no significant change was 
observed in the standard deviation (σg) of the C-helix probe on either maximum 





Table 5.3: Parameters for the role of force-generating cross-bridges in the effect of SL on cTnC in situ orientation. (A): C-helix probe experiments; (B): 
E-helix probe experiments. Order parameters <P2> and <P4> were obtained at pCa 9.0 and 4.5 using FISS. θf and σg respectively indicate the peak 
angle and standard deviation of the Gaussian orientation distribution of the probe angle with respect to the fibre axis (indicated in the text and Section 
2.4). Mean ± SEM. Δ is the difference of each parameter between pCa 9.0 and pCa 4.5. n is the number of trabeculae in experiments. Comparison: 
paired two-tailed student t-test between SL 1.9 and 2.3 μm in the presence of blebbistatin (statistical significance *p<0.05, **p<0.01). 
C-helix  


























pCa 9.0  0.081 ± 0.005 -0.147 ± 0.015  52.9 ± 0.3 17.9 ± 0.8  0.081 ± 0.004 -0.157 ± 0.010  52.8 ± 0.2 17.3 ± 0.5  
pCa 4.5  0.014 ± 0.002 -0.135 ± 0.015  56.2 ± 0.2 18.0 ± 0.8 0.022 ± 0.003*  -0.147 ± 0.010  55.7 ± 0.1*  17.4 ± 0.5 
Δ  0.066 ± 0.004  -0.011 ± 0.005  -3.3 ± 0.2    0.059 ± 0.002*  -0.010 ± 0.002  -2.9 ± 0.1*    
n  7  
  
E-helix  






















pCa 9.0  0.280 ± 0.010  -0.080 ± 0.011  43.1 ± 0.5  19.0 ± 0.5  0.284 ± 0.008 -0.100 ± 0.012*  43.2 ± 0.4 17.9 ± 0.6*  
pCa 4.5  0.205 ± 0.006  -0.126 ± 0.012  46.9 ± 0.3  18.1 ± 0.6  0.227 ± 0.006**  -0.127 ± 0.012  45.9 ± 0.3**  17.7 ± 0.6*  






The E-helix in the IT arm of troponin had a more parallel orientation with respect to the 
fibre axis (smaller axial angel θf) compared to the C-helix under all conditions 
(relaxation and maximum activation at both SLs) (Table 5.3). At both SL 1.9 and 2.3 
μm in the presence of blebbistatin, maximum Ca2+-activation decreased <P2> value 
(Δ<P2>) by 0.075 ± 0.004 at 1.9 μm and 0.057 ± 0.005 (± SEM, n = 8) at 2.3 μm. The 
reduction in <P2> can be translated to an increase in θf (Δθf) by 3.8 ± 0.2° at 1.9 μm 
and 2.7 ± 0.3° (± SEM, n = 8) at 2.3 μm, as a result of the perpendicular shifting of the 
E-helix upon activation (Table 5.3 B). Increasing SL to 2.3 μm in the presence of 
blebbistatin induced a small but significant change in the active orientation of the 
E-helix — decreased θf at pCa 4.5 from 46.9 ± 0.3° to 45.9 ± 0.3° (± SEM, n = 8), 
indicating the perpendicular shifting of the E-helix upon maximum activation was 
reduced at longer SL. On the other hand, the relaxed orientation of the E-helix did not 
appear to change with SL. As a consequence, increasing SL in the presence of 
blebbistatin perturbed the amplitude of E-helix orientation change from pCa 9.0 to 
pCa 4.5 by decreasing Δ<P2> significantly from 0.075 ± 0.004 to 0.057 ± 0.005 (or Δθf 
from 3.8 ± 0.2° to 2.7 ± 0.3°, ± SEM, n = 8), similar with the situation obtained for 
BR-cTnC-C. Previous measurements in the absence of blebbistatin have shown the 
net angular change of the E-helix was not affected by SL change either, as in the case 
of BR-cTnC-C (Table 4.4 B). Thus, it must be the inhibition of active force that 
compromises the structural change in cTnC corresponding to SL increasing. 
Moreover, probe dispersion σg for BR-cTnC-E had a minor decrease at both 
relaxation and maximum activation in response to sarcomere lengthening in the 
presence of blebbistatin, which might be the reason of a slightly more stabilised 
conformation of the E-helix at longer SL. Figure 5.4 gives a more direct view of the in 
situ orientation change in cTnC during relaxation and maximal activation at both SLs 
in the presence of blebbistatin. 




Figure 5.4: Role of force-generating cross-bridges in SL’s effect on cTnC in situ 
orientation. (A): BR-cTnC-C; (B): BR-cTnC-E. Green and red bar in each set respectively 
represent <P2> value at relaxation (pCa 9.0) and maximum activation (pCa 4.5). First set 
in each graph is at SL 1.9 μm, second one at 2.3 μm, both in the presence of blebbistatin. 
Error bars denote SEM. n = 7 for the C-helix probe and n = 8 for the E-helix probe. 
Statistical significance of differences between the <P2> values from two SLs in the 
presence of blebbistatin for each helix probe was assessed using paired two-tailed 
student t-test: *p< 0.05, **p<0.01 (<P2> values are presented in Table 5.3). 
 
5.3.2 Role of Force-generating Cross-bridges in the SL-dependent 
Ca2+-regulation 
 
The effect of SL variation on the Ca2+ dependence of cTnC orientation change in the 
presence of blebbistatin was investigated using the same two sets of Ca2+ titration 
experiments described above — SL 1.9 μm+blebbistatin and SL 2.3 μm+blebbistatin.  
The data were described by individual Hill fitting, and the <P2>-pCa curve was set 
through the maximum and minimum <P2> values, whilst pCa50 and nH were obtained 
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Table 5.4: Hill parameters for the role of force-generating cross-bridges in the 
SL-dependent Ca
2+
 regulation. (A): C-helix probe experiments; (B): E-helix probe 
experiments. Parameters were obtained by individually fitting data for each trabecula at 
SL 1.9 μm and 2.3 μm respectively in the presence of blebbistatin. Δ<P2> represents the 
overall orientation change in cTnC from relaxation to maximum activation. Mean ± SEM. n 
is the number of trabeculae used in experiments. Δ indicates the difference in each 
parameter from SL 1.9 to 2.3 μm in the presence of blebbistatin. Comparison: paired 
two-tailed student t-test between two SLs in the presence of blebbistatin (statistical 








> pCa 9.0 0.081 ± 0.005 0.081 ± 0.004   
<P
2
> pCa 4.5 0.014 ± 0.002 0.022 ± 0.003*    
Δ<P
2
>  0.066 ± 0.004  0.059 ± 0.002*    
pCa
50 
 5.35 ± 0.01  5.42 ± 0.02*  0.07 ± 0.02*  
n
H 
 2.74 ± 0.33 2.22 ± 0.17   -0.52 ± 0.27 








> pCa 9.0 0.280 ± 0.010  0.284 ± 0.008   
<P
2
> pCa 4.5 0.205 ± 0.006  0.227 ± 0.006**    
Δ<P
2
> 0.075 ± 0.004  0.057 ± 0.005**    
pCa
50 5.29 ± 0.03  5.36 ± 0.02**  0.07 ± 0.02**  
n
H 
 2.96 ± 0.27  2.70 ± 0.24  -0.26 ± 0.24 






Figure 5.5: Effect of force inhibition on the Ca
2+
 dependence of cTnC orientation change. 
<P2> values were plotted as functions of pCa at SL 1.9 μm (red triangles) and 2.3 μm 
(blue triangles) in the presence of blebbistatin for A. C-helix; and B. E-helix probe. Dotted 
lines indicate the Hill fitting after adding blebbistatin. Error bars denote SEM. Trabeculae 
number n = 7 for BR-cTnC-C and n = 8 for BR-cTnC-E. (Hill parameters are provided in 
Table 5.4). 
 
As shown in Figure 5.5 A, both curves had similar baselines at the lower range of 
[Ca2+], whilst the difference became biggest at pCa 4.5, indicating that stretching SL 
from 1.9 μm to 2.3 μm in the presence of blebbistatin shifted the curve towards more 





C-helix    
(B) 
E-helix   
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absence of blebbistatin, SL elongation in the presence of blebbistatin depressed the 
overall orientation change of the C-helix probe from relaxation to maximum activation 
(as demonstrated in last section, see Table 5.3 A and 5.4 A). Additionally, the present 
results showed a significant increase in the Ca2+ sensitivity for C-helix orientation 
change with the increasing SL, indicated by an increase in the pCa50 from 5.35 ± 0.01 
at 1.9 μm to 5.42 ± 0.02 at 2.3 μm, with a ΔpCa50 of 0.07 ± 0.02 pCa units (± SEM, n = 
7) in response to SL elongation after active force inhibition (Table 5.4 A). Our results 
showed that the SL-dependent increase in the Ca2+ sensitivity could still happen, even 
without the presence of cross-bridges, though this increase was smaller than that in 
the absence of blebbistatin (~0.11 pCa units, Table 4.5 A). Moreover, there was a 
small, but not significant, tendency of reducing the cooperativity of the Ca2+ regulation 
at longer SL in the presence of blebbistatin (ΔnH = -0.52 ± 0.27, ± SEM, n = 7).  
Similar to the measurements described previously for BR-cTnC-E, an additional 
component was observed here for the orientation change of the E-helix in the 
subthreshold range of pCa (pCa 9.0 to 6.7) (Figure 5.5 B). This small component of 
the <P2>-pCa relation for the E-helix probe was found at both SLs in the presence of 
blebbistatin. To ease analysis, the major component of the E-helix orientation change 
between pCa 6.7 and 4.5 was fitted to the Hill equation. 
As shown in Figure 5.5, stretching SL from 1.9 μm to 2.3 μm in the presence of 
blebbistatin had a more pronounced effect on the E-helix of cTnC — <P2> value was 
increased significantly over the whole range of pCa (pCa 7.0 to 4.5), shifting the 
<P2>-pCa curve downward. Although SL elongation in the presence of blebbistatin 
shifted the curve towards bigger <P2> value at each pCa, the relaxed orientation of 
the E-helix at pCa 9.0 was not affected (Table 5.3 B and 5.4 B). The net <P2> change 
from relaxation to maximum activation (Δ<P2>) decreased upon SL stretching, 
different from what has been seen in the absence of blebbistatin. Additionally, 
stretching SL in the presence of blebbistatin increased the Ca2+ sensitivity for the 
E-helix orientation change pCa50 from 5.29 ± 0.03 to 5.36 ± 0.02 (ΔpCa50 = 0.07 ± 
0.02, ± SEM, n = 8, Table 5.4 B). The SL-dependent increase in the Ca2+ sensitivity for 
the E-helix orientation change was almost identical to the ΔpCa50 reported above for 
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the C-helix probe (ΔpCa50 = 0.07 ± 0.02 pCa units (± SEM, n = 7, Table 5.4 A)), which 
was less than that in the absence of blebbistatin (~0.11 pCa units, see Table 4.5). 
These results suggested that the force-generating cross-bridges might not be an 
essential component in the SL-dependent Ca2+ sensitivity in LDA. It might be involved 
in increasing the Ca2+ sensitivity with increased SL as a positive feedback factor. 
Moreover, there was a tendency towards reducing the cooperativity of the Ca2+ 
dependent E-helix orientation change (Table 5.4 B). However, it was not statistically 
significant.  
Taken together, the present results showed that the inhibition of active force 
disturbed the effect of SL elongation on both cTnC in situ orientation and the Ca2+ 
dependence of cTnC orientation. Increasing SL in the presence of blebbistatin 
decreased the amplitude of cTnC orientation change by shifting the active orientation 
slightly towards the relaxed state. The effect was in support of the theory that the 
formation of the force-generating cross-bridges stabilizes the conformational changes 
in cTnC upon maximum Ca2+-activation by favouring the attachment of the switch 
peptide of cTnI to cTnC. More importantly, blebbistatin decreased the SL-dependent 
increase in the Ca2+ sensitivity for both helices’ orientation change from ~0.11 pCa 
units to ~0.07 pCa units, implying the importance of force-generating cross-bridges in 
the regulation of LDA. However, the present results also showed that even without 
force-generating cross-bridges, there was still SL-dependent Ca2+ sensitivity in the 
thin filament, indicating that strongly bound myosin heads might not be the essential 
component in the length dependent Ca2+ sensitivity in LDA. The thin filament, on the 
other hand, is more likely to be the centre of transmitting the signal of sarcomere 





5.4 Discussion  
 
5.4.1 Impact of Force-generating Cross-bridges on Ca2+ regulation 
 
Strong cross-bridge attachment has long been considered to be the primary mediator 
of Ca2+ binding properties through switching on the thin filament activation (Bremel 
and Weber, 1972). It was suggested that the actomyosin interaction was able to hold 
Tm in a position where the high Ca2+ binding affinity to cTnC was favoured. Yet its 
dominant role has been challenged in more recent investigations, which suggested 
such a mechanism can only occur in rigor conditions, not under physiological 
conditions (Sun et al., 2009). Under physiological conditions, the thin filament 
activation is driven by Ca2+ binding-induced cTn structural change, which leads to Tm 
movement and cross-bridges formation.  
    In this chapter, we first examined the impact of force-generating cross-bridges on 
the Ca2+-regulated activation by inhibiting the formation of them at SL 1.9 μm. We 
used the myosin binding inhibitor — blebbistatin to prevent the strong binding of 
myosin heads to actin and reduced the active force development by ~94%. Active 
force inhibition depressed the orientation change in the C-helix of cTnC from 
relaxation to maximum activation by ~0.5°, with the effect being slightly bigger in the 
E-helix (~0.8°). Although these net angular reductions were small, they were 
significant and highly reproducible. The reduction in the amplitude of cTnC structural 
change after active force inhibition were in good agreement with the previous 
investigations by our group members (Sevrieva, 2014; Sun et al., 2009), implying an 
impact of the force-generating cross-bridges on the structural change of cTnC upon 
Ca2+-activation. The addition of blebbistatin also reduced the Ca2+ sensitivity for both 
helices’ orientation change by a similar amount (~0.07 pCa units), suggesting the 
force-generating cross-bridges may be involved in modulating the Ca2+ sensitivity 
through interfering with the structural change in cTnC upon activation. 
As reported by Zhou et al. (2012), the strong binding of myosin heads to actin 
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stabilized the interaction between the switch peptide of cTnI and the N-lobe of cTnC. 
The attachment of the switch region of cTnI to cTnC is known to further open the 
N-lobe of cTnC from studies in isolated cTnC (Li et al., 1999; Sia et al., 1997). Thus, 
the strong cross-bridge attachments may be necessary to support the fully open 
conformation of cTnC by keeping cTnI off of actin and stabilizing the cTnI/cTnC 
interaction. According to Johnson et al. (1980), attachment of the switch peptide of 
cTnI to cTnC substantially increased the Ca2+ binding affinity to cTnC. Therefore, the 
reduction in the Ca2+ sensitivity and the structural change of cTnC after inhibiting the 
formation of cross-bridges may be due to the fewer cTnI/cTnC interactions, as a result 
of lacking support from strong binding cross-bridges.  
In addition, no significant difference was observed in the cooperativity of the Ca2+ 
regulation (indicated by nH) after force inhibition, consistent with the results in Sun et 
al. (2009), which recognised the cooperative Ca2+ regulation is not due to the 
force-generating cross-bridges, but an intrinsic property of the thin filaments. 
 
5.4.1.1 Comparison with Previous Studies 
The molecular mechanisms linking the myosin heads binding with the Ca2+ sensitivity 
modulation have been investigated extensively over these years. Our current 
conclusion, that the force-generating cross-bridges may be involved in regulating the 
Ca2+ sensitivity through stabilizing the structural change in cTnC upon activation, was 
in agreement with the previous studies. 
    Experiments by Hofmann and Fuchs (1987b) used a phosphate analog vanadate 
to inhibit the strong binding of myosin to actin. Their results showed that the amount of 
Ca2+ binding to cTnC was a function of not only the [Ca2+]i, but also the force 
development. Active force inhibition by vanadate reduced Ca2+ binding, i.e. Ca2+-cTnC 
affinity, significantly. Subsequent study by Martyn et al. (2001) showed that this strong 
binding cross-bridges-induced Ca2+-cTnC affinity change was accompanied by 
changes in cTnC conformation. Both the amplitude of cTnC structural change and the 
Ca2+ sensitivity were reduced after inhibiting actomyosin interaction. These studies 
indicated the importance of force-generating cross-bridges in modulating Ca2+ binding 
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properties, possibly through modulating the structural changes in cTnC upon 
Ca2+-activation.  
However, the results from Martyn et al. (2001) have shown that inhibition of force 
generation caused both the structural change and the Ca2+ sensitivity for this 
structural change to decrease in the N-lobe of cTnC, while only the Ca2+ sensitivity 
decreased for the C-lobe, with no significant change in the structure. These were at 
variance with our conclusions that force inhibition decreased the amplitude of both the 
C- and E-helix orientation change. The main difference between our present work and 
Martyn et al. (2001) is that we used bifunctional probes to label specific cTnC helices 
to measure the structural change in cTnC, whilst they used monofunctional probes. 
Bifunctional probe cross-links with two cysteine residues at sites chosen from the 
static structure. The averaged orientation of the probe dipole is expected to be parallel 
to a line joining the two cysteines. Whilst with monofunctional probe, the orientation 
and motion of the probe with respect to the attached protein domain is unknown, and 
different results were obtain with different probe sites (Martyn et al., 2001; Putkey et 
al., 1997). Therefore, experiment results from bifunctional probes are likely to be more 
reliable. 
Additionally, in the studies carried out by Lehrer (1994); McKillop and Geeves 
(1993), three thin filament states, associated with two cross-bridges states, have been 
proposed to explain the role of the cross-bridges in the thin filament activation. 
Although the movement of Tm is initially determined by Ca2+ binding to cTnC, the 
model postulates that the isomerisation transition from weak to strong cross-bridge 
attachments pushes Tm further into the groove of the actin filament, allowing the 
formation of more force-generating cross-bridges. It was suggested that the second 
dislocation of Tm driven by strong-binding cross-bridges was highly cooperative via 
the propagation by neighbouring RUs, which promoted further Ca2+ binding to the 
adjacent cTnCs, along with increasing conformational changes in cTnC (Fuchs and 
Martyn, 2005; Regnier et al., 2002). However, both our current results and those from 
our group’s previous publications have shown no significant difference in the nH for the 
Ca2+ dependence of cTnC structural change after inhibiting the strong-binding of 
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myosin to actin by blebbistatin. These results provided strong evidence that even if 
the force-generating cross-bridge did push Tm to move further along the actin filament, 
they are not responsible for the cooperativity of Ca2+ binding, which must be intrinsic 
to the thin filaments.   
Current results promote a link between the force-generating cross-bridges and 
the Ca2+ dependence of cTnC structural change. Disruption of strong binding 
cross-bridges hindered the Ca2+-induced cTnC structural change and the Ca2+ 
sensitivity for this structural change without interfering with the cooperativity. Thus, the 
formation of strong binding cross-bridges may be involved in regulating the Ca2+ 
sensitivity through stabilising the Ca2+-sensing cTnI/cTnC interactions, which in turn, 
stabilises the conformational change in cTnC in Ca2+-activation.  
 
5.4.2 Role of Force-generating Cross-bridges in LDA 
 
Our results presented in Chapter 4 have shown a ~40% increase in the maximum 
force production in response to SL increasing from 1.9 to 2.3 μm, which was not due 
to an increase in the amplitude of cTnC structural change upon activation. Over the 
years, the molecular basis that underlies the increasing force production upon 
increased SL has been focused on the effect of force-generating cross-bridges. 
Studies with skinned cardiac fibres showed that the increase in force development 
was accompanied by a SL-dependent increase in the number of force-producing 
cross-bridges in the sarcomere (Allen and Kentish, 1985; Wannenburg et al., 2000; 
Wannenburg et al., 1997). Yet the role of the cross-bridges in the other outcome of 
LDA — the SL-dependent Ca2+ sensitivity, still remained controversial.  
    In our results reported in Chapter 4, we concluded that with the increasing SL, the 
increasing Ca2+ sensitivity for force was very likely to be modulated by increasing the 
Ca2+ sensitivity for cTnC structural change. In this chapter, we focused on 
investigating the role of the force-generating cross-bridges in LDA, especially the 
SL-dependent Ca2+ sensitivity, by increasing SL from 1.9 to 2.3 μm in the presence of 
the myosin-binding inhibitor — blebbistatin.   
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    Unlike in the absence of blebbistatin, after active force inhibition, there was a 
decrease in the amplitude of cTnC structural change in response to SL increasing, 
together with a reduced SL-dependent difference in the Ca2+ sensitivity between short 
and long SL (~0.07 pCa units in the presence of blebbistatin versus ~0.11 pCa units 
without blebbistatin). About one third of the length-dependent Ca2+ sensitivity increase 
was hindered after myosin binding inhibition, suggesting the force-generating 
cross-bridges may be partly involved in mediating the Ca2+ sensitivity with SL. More 
importantly, our results showed that the SL-dependent modulation of the Ca2+ 
sensitivity can still happen even without the presence of the force-generating 
cross-bridges, indicating that cross-bridges may not be the essential component in 
the length-dependent Ca2+ sensitivity in LDA. 
Our results from the last chapter have shown that the total amplitude of cTnC 
structural change was not affected by SL. Thus, the reduction in cTnC conformational 
change reported here—at SL 2.3 μm in the presence of blebbistatin, indicated the 
strong binding of myosin to actin was fairly important to hold the structural change in 
cTnC to be not affected by SL variation. As discussed in last section, the interaction of 
myosin heads to actin stabilizes the conformational change in cTnC upon activation 
by favouring the attachment of cTnI to cTnC (Zhou et al., 2012). Therefore, without 
the support from the force-generating cross-bridges, SL alteration may indirectly affect 
the opening conformation in cTnC, probably through the interactions between titin and 
the thin filament. In turn, the less conformational change in cTnC caused by 
cross-bridges disruption may be the reason of the reduced Ca2+ sensitivity difference 
between SLs. Our results suggested that the strong binding cross-bridges may be 
partly involved in the mediation of Ca2+ sensitivity through the feedback from 
stabilising the conformational change in cTnC. 
In conclusion, increasing SL after the disruption of the force-generating 
cross-bridges caused a small but significant decrease in the total amplitude of cTnC 
structural change upon activation, in association with reduced SL-dependent Ca2+ 
sensitivity. Our results suggested the effect of strong myosin binding may play a role, 
but not essential, in modulating the SL-dependent Ca2+ sensitivity. The SL-dependent 
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Ca2+ sensitivity can still occur even without the presence of force-generating 
cross-bridges. Therefore, we conclude that the two outcomes of LDA are very likely 
due to two independent pathways: the control centre for regulating the SL-dependent 
Ca2+ sensitivity locates on the thin filament by cTnC, and that for regulating the 
SL-dependent maximum force located on the thick filament by force-generating 
cross-bridges. In the meantime, the thick filament cross-bridges may provide a 
positive feedback to support the increasing Ca2+ sensitivity with increasing SL, 
possibly by stabilizing the structural change in cTnC upon Ca2+-activation. 
 
5.4.2.1 Comparison with Previous Studies 
The role of force-generating cross-bridges in LDA has been investigated for a very 
long time. Although it has been well-established that the SL-dependent change in the 
cross-bridges (either the increasing number or the increasing capacity for force 
generation) is mostly responsible for the SL-dependent increase in maximum force, 
whether cross-bridges play a part in the SL-dependent Ca2+ sensitivity still remained 
debatable over years.  
In this study, we found that in the presence of blebbistatin, the SL-dependent 
increase in the Ca2+ sensitivity still happened, although this increase was smaller than 
what we have reported in the previous experiments without blebbistatin. We 
concluded that the force-generating cross-bridges may not be the essential 
component in the SL-dependent Ca2+ sensitivity. The strong binding of myosin to actin 
may provide a positive feedback to support the increasing Ca2+ sensitivity with 
increased SL by stabilizing the structural change in cTnC upon activation. The present 
conclusion is at variance with that from the previous studies, which suggested that 
myosin binding is essential in changing the Ca2+ sensitivity with SL.  
In the investigations carried out by Hofmann and Fuchs (1987a), suppressing the 
actomyosin interaction with 1.0mM vanadate eliminated the SL-dependent Ca2+ 
binding to cTnC. They showed that the SL-dependent Ca2+ sensitivity in LDA was 
associated with a SL-dependent binding affinity of the Ca2+ to cTnC. This 
SL-dependent Ca2+ binding disappeared when myosin binding was inhibited by 
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pre-treatment with vanadate. Their results indicated that it was the length-dependent 
number of cross-bridges, not the SL per se, that determines the SL-dependent Ca2+ 
sensitivity. In the current study, we found the SL-dependent Ca2+ sensitivity still 
existed after active force inhibition, though it reduced about one third compared to that 
in the presence of attached cross-bridges.  
The main difference between our study and the one presented above is the 
various myosin-binding inhibitors applied in the experiments (25mM blebbistatin in 
this study vs 1.0mM vanadate in Hofmann and Fuchs (1987a)). As described in 
Section 5.1, compared to the non-specific effect of vanadate may have on other 
sarcomeric proteins, blebbistatin is a more potent inhibitor that binds to the 
actin-binding cleft of myosin specifically. Thus, the effects of vanadate reported in the 
previous studies may not have been solely due to its inhibition of attachment of 
cross-bridges. 
There was an alternative theory in terms of the role of force-generating 
cross-bridges in LDA, which suggested the strong binding of myosin to actin was 
secondary to the SL-dependent modulation of the Ca2+ sensitivity. Thus even if the 
number of cross-bridges does increase with SL, it does not mediate the 
length-dependent Ca2+ sensitivity (Farman et al., 2010). Blebbistatin was also used to 
inhibit the force-generating cross-bridges in this study. Their results showed the 
addition of blebbistatin had no effect on the SL-dependent modulation of either the 
Ca2+ sensitivity or the cooperativity. Despite the fact that they were consistent with our 
results in terms of the cooperativity, the lack of change in the SL-dependent Ca2+ 
sensitivity was not in agreement with our finding.  
In Farman et al. (2010), skinned trabeculae were incubated in 1.0 μM blebbistatin 
overnight, which was quite a modest amount compared to the 25 μM in our 
experiments. Consequently, the reduction in active force was not comparable as well 
— ~61% in Farman’s versus ~94% in ours. Thus, it seems reasonable to argue that 
the inhibition of cross-bridge attachments by 1.0 μM blebbistatin may be incomplete, 
that large number of myosin heads may still be able to bind with actin under this 
circumstance. Their results cannot rule out the possibility that the remaining 
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cross-bridge attachments in the presence of 1.0 μM blebbistatin were sufficient to 
function in mediating Ca2+ sensitivity with SL.  
Additionally, recent investigations suggested the variation in the number of the 
weak binding cross-bridges, or the orientational disordering of the myosin heads in 
resting muscle, may be important determinants in transmitting the changes in SL to 
affect the Ca2+ sensitivity as well. Details are not considered further in this study (see 
Farman et al. (2010) and Farman et al. (2011) for detailed description). 
In this chapter, we investigated whether there was a link between 
force-generating cross-bridges and the Ca2+ sensitivity with varied SL. To characterise 
the step prior to that, i.e. how cardiac sarcomere transmits the signal from lengthening 















Role of Lattice Spacing in the 




6.1 Introduction  
 
The SL-dependent modulation of maximum force production and Ca2+ sensitivity in 
cardiac muscle contraction are known as the cellular basis of the Frank-Starling 
relationship of the heart. Our results from the last two chapters suggest that 
force-generating cross-bridges are partly involved in transmitting the information of SL 
change in LDA. The increasing number of myosin heads binding at longer SL results 
in the SL-dependent increase in maximum force. Although cross-bridges may not be 
the essential component in the SL-dependent Ca2+ sensitivity in LDA, myosin heads 
binding may provide a positive feedback to support the increasing Ca2+ sensitivity with 
increased SL. In this chapter, we focused on how sarcomere lengthening affects 
force-generating cross-bridges.  
We examined one of the most popular hypothesis — the interfilament spacing (IS) 
theory. The hypothesis basically proposes that it is the corresponding change in the 
radial distance between the thick and thin filament (the interfilament spacing) that 
determines the effect of SL in LDA. Increasing the SL is expected to cause a 
corresponding reduction in the IS, this closer distance between the myosin heads and 
actin filament enhances the possibility of cross-bridges formation, which in turn 
increases the Ca2+ sensitivity . 
For the time-being, the theory has been investigated quite thoroughly. However, 
more and more recent findings have shown that there may be no certain relationship 
between the changes in IS and the changes in Ca2+ sensitivity (Section 1.5.3). These 
results implied that changes in IS alone may not be a primary determinant in LDA, 
which disagrees with the IS hypothesis. So the main purpose of our experiments in 
this chapter was more like to confirm the disagreement of the IS theory, and more 
importantly, to discover the impact of different degrees of osmotic compression on thin 
filament activation, i.e. the Ca2+ dependence of force and cTnC structure. 
According to Konhilas et al. (2002b), neither the SL-induced nor the osmotic 
compression-induced reduction in muscle width was in proportion to the reduction in 
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IS in cardiac trabeculae (Figure 6.1). Both SL change and dextran compression have 
different impacts on muscle width and IS. They showed that much less dextran is 
needed to mimic the SL-induced changes in IS than in muscle width. So in my study, 1% 
and 4% dextran were chosen to respectively mimic the reductions in IS and muscle 
width as those induced by SL stretching from 1.9 to 2.3 μm without changing SL. The 
experiments were performed in the skinned cardiac trabeculae at SL 1.9 μm. The 
choice of the two concentrations were based on the calculations from previous studies 
(Farman et al., 2006; Fuchs and Wang, 1996; Irving et al., 2000; Konhilas et al., 
2002b; Wang and Fuchs, 1995). 
Figure 6.1: Different impacts of SL change and dextran concentration on muscle width 
(measured by microscopy) and IS (measured by X-ray diffraction) (Konhilas et al., 2002b). 
Muscle width and lattice spacing were determined at 3 SLs (1.95 μm, 2.10 μm, and 2.25 
μm) with 0%, 3%, or 6% dextran in the solutions. The dotted line is the predicted 
relationship if IS were directly proportional to fibre width; normalized to SL 2.10 μm with 0% 
dextran. 
 
6.2 Effect of Osmotic Compression on the Ca2+-regulated 
Force Development 
 
In order to investigate the impact of osmotic compression on the Ca2+ sensitivity for 
force development, Ca2+ titration measurements were performed in permeabilized rat 
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trabeculae exchanged with either BR-cTnC-C or -E, using dextran T-500 at either 1% 
or 4% (weight/volume, g/100ml). Dextran T-500 (Sigma-Aldrich) is a high molecular 
weight molecule which cannot enter the myofilament lattice structure, thus is able to 
shrink the distance between thick and thin filaments via osmotic compression. As 
mentioned above, 1% and 4% were chosen based on previous studies (Farman et al., 
2006; Fuchs and Wang, 1996; Irving et al., 2000; Konhilas et al., 2002b; Wang and 
Fuchs, 1995) to mimic the corresponding changes induced by increasing SL (from 1.9 
μm to 2.3 μm) in IS and fibre width, respectively. The skinned trabecula was first 
activated continuously from pCa 9.0 to pCa 4.5 at SL 1.9 μm (as the control group), 
followed by 10mins incubation in relaxing solution containing either 1% or 4% dextran. 
The trabecula was then activated for a second round of Ca2+ titration in the presence 
of either 1% or 4% dextran. Dextran was prepared as a stock solution before adding 
into pCa solutions on the day of experiment. SL was set and checked according to 
laser diffraction pattern (Section 2.5.1) prior to, and after each series of activations. 
Isometric force was measured after steady force was established at each pCa. The 
force was normalized to the maximal Ca2+-activated force at pCa 4.5 in each found of 
titration and plotted as function of pCa. Data from individual fibre in each titration were 
fitted to the Hill equation, pCa50 (Ca
2+ sensitivity) and nH (cooperativity) were 
determined from each individual fitting. The average parameters are summarized in 
Tables 6.1 (1% dextran) and 6.3 (4% dextran).  
 
6.2.1 Osmotic Compression with 1% Dextran 
 
In this study, 1% dextran was used to compress the interfilament spacing of cardiac 
trabeculae at SL 1.9 μm to match that at 2.3 μm. As shown in Table 6.1, 1% dextran 
reduced the maximum Ca2+-activated force, with the effect being statistically 
significant only in BR-cTnC-E (-18 ± 4% (± SEM, n = 5)). However, current results are 
at odds with the previous studies that showed that the moderate compression of 
cardiomyocytes by less than 10% dextran increased maximum force production 
(Wang and Fuchs, 1995).  
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Table 6.1: Hill parameters for the effect of 1% dextran on the Ca
2+
 dependence of force 
development. (A). C-helix probe experiments; (B). E-helix probe experiments. Mean ± 
SEM. The parameters were obtained by fitting data from each trabecula, with or without 1% 
dextran. SL was set to 1.9 μm in this study. Fmax is the maximum Ca
2+
-activated force. Δ 
indicates the difference in each parameter caused by 1% dextran compression. 
Comparison: paired two-tailed student t-test (* p<0.05).  
C-helix 
 
1.9 μm 1.9 μm+1%Dex  Δ 
Fmax (mN/mm
2
) 21.9 ± 2.5 20.1 ± 3.2             -10 ± 5%  
pCa
50
 5.46 ± 0.03 5.45 ± 0.03  -0.01 ± 0.02 
n
H 
 3.63 ± 0.50 4.21 ± 0.41  0.58 ± 0.20 
n  4  
   
E-helix 
 
1.9 μm 1.9 μm+1%Dex  Δ 
Fmax (mN/mm
2
) 28.3 ± 5.2 23.4 ± 4.7*   -18 ± 4%*  
pCa
50
 5.49 ± 0.02 5.50 ± 0.02 0.01 ± 0.01 
n
H  3.62 ± 0.47 3.49 ± 0.42  -0.13 ± 0.23 
n  5  
 
In this set of experiments, the maximum force production was measured at the 
end of the titration. Fibre deterioration from multiple activations might result in a 
decreased maximum activated force at the end of each titration measurement. To 
determine the effect of dextran (1% and 4%) alone on force generation, steady-state 
measurements of maximum force development with and without osmotic compression 
were performed on another batch of trabeculae (Table 6.2). Each fibre was maximally 
activated at 1.9 μm in the absence of dextran and in the presence of 1% or 4% 
dextran. Results showed no significant effect of dextran on force generation. The 
relative changes in maximal Ca2+-activated force are -3 ± 5% for 1% dextran and -11 ± 
6% for 4% dextran (± SEM, n = 9). These changes were not statistically significant. 





addition of dextran (Table 6.1), and are most likely to be the result of fibre damage by 
multiple activations.    
 
Table 6.2: Steady-state measurements for the effect of 1% or 4% dextran on maximal 
Ca
2+
-activated force (Fmax). Each trabecula was fully activated three times: control, added 
1% dextran, and added 4% dextran. Measurements were performed at SL 1.9 μm. Fmax 
was normalised to the one produced in control group without dextran. Both force per 
cross-sectional area and normalization were presented. n is the number of trabeculae. 
Mean ± SEM. Comparison: paired two-tailed student t-test — control vs 1% dextran (not 
significant) and control vs 4% dextran (not significant). 
n = 9 Control 1% DEX 4% DEX 
Fmax (mN/mm
2
) 17.5 ± 2.4 16.9 ± 2.1 15.5 ± 2.1 
Normalized (%) 1.00 0.97 ± 0.05 0.89 ± 0.06 
Δ (%) / -3 ± 5 -11 ± 6 
 
As illustrated in Figure 6.2 A, the force-pCa curve for the trabeculae reconstituted 
with the C-helix probe of cTnC after osmotic compression by 1% dextran was almost 
identical to that in control conditions. Lattice spacing shrinkage with 1% dextran at 1.9 
μm did not affect the Ca2+ sensitivity for force development. The pCa50 for force was 
5.46 ± 0.03 in the control and 5.45 ± 0.03 (± SEM, n = 4) in the presence of 1% 
dextran (Table 6.1 A). There was a tendency of increased cooperativity for the Ca2+ 
dependence of force after the addition of 1% dextran (ΔnH = 0.58 ± 0.20 (± SEM, n = 
4)), although the opposite situation was observed in the nH for BR-cTnC-E (ΔnH = 
-0.13 ± 0.20 (± SEM, n = 5)), neither of them were significant according to the paired 
t-test.  
Trabeculae reconstituted with BR-cTnC-E exhibited the same behaviour as with 
BR-cTnC-C in response to osmotic compression with 1% dextran (Figure 6.2 B). The 
pCa50 for force was altered slightly from 5.49 ± 0.02 to 5.50 ± 0.02 (± SEM, n = 5) after 




Figure 6.2: Effect of 1% dextran on the Ca2+ dependence of force development. Force 
was normalized to the maximum force at pCa4.5 and plotted as a function of pCa at SL 
1.9 μm (red squares) and at 1.9 μm with 1% dextran (green squares). (A). BR-cTnC-C; (B). 
BR-cTnC-E. Red and green lines indicate the fittings by Hill equation for control and 1% 
dextran, respectively. Error bars denote S.E.M. Trabeculae number n = 4 for the C-helix 
probe and n = 5 for the E-helix probe. (Hill parameters are provided in Table 6.1). 
 
The above results showed no significant effect of 1% dextran on the Ca2+ 
sensitivity for force production when SL was unchanged. Given the osmotic 
compression with 1% dextran was supposed to reduce the IS at short SL to match 
that at long SL without actually changing SL, an increase in myofilament Ca2+ 
(A) 
C-helix     
(B) 
E-helix     
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sensitivity similar to that in response to SL elongation was expected. However, in 
comparison with our results in Chapter 4, where SL was increased from 1.9 μm to 2.3 
μm (Table 4.3), the difference in the Ca2+ dependence of force upon 1% dextran 
compression was in no way comparable with that obtained by actual SL increasing. 
However, our current results were consistent with a similar study carried out by 
Konhilas et al. (2002b), where the Ca2+ sensitivity at short SL did not increase by 1% 
dextran treatment.  
 
6.2.2 Osmotic Compression with 4% Dextran  
 
4% dextran was added to experimental solutions to osmotically compress the fibre at 
SL 1.9 μm to mimic the fibre width reduction when SL was increased to 2.3 μm. With 
no change in the SL (remained 1.9 μm), 4% dextran showed much more pronounced 
effect on the Ca2+ dependence of force compared to 1% dextran.  
Osmotic compression with 4% dextran induced a leftward shift of the force-pCa 
curve for the trabeculae reconstituted with the C-helix probe (Figure 6.3 A), similar to 
that induced by increasing SL from 1.9 to 2.3 μm (Figure 4.3 A). In contrast to the 
findings with 1% dextran, 4% dextran remarkably increased pCa50 for force at SL 1.9 
μm from 5.37 ± 0.02 to 5.51 ± 0.03 for BR-cTnC-C, with a total increase (ΔpCa50) of 
0.14 ± 0.03 pCa units (± SEM, n = 4) (Table 6.3 A).  
Similarly, the addition of 4% dextran increased the Ca2+ sensitivity for force 
development in trabeculae reconstituted with BR-cTnC-E by a similar amount from 
5.53 ± 0.03 to 5.67 ± 0.02, with a ΔpCa50 of 0.14 ± 0.02 pCa units (± SEM, n = 6) 
(Table 6.3 B and Figure 6.3 B). Like the addition of 1% dextran, there was no effect of 
the compression on the cooperativity (nH) for the Ca
2+ dependence of force by 4% 




Figure 6.3: Effect of 4% dextran on the Ca2+ dependence of force development. Force 
was normalized to the one produced at maximum activation and plotted as a function of 
pCa at SL 1.9 μm (red solid squares) and at 1.9 μm with 4% dextran (purple solid squares) 
for (A). BR-cTnC-C; (B). BR-cTnC-E. Red and purple lines respectively indicate the Hill 
fitting for control and 4% dextran. Error bars denote S.E.M. Trabeculae number n = 4 for 
BR-cTnC-C and n = 6 for BR-cTnC-E. (Hill parameters are provided in Table 6.3). 
  
(A) 
C-helix     
(B) 
E-helix     
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Table 6.3: Hill parameters for the effect of 4% dextran on the Ca2+ dependence of force 
development. (A). C-helix probe; (B). E-helix probe. Mean ± SEM of the parameters 
obtained by individual fitting data for each trabecula. SL was set to 1.9 μm in this study. 
Fmax indicates the maximum Ca
2+
-activated force. Δ describes the difference in each 
parameter that brought by 4% dextran. Comparison: paired two-tailed student t-test — 
before and after 4% dextran compression (* p<0.05, *** p<0.001).  
C-helix 
 
1.9 μm 1.9 μm + 4%Dex  Δ 
Fmax (mN/mm
2
) 24.0 ± 6.8 20.3 ± 5.1   -14% ± 5%  
pCa
50
 5.37 ± 0.02 5.51 ± 0.03*  0.14 ± 0.03*  
nH
 
 3.41 ± 0.24 3.66 ± 0.41 0.25 ± 0.49 




1.9 μm 1.9 μm + 4%Dex  Δ 
Fmax (mN/mm
2
) 21.7 ± 4.3 19.8 ± 3.6              -8% ± 4%  
pCa
50
 5.53 ± 0.03 5.67± 0.02***  0.14 ± 0.02***  
nH
 
 4.45 ± 0.41 3.86 ± 0.32  -0.59 ± 0.31 
n  6  
 
In conclusion, compression of the trabeculae by 1% dextran to mimic the 
reduction in IS in response to SL increase did not reproduce the SL-dependent 
increase in the Ca2+ sensitivity. However, 4% dextran did increase the myofilament 
Ca2+ sensitivity by a similar amount as that induced by SL elongation. The current 
results suggested the impact of mimicking the SL-induced change in lattice spacing 
on Ca2+ sensitivity was not as pronounced as mimicking the change in fibre width. 
However, this does not necessarily imply that fibre width is the primary determinant of 
LDA. These results indicated the impact of different degrees of osmotic compression 







6.3 Effect of Osmotic Compression on the Ca2+-regulated cTnC 
In Situ Orientation Change  
 
In Chapter 4, we showed that the elongation of SL had similar effects on the Ca2+ 
dependence of force development and cTnC orientation change in both the C- and 
E-helix of cTnC. In order to investigate the impact of osmotic compression with 
dextran on cTnC orientation change-pCa relationship, the in situ orientation of the C- 
or E-helix was measured simultaneously with isometric force in the same batch of 
skinned trabeculae exchanged with either BR-cTnC-C or -E. In this chapter, the in situ 
orientation of cTnC and its Ca2+ dependence were determined in the same set of 
titration experiments described in the last section. As described in Chapter 4, 
orientation change was determined from the fluorescence polarization of the BR 
dipole attached along C- or E-helix of cTnC using FISS, and was described by order 
parameters <P2> and <P4>. Gaussian model was used to acquire the mean axial 
angle θf and standard deviation σg of these dipole orientation distributions at 
relaxation and maximum activation state (data reported in Table 6.4 and 6.6). 
<P2>-pCa data were fit by the Hill equation for each fibre with and without 
compression. The fitting was set through the maximum and minimum of <P2> values 
and the averaged pCa50 and nH were shown in Table 6.5 and 6.7.  
 
6.3.1 Osmotic Compression with 1% Dextran 
 
As demonstrated in Table 6.4, at SL 1.9 μm, both the C- and E-helix of cTnC had a 
more parallel conformation with respect to the trabecular axis at pCa 9.0 than at pCa 
4.5. Maximum Ca2+ activation shifted cTnC towards a more perpendicular 
conformation, indicated by Δθf = 4.7 ± 0.8° for the C-helix probe (± SEM, n = 4) and 




Table 6.4: Parameters for the effect of 1% dextran on cTnC in situ orientation change. (A). C-helix probe; (B). E-helix probe. Order parameters <P2> 
and <P4> were obtained at relaxation and maximum activation using FISS. θf and σg respectively indicates the peak angle and standard deviation of the 
Gaussian orientation distribution of the probe angle with respect to the fibre axis. Mean ± SEM. Δ is the difference of each parameter between pCa 9.0 
and pCa 4.5. n = 4 for the C-helix probe and n = 5 for the E-helix probe. Comparison: paired two-tailed student t-test — no dextran vs 1% dextran 
(statistical significance * p<0.05, ** p<0.01, *** p<0.001). Changes in <P4> upon 1% dextran compression for BR-cTnC-C had a p value of 0.0536. 
   
E-helix  
1.9 μm  1.9 μm + 1% Dextran  
<P
2
>  <P4>  Θf (°) σg (°)  <P2>  <P4>  Θf (°) σg (°)  
pCa9.0  0.250 ± 0.012 -0.120 ± 0.033  44.7 ± 0.6 17.8 ± 1.7 0.242 ± 0.011 -0.176 ± 0.024*  45.3 ± 0.5  15.2 ± 1.1*  
pCa4.5  0.164 ± 0.004 -0.159 ± 0.022  48.8 ± 0.2 17.0 ± 1.0 0.164 ± 0.010 -0.199 ± 0.018*  48.8 ± 0.5 15.1 ± 0.8*  
Δ  0.085 ± 0.012 0.039 ± 0.015 -4.1 ± 0.6 
 
0.078 ± 0.010 0.023 ± 0.013**  -3.5 ± 0.5  
 n  5 
 
C-helix  
1.9 μm  1.9 μm + 1% Dextran  
<P
2
>  <P4>  Θf (°)
 
 σg (°)  <P2>  <P4>  Θf (°) σg (°)  
pCa9.0  0.096 ± 0.005 -0.085 ± 0.021  52.5 ± 0.1 21.4 ± 1.3 0.091 ± 0.001 -0.135 ± 0.026**  52.5 ± 0.2 18.5 ± 1.4***  
pCa4.5  0.005 ± 0.007 -0.107 ± 0.029  57.2 ± 0.7 19.7 ± 1.6 0.013 ± 0.005  -0.131 ± 0.027*  56.4 ± 0.5  18.3 ± 1.5*  
Δ  0.091 ± 0.010 0.022 ± 0.008 -4.7 ± 0.8   0.078 ± 0.004 
-0.004 ± 0.003 
(p=0.0536) 
-3.9 ± 0.3   





As shown in Table 6.4 A, the <P2> values for the C-helix probe at both relaxation 
(pCa 9.0) and maximum activation (pCa 4.5) were not significantly affected by 
osmotic compression with 1% dextran, neither was the amplitude of C-helix’s 
orientation change upon maximum activation — Δ<P2>. Similarly, 1% dextran did not 
affect the corresponding changes in the mean axial angle θf. Interestingly, another 
order parameter <P4>, which reports higher resolution information about the 
orientation change of the BR probes, was reduced significantly both at pCa 9.0 (from 
-0.085 ± 0.021 to -0.135 ± 0.026) and at pCa 4.5 (-0.107 ± 0.029 to -0.131 ± 0.027), 
giving a total reduction in Δ<P4> from 0.022 ± 0.008 to -0.004 ± 0.003 (± SEM, n = 4) 
upon 1% dextran compression. However, the difference in Δ<P4> between the 
absence and presence of 1% dextran reported in Table 6.4 A was only nearly 
significant according to the paired two-tailed student t-test with a statistical 
significance p value equals to 0.0536. More direct comparison of the in situ orientation 
of both the C- and E-helix of cTnC during relaxation and maximum activation, with and 
without 1% dextran, is illustrated in Figure 6.4.  
Figure 6.4: Effect of 1% dextran on cTnC in situ orientation. Bar Charts show changes in 
<P2> upon maximum activation and addition of 1% dextran for A. C-helix probe; and B. 
E-helix probe. Green and red bar in each set respectively represent <P2> value at 
relaxation (pCa 9.0) and maximum activation (pCa 4.5). First set in each graph is the 
control group, second is with 1% dextran. Error bars denote SEM. n = 4 for BR-cTnC-C 
and n = 5 for BR-cTnC-E. (<P2> values are presented in Table 6.4). 
C-helix                                 E-helix 




On the other hand, in spite of an additional component in the <P2> values at 
higher pCa (9.0 to 6.0), the main part of <P2>-pCa curve of the C-helix probe did not 
shift upon compression with 1% dextran (Figure 6.5 A). The Ca2+ sensitivity (pCa50) 
was 5.46 ± 0.02 and 5.45 ± 0.03, respectively, for control and in 1% dextran, with 
ΔpCa50 being 0.01 ± 0.01 pCa units (± SEM, n = 4, not significant) (Table 6.5 A). The 
changes in nH showed a tendency towards increased cooperativity for the 
Ca2+-dependent change in C-helix orientation upon compression (ΔnH = 0.52 ± 0.65, p 
= 0.0836). These results were consistent with those obtained from the force-pCa 
relationship (Table 6.1 A).  
Similar to that for BR-cTnC-C, Δ<P2> and Δθf were also unaltered upon the 
treatment with 1% dextran in the E-helix probe experiments (Table 6.4 B). Likewise, in 
response to the osmotic compression with 1% dextran, <P4> was significantly 
decreased from -0.120 ± 0.033 to -0.176 ± 0.024 at relaxation, and from -0.159 ± 
0.022 to -0.199 ± 0.018 at maximum activation (± SEM, n = 5). The overall changes in 
<P4> between pCa 9.0 and 4.5 (Δ<P4>) were significantly reduced from 0.039 ± 0.015 
to 0.023 ± 0.013 (± SEM, n = 5).  
Similar to the previous measurements of BR-cTnC-E in the presence of 1% 
dextran, there was an additional component in the <P2>-pCa relationship for the 
E-helix probe at subthreshold pCa (pCa 9.0 to 6.2) (Figure 6.5 B). To simplify the 
analysis, the major component of the E-helix orientation change below pCa 6.2 was 
fitted to the Hill equation. As illustrated in Figure 6.5 B, <P2>-pCa curves were similar 
between the control and in the presence of 1% dextran, indicating a similar Ca2+ 
dependence. The Ca2+ sensitivity for the <P2>-pCa relationship for the E-helix probe 
was not significantly changed in response to the shrinkage of IS by 1% dextran, 
indicated by pCa50 = 5.46 ± 0.02 in control and 5.46 ± 0.02 (± SEM, n = 5) with 
addition of 1% dextran. nH was not affected by 1% dextran significantly either (ΔnH = 
-0.12 ± 0.16, p = 0.916). The results were comparable with those from the Ca2+ 






Figure 6.5: Effect of 1% dextran on the Ca
2+
 dependence of cTnC orientation change. 
<P2> values were plotted as functions of pCa at SL 1.9 μm (red circles) and at 1.9 μm with 
1% dextran (green circles) for A. C-helix probe; and B. E-helix probe. Red and green lines 
respectively indicate the Hill fitting for control and with 1% dextran. Error bars denote SEM. 
n = 4 for the C-helix labelled trabeculae and n = 5 for the E-helix labelled ones. (Hill 
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(B) 
E-helix     
183 
  
Table 6.5: Hill parameters for the effect of 1% dextran on the Ca
2+
 dependence of cTnC 
orientation change. (A). C-helix probe experiments; (B). E-helix probe experiments. 
Parameters were obtained by individually fitting data for each trabecula with and without 1% 
dextran. Δ<P2> represents the orientation change from relaxation to maximum activation. 
Mean ± SEM. n = 4 for the C-helix probe and n = 5 for the E-helix probe. Δ indicates the 
difference in each parameter after adding 1% dextran. Comparison: paired two-tailed 
student t-test before and after 1% dextan compression (not significant). 
C-helix  
  




> pCa 9.0 0.096 ± 0.005 0.091 ± 0.001   
<P
2
> pCa 4.5 0.005 ± 0.007 0.013 ± 0.005    
Δ<P
2
>  0.091 ± 0.010 0.078 ± 0.004    
pCa
50 
 5.46 ± 0.02 5.45 ± 0.03  -0.01 ± 0.01 
n
H 









> pCa 9.0 0.250 ± 0.012 0.242 ± 0.011        
<P
2
> pCa 4.5 0.164 ± 0.004 0.164 ± 0.010   
Δ<P
2
> 0.085 ± 0.012 0.078 ± 0.010   
pCa
50
 5.46 ± 0.02 5.46 ± 0.02  0.00 ± 0.01 
n
H 
 3.51 ± 0.31 3.38 ± 0.39 -0.12 ± 0.16 
n 5 
 
Additionally, the standard deviation σg for both C- and E-helix probes decreased 
slightly in response to dextran treatment, implying a less dispersion of probe 
distribution in the presence of dextran.  
The results so far showed that the Ca2+ sensitivity for both force and cTnC 
structural change were unaffected by 1% dextran, suggesting that the SL-dependent 
Ca2+ sensitivity in LDA is not determined by the corresponding changes in IS. There 
must be other mechanisms linking the information of SL to the myofilament Ca2+ 
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6.3.2 Osmotic Compression with 4% Dextran 
 
At SL 1.9 μm, the orientation of both the C- and E-helix of cTnC showed a parallel 
preference with respect to the fibre axis at relaxation state compared to the maximum 
activation state (Table 6.6). The similar slight perpendicular shift of cTnC conformation 
upon activation was found in previous experiments. Although there were small 
discrepancies among data reported in each study, it was very likely due to the 
variance in many factors, such as daily calibration of the experimental apparatus, 
different batches of trabeculae and solutions, etc.  
Osmotic compression with 4% dextran significantly affected the orientation of the 
C-helix at pCa 9.0 by decreasing <P2> from 0.079 ± 0.006 to 0.072 ± 0.006, resulting 
to a small increase in the axial angle θf from 53.5 ± 0.4° to 53.6 ± 0.3° (± SEM, n = 4) 
(Table 6.6 A). At the same time, the other order parameter <P4>, which describes the 
orientation of the BR probe with higher resolution information, also changed 
significantly in relaxation upon 4% dextran treatment. The significant effect of 
compression on the C-helix orientation at relaxing state has not been seen in the 
presence of 1% dextran (Table 6.4 A). However, there was no further impact of 4% 
dextran on the orientation of the C-helix either at pCa 4.5 or the overall change upon 
maximum activation (Δ<P2> or Δθf), similar to that for 1% dextran. In addition, a lower 
standard deviation σg in the presence of 4% dextran was observed for the C-helix 
probe at relaxation state (21.6 ± 0.6° in control, 19.8 ± 0.7° in 4% dextran (± SEM, n = 
4)). The comparisons of the in situ orientation of the C- and E-helix, at relaxation and 




Table 6.6: Parameters for the effect of 4% dextran on cTnC in situ orientation change. (A). C-helix probe experiments; (B). E-helix probe experiments. 
Order parameters <P2> and <P4> were obtained at relaxation and maximum activation using FISS. θf and σg respectively indicates the peak angle and 
standard deviation of the Gaussian orientation distribution of the probe with respect to the fibre axis. Mean ± SEM. Δ is the difference of each parameter 
between pCa 9.0 and pCa 4.5. n = 4 for the C-helix probe and n = 6 for the E-helix probe. Comparison: paired two-tailed student t-test — no dextran vs 
4% dextran (statistical significance * p<0.05, ** p<0.01).  
C-helix  
1.9 μm  1.9 μm + 4% Dextran  
<P
2
>  <P4>  Θf (°)
 
 σg (°)  <P2>  <P4>  Θf (°) σg (°)  
pCa 9.0  0.079 ± 0.006 -0.089 ± 0.010  53.5 ± 0.4 21.1 ± 0.6 0.072 ± 0.006* -0.109 ± 0.012**  53.6 ± 0.3*  19.8 ± 0.7**  
pCa 4.5  -0.004 ± 0.000  -0.079 ± 0.010  58.1 ± 0.2 21.3 ± 0.7 -0.002 ± 0.004  -0.094 ± 0.007  57.7 ± 0.3 20.3 ± 0.4  
Δ  0.083 ± 0.007 -0.010 ± 0.005  -4.6 ± 0.4 /  0.074 ± 0.010 -0.016 ± 0.006  -4.0 ± 0.6  /  
n  4 
 
E-helix  
1.9 μm  1.9 μm + 4% Dextran  
<P
2
>  <P4>  Θf (°) σg (°)  <P2>  <P4>  Θf (°) σg (°)  
pCa 9.0  0.219 ± 0.013 -0.094 ± 0.010  55.4 ± 0.7 19.5 ± 0.5  0.218 ± 0.016   -0.121 ± 0.014*  46.3 ± 0.8 18.1 ± 0.7*  
pCa 4.5  0.131 ± 0.009 -0.127 ± 0.007  60.6 ± 0.4 18.7 ± 0.4 0.134 ± 0.009  -0.147 ± 0.012*  50.3 ± 0.5 17.7 ± 0.6*  
Δ  0.088 ± 0.005 0.033 ± 0.008 -5.2 ± 0.3 /  0.084 ± 0.008 0.026 ± 0.007 -4.0 ± 0.4 /  






Figure 6.6: Effect of 4% dextran on cTnC in situ orientation. Bar Charts show changes in 
<P2> upon activation and addition of 4% dextran for A. C-helix probe; and B. E-helix probe. 
Green and red bar in each set represent <P2> value at relaxation (pCa 9.0) and maximum 
activation (pCa 4.5), respectively. First set in each graph is the control group, second is 
with 4% dextran. Error bars denote SEM. n = 4 for BR-cTnC-C and n = 6 for BR-cTnC-E. 
Statistical significance of the differences in the <P2> values between 0% dextran group 
and 4% dextran group for each helix probe was assessed using paired two-tailed student 
t-test: *p< 0.05. (<P2> values are presented in Table 6.6). 
 
As illustrated in Figure 6.7 A, the <P2> values fluctuated in the higher range of 
pCa. In this study, the Hill fitting was set through the maximum and minimum <P2> 
values in each condition. Figure 6.7 A showed the impact of 4% dextran on <P2> was 
over a very large range of pCa and became smaller near the maximum [Ca2+]. The 
Ca2+ sensitivity increase upon compression was indicated by an increase in pCa50 
from 5.41 ± 0.02 to 5.51 ± 0.02 (± SEM, n = 4) (Table 6.7 A). Also, there was no 
significant change in the cooperativity for the Ca2+-regulation of the C-helix orientation 
in the presence of 4% dextran. Current results were in agreement with the impact of 4% 









C-helix                                 E-helix 
(A)                                     (B) 
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Figure 6.7: Effect of 4% dextran on the Ca
2+
 dependence of cTnC orientation change. 
<P2> values were plotted as functions of pCa at SL 1.9 μm (red circles) and at 1.9 μm with 
4% dextran (purple circles) for A. C-helix probe; and B. E-helix probe. Red and purple 
lines indicate the Hill fitting for control and with 4% dextran, respectively. Error bars 
denote SEM. n = 4 for BR-cTnC-C and n = 6 for BR-cTnC-E. (Table 6.7). 
 
For BR-cTnC-E, there were no significant changes in <P2> and θf in response to 
compression with 4% dextran. On the other hand, <P4> was significantly reduced 
from -0.094 ± 0.010 to -0.121 ± 0.014 at pCa 9.0 and from -0.127 ± 0.007 to -0.147 ± 
0.012 at maximum activation at pCa 4.5(± SEM, n = 6) (Table 6.6 B). However, no 
significant difference in Δ<P4> between pCa 9.0 and pCa 4.5 was observed after 
(A) 
C-helix     
(B) 
E-helix       
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adding 4% dextran. Additionally, during both relaxation and maximum activation, there 
were reductions in the standard deviation σg for the E-helix probe in 4% dextran, 
similar to those in the presence of 1% dextran, suggesting a decrease in the 
dispersion of the orientation distribution for the BR probe by osmotic compression. 
As described previously, the orientation changes of the E-helix in 4% dextran 
showed an additional component in the subthreshold range of pCa (pCa 9.0 to 6.7) 
(Figure 6.7 B). The major component between pCa 6.7 and pCa 4.5 was then fitted to 
the Hill equation. Unlike the C-helix, the orientation of the E-helix, indicated by <P2>, 
was not significantly affected by 4% dextran at either relaxed or maximum activated 
state (Table 6.7 B, Figure 6.7 B). However, the compression by 4% dextran did 
increase the Ca2+ sensitivity for the E-helix orientation change significantly. The pCa50 
was increased from 5.46 ± 0.03 to 5.59 ± 0.02 with a ΔpCa50 of 0.13 ± 0.02 pCa units 
(± SEM, n = 6). Similar to those in the force measurement and the C-helix probe 
experiment, there was no significant change in the cooperativity (nH) for the Ca
2+ 
dependence of the E-helix orientation.  
The present results showed that the amplitude of orientation changes in both C 
and E helices of cTnC upon activation were not affected by osmotic compression, 
similar to that observed in increasing SL from 1.9 to 2.3 μm reported in Chapter 4. 
However, only in the presence of 4% dextran, there were increases in the Ca2+ 
sensitivity for both the force production and cTnC structural change (~0.14 pCa units). 
1% dextran did not affect the Ca2+ sensitivity significantly. Moreover, the increase in 
the Ca2+ sensitivity upon 4% dextran treatment reported here was largely comparable 
with that induced by SL increasing from 1.9 μm to 2.3 μm in Chapter 4 (~0.11 pCa 
units) (Table 4.3 & 4.5). Thus, mimicking the SL-induced changes in fibre width using 






Table 6.7: Hill parameters for the effect of 4% dextran on the Ca
2+
 dependence of cTnC 
orientation. (A). C-helix probe experiments; (B). E-helix probe experiments. Parameters 
were obtained by fitting data from each trabecula with and without 4% dextran. Δ<P2> 
represents the orientation change from pCa 9.0 to pCa 4.5. Mean ± SEM. n = 4 for 
BR-cTnC-C and n = 6 for BR-cTnC-E. Δ indicates the difference in each parameter after 
adding 1% dextran. Comparison: paired two-tailed student t-test before and after 4% 
dextran compression (* p<0.05, *** p<0.001). 
C-helix  
  




> pCa 9.0 0.079 ± 0.006 0.072 ± 0.006*    
<P
2
> pCa 4.5 -0.004 ± 0.000 -0.002 ± 0.004   
Δ<P
2
>  0.083 ± 0.007 0.074 ± 0.010   
pCa
50 
 5.41 ± 0.02 5.51 ± 0.02*  0.10 ± 0.02* 
n
H 









> pCa 9.0 0.219 ± 0.013 0.218 ± 0.016   
<P
2
> pCa 4.5 0.131 ± 0.009 0.134 ± 0.009   
Δ<P
2
> 0.088 ± 0.005 0.084 ± 0.008   
pCa
50
 5.46 ± 0.03 5.59 ± 0.02***  0.13 ± 0.02*** 
n
H 








6.4 Discussion  
 
6.4.1 Role of Interfilament Spacing in LDA 
 
Our results from the last two chapters have suggested that the LDA was likely 
controlled via two signalling pathways. The SL-dependent Ca2+ sensitivity was mainly 
regulated by the thin filament, while the SL-dependent maximum force generation 
was controlled by the thick filament. Yet how the signal of sarcomere lengthening 
transmits to affect both myofilaments is still an issue of discussion. One of the most 
popular hypothesis — the interfilament spacing theory, relates the radial distance 
between the thick and thin filaments to the SL-dependent regulation in LDA. 
    In this chapter, we first re-examined the role of IS in LDA. We investigated the 
relationship between changes in IS and the changes in maximum force/Ca2+ 
sensitivity without changing SL. The experiments were performed by osmotically 
compressing the myofilament lattice at SL 1.9 μm using 1% or 4% dextran to mimic 
the IS or fibre width change as induced by increasing SL to 2.3 μm. However, the 
amount of neither IS nor fibre width change was measured directly in this study. Our 
results also showed the effect of different degrees of osmotic compression on the 
Ca2+-regulated thin filament activation. 
As shown in the present study, the addition of either 1% or 4% dextran did not 
have significant effect on the maximum force development. This was not consistent 
with the previous reports, which showed the osmotic compression with less than 10% 
dextran increased the maximum force production markedly (Konhilas et al., 2002b; 
Wang and Fuchs, 1995). Our results disagreed with the IS theory, that the closer 
distance between the thick and thin filaments brought by osmotic compression 
enhances the probability of cross-bridges formation. However, as elucidated by 
Konhilas et al. (2002b), the osmotic compression-induced change in the IS depends 
on both the applied dextran concentration and the SL of the fibre. Therefore, one 
possible explanation for the different impacts of lattice compression on the maximum 
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force production amongst these studies, may be due to the different amounts of IS 
changes caused by various [dextran] and SL. On the other hand, we argued that, 
instead of increasing the number of force-generating cross-bridges, the osmotic 
compression-induced shrinkage of the myofilament lattice may have a structural 
impact on the myofilaments, especially on the relatively loose structure of the thick 
filament. The thick filament has a relatively loose structure as it contains 
parallel-organised and electrostatic interactions-aligned myosin molecules (Farman et 
al., 2006; McLachlan and Stewart, 1982). The structural impact of osmotic 
compression on the thick filament may include changes in the mobility, orientation, 
and position of the myosin heads, together with variations in the interactions with 
other sarcomeric proteins, either of them may affect Ca2+ sensitivity indirectly.    
In this study, we showed that the Ca2+ sensitivities for both force development 
and cTnC structural change were not affected by 1% dextran. The present results 
suggested that, under moderate compression with 1% dextran, there was no direct 
correlation between changes in the IS and the Ca2+ sensitivity. Mimicking the SL 
increasing-induced reductions in IS with 1% dextran did not reproduce the 
SL-dependent increase in Ca2+ sensitivity, disagreed with the IS theory.  
However, osmotic compression with 4% dextran significantly increased the Ca2+ 
sensitivity for both force and cTnC structural change. The increasing Ca2+ sensitivity 
was comparable with that induced by sarcomere lengthening from 1.9 μm to 2.3 μm. 
Although our current study showed that the SL-dependent Ca2+ sensitivity did not 
correlate with changes in the IS as well as with the fibre width, it did not necessarily 
imply a role of muscle width instead of lattice spacing as a determinant of SL change 
in LDA. Under physiological conditions, SL variation may have additional impacts on 
the extra-sarcomeric structures in addition to inducing inverse changes in IS. 
Therefore in our current results, osmotic compression with 1% dextran might only be 
sufficient to shrink the IS to match that at longer SL, yet the impact of SL elongation 
on the entire trabecula is more appropriately imitated by larger degree of compression 
with 4% dextran. 
Together with the results from 1% dextran, our results suggested there was no 
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simple relationship between the changes in the IS and the changes in the Ca2+ 
sensitivity. Osmotic compression at a short SL was not functionally equivalent to 
sarcomere lengthening. Our results suggested the effect of dextran treatment on Ca2+ 
sensitivity may be independent of changes in IS, indicating that changes in IS alone 
may not be a primary determinant in LDA. The different effects of 1% and 4% dextran 
compression on the Ca2+ sensitivity implied the existence of an osmotic 
compression-sensitive mechanism, by which the Ca2+ sensitivity is modulated 
independent of changes in the IS. 
 
6.4.2 Comparison with Previous Studies 
 
As the molecular basis of the Frank-Starling relationship, the two outcomes of LDA 
are regulated via two signalling pathways — the thick filament-regulated 
SL-dependent maximum force, and the thin filament-regulated SL-dependent Ca2+ 
sensitivity. In investigating how sarcomere lengthening transmits to affect both the 
thick and thin filaments, one particular hypothesis — the IS theory, has gained 
considerable experimental supports over the years. It proposes that it is the 
corresponding change in the radial distance between the thick and thin filament (the 
IS) that determines the effect of SL in LDA. The evaluations of the IS hypothesis have 
been performed by osmotically compression the myofilament lattice at short SL using 
high molecular weight molecule, dextran, to mimic the IS reduction induced by SL 
increasing.  
In this study, we found osmotic compression with either 1% or 4% dextran had no 
significant effect on maximum force production, which was not in agreement with the 
previous studies (Konhilas et al., 2002b; Wang and Fuchs, 1995). In the experiments 
by Wang and Fuchs (1995), compressing skinned cardiac fibre at SL 1.7 μm 
increased the force production at pCa 5.0 (maximum activation) of ~8%. Similarly, 
Konhilas et al. (2002b) found that the application of 1%, 3%, and 6% dextran at SL 2.2 
μm increased maximum force production by 13.3%, 12.2%, and 11.9%, respectively, 
compared with that in the absence of dextran. Our results in this study therefore 
193 
  
challenge the role of IS in determining the SL-dependent maximum force production. 
Our current conclusion implies that the reduction of IS is more likely to affect the 
structure of myosin-containing thick filaments than the number of force-generating 
cross-bridges. There is a possible structural effect of osmotic compression on 
potentially all components in the sarcomere, especially on the relatively loose 
composition of the thick filaments. 
The present experiments also showed the Ca2+ sensitivity for both force and 
cTnC structural change did not change significantly upon 1% dextran compression. 
The results were not in supportive of the earlier studies of the hypothesis, which 
concluded that the effect of SL on Ca2+ sensitivity in LDA could be largely accounted 
for by mimicking the SL-induced changes in IS (Fuchs and Wang, 1996; McDonald 
and Moss, 1995; Wang and Fuchs, 1995). However, this conclusion came almost 
entirely from the experiments in which the changes in IS were estimated from the 
reductions in muscle width, based on the assumption that the the changes in muscle 
width were proportional to the changes in IS. The assumption has been proved 
invalidate in cardiac muscle by the direct measurement of IS with X-ray diffraction. In 
contrast with the earlier studies using muscle width as an indicator of IS, our results 
were more consistent with that by Konhilas et al. (2002b), in which the actual IS was 
measured by X-ray diffraction. They showed that moderate compression with 1% 
dextran, which reduced the IS equivalent to that induced by SL increasing from 2.02 
μm to 2.19 μm in uncompressed trabeculae, did not increase the Ca2+ sensitivity 
significantly. 
Further compression with 4% dextran markedly increased the Ca2+ sensitivity by 
~0.14 pCa units. Our results showed no constant relationship between the changes in 
the IS and the changes in the Ca2+ sensitivity. Changes in the IS alone may not 
determine the effect of changing SL in LDA. More importantly, the various effects of 1% 
and 4% dextran compression on the Ca2+ sensitivity may rely on other mechanisms, 
such as the optimal IS theory, or the osmotic pressure-sensitive mechanism 
(explained below). 
It was suggested that there was an optimal lattice spacing between cardiac 
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myofilaments at which the position and formation of the cross-bridges was ideal to 
participate in the regulation of the Ca2+ sensitivity. An interfilament spacing smaller or 
larger than the optimal distance would result in imperfect attachments of myosin 
heads (Farman et al., 2006). In agreement with this theory, Konhilas et al. (2002b) 
showed that the relationship between IS and the Ca2+ sensitivity was highly non-linear. 
There was only a narrow range of IS within which the formation of cross-bridges, 
along with the changes in Ca2+ sensitivity were best correlated with the changes in IS. 
As described previously, the effect of osmotic compression on the myofilament lattice 
depends on both the concentration of dextran and SL. Thus, if the distance between 
myosin heads and actin is too far away from the optimal value (short SL), a small 
degree of compression would produce little or no change in the Ca2+ sensitivity 
(Cazorla et al., 2001). Therefore, at SL 1.9 μm in this study, 1% dextran might not be 
sufficient to reduce the IS into the narrow range of optimal IS. On the other hand, 4% 
dextran compression might produce a IS much closer to the ideal distance than that 
with 1% dextran (Fuchs and Martyn, 2005; Konhilas et al., 2002b). In such a case, 
myosin heads were able to interact with actin in a more optimal and efficient manner, 
resulting in an increase in the Ca2+ sensitivity.   
Additionally, studies by Farman et al. (2006) implied the existence of a osmotic 
pressure-sensitive mechanism, through which the Ca2+ sensitivity was regulated 
largely by the changes in the external osmotic pressure, independent of the changes 
in the IS. The mechanism assumes the Ca2+ sensitivity is regulated by osmotic 
pressure through the structural effect of compression on myosin heads. In their 
experiments, Farman et al. (2006) showed that there was a narrow range of osmotic 
pressure (0.24~0.38kPa, corresponding to 0.7%~1.0% dextran T-500) in which the 
Ca2+ sensitivity, together with the relative position of myosin heads, increased 
substantially upon compression. Further compression with higher osmotic pressure 
up to 6.7kPa (6% dextran) did not further increase either the Ca2+ sensitivity or the 
disposition of myosin heads, suggesting a switch-like mechanism in the regulation of 
Ca2+ sensitivity that highly depends on the extent of external osmotic compression 
rather than the alterations in the IS. It should be noted that these experiments were 
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performed at SL 2.2 μm, longer than the 1.9 μm employed in our investigations. 
Because the required osmotic compression to induce the switch-like activation 
depends on both SL and dextran concentration, the critical range of osmotic pressure 
that switches on the regulation of Ca2+ sensitivity in our current study might be 
reached by the addition of dextran between 1 and 4% at SL 1.9 μm.    
In conclusion, mimicking the SL-induced alterations in IS with 1% dextran did not 
reproduce the SL-dependent increase in the Ca2+ sensitivity, whereas further 
compression with 4% dextran significantly enhanced the Ca2+ sensitivity for both force 
and cTnC structural change. These results suggest that there is no simple relationship 
between the IS and the Ca2+ sensitivity. The different impacts of 1% and 4% dextran 
compression on the Ca2+ sensitivity may be due to the following mechanisms. 
Firstly, compression with 4% dextran that mimics the changes of fibre width as 
produced by stretching SL from 1.9 to 2.3 μm might lead to an IS much closer to the 
optimal one to which the myosin heads and the Ca2+ sensitivity are most sensitive; 
Secondly, changing SL may not only affect IS, but also alter interactions between the 
extra-sarcomeric proteins which consequently affect fibre width more than IS. Thus, 
mimicking changes in fibre width with 4% dextran might better reproduce the impact 
of SL stretching from 1.9 μm to 2.3 μm; moreover, there may be an osmotic 
pressure-sensitive mechanism in the regulation of Ca2+ sensitivity that depends on the 
extent of compression in a narrow range rather than the IS. In this study at SL 1.9 μm, 






















7.1 Conclusions and Future Work 
 
The Frank-Starling relationship describes an important regulatory system in the heart 
which correlates the amount of cardiac output with the amount of diastolic ventricular 
filling. During the time course of a heartbeat, increasing the blood filling in the ventricle 
stretches the ventricular wall, and leads to a stronger contraction in the heart. The 
stronger heart muscle contracts, the greater the ventricular pressure during systole, 
and ultimately, the more ejection volume. At its basis, the Frank-Starling relationship 
in the heart is caused by a phenomenon called LDA on the level of a cardiac muscle 
cell. Increasing the diastolic ventricular filling in the heart stretches the SL in the 
cardiomyocytes, leads to greater force production in the cardiac muscle contraction, 
which results in an enhancement of the heart’s performance in the next beat. It was 
suggested that this SL-dependent increase in the force production was not due to the 
increasing Ca2+ supply but the increasing Ca2+ sensitivity with increased SL. 
Therefore, in response to the increasing SL, the outcome of LDA has two aspects: the 
increasing maximum force production, and the increasing Ca2+ sensitivity.  
  In the scope of this thesis, the primary goal was to investigate the potential 
determinants and/or major events in LDA. As the cellular basis of the Frank-Starling 
relationship, the importance of LDA has been appreciated for a very long time. 
However, despite the extensive research regarding the molecular mechanisms 
underlying this length dependence in cardiomyocytes, no definite answer has yet to 
be produced. So this project mainly focused on the molecular mechanisms in sensing 
sarcomere lengthening and transmitting the signal to increase the maximum force 
generation and the Ca2+ sensitivity.  
  Early investigations have suggested that in a typical event of LDA, associated 
with the increased Ca2+ sensitivity for force, there was also an increased Ca2+ binding 
affinity for cTnC as SL increased (Hofmann and Fuchs, 1987a; Hofmann and Fuchs, 
1988; Wang and Fuchs, 1995). Our group’s previous studies have shown that the 
force development in cardiac muscle contraction was linearly related to the structural 
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change in cTnC upon Ca2+ activation, implying similar Ca2+ dependent behaviour in 
force and cTnC structural change (Sun et al., 2009). As the Ca2+-binding protein, 
cTnC has long been considered as an important modulator of the Ca2+ sensitivity. 
Therefore, our first investigation focused on the possibility of cTnC in sensing the SL 
change to modulate the maximum force and the Ca2+ sensitivity.  
  In this study, we used a fluorescence polarization technique, FISS, on a specific 
experimental set-up to examine some of the most promising hypotheses that may 
contribute to the signal transmission from sarcomere lengthening to increase the 
maximum force and the Ca2+ sensitivity. It allows us to measure the force 
development and cTnC structural change simultaneously, and to correlate the 
structure with the function of cTnC in the native environment of a working cardiac 
muscle cell on the timescale of a heartbeat. 
  As described before, cardiac muscle functions on the ascending limb of the 
length-tension curve under physiological conditions, corresponding to SL 1.7 μm to 
2.3 μm in human hearts (Hibberd and Jewell, 1982; Kentish et al., 1986). Within this 
working SL range, the contraction of the generally sub-maximally activated 
cardiomyocyte has large contractile reserve which is primarily subject to the 
regulation by SL change at a given [Ca2+] (Fabiato, 1981). In our experiments, in order 
to investigate the possible underlying mechanisms of the steep SL dependence in 
cardiac muscle contraction, we examined the alterations in some of the sarcomeric 
properties upon sarcomere lengthening from 1.9 μm to 2.3 μm in demembranated 
ventricular trabeculae from rat. The two SLs were chosen to represent lengths just 
above slack and optimally stretched, respectively, and each was set carefully by laser 
diffraction before activation (Section 2.5.1). As reported by Kentish et al. (1986), 
maximum Ca2+-activation at high SL caused an irreversible deterioration of the 
diffraction pattern. Even though the pattern could recovery after the muscle was 
slacked and relaxed, the pattern in subsequent contractions was compromised. For 
this reason, we investigated the impact of SL change on myofilament activation by 
stretching the trabeculae from SL 1.9 μm to 2.3 μm, instead of shortening them in the 
opposite direction, to leave the high [Ca2+] high SL condition at the end of the 
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experiment and minimise the muscle deterioration.  
  The key results of this project are concluded below.    
 
1. The role of cTnC 
In evaluating the possible role of cTnC in transmitting the information concerning SL 
variation to modulate the maximum force and the Ca2+ sensitivity for force, we found 
almost identical leftward shifts of the force-[Ca2+] and cTnC structural change-[Ca2+] 
relationships as SL increased from 1.9 to 2.3 μm, indicating similar SL-dependent 
increases in the Ca2+ sensitivity for both force and cTnC structural change. We have 
shown a ~40% increase in the maximum Ca2+-activated force upon SL increasing 
from 1.9 μm to 2.3 μm, together with ~0.11 pCa units increase in the Ca2+ sensitivity 
for force and cTnC structural change. However, the amplitude of orientation changes 
in either the C-helix in the regulator lobe of cTnC or the E-helix in the IT arm upon 
Ca2+-activation were not affected by SL increasing. That is, the SL-dependent 
increase in the force production was not accompanied by the increasing extent of 
structural changes in cTnC. Thus, we concluded, of the two outcomes of LDA, while 
the SL-dependent Ca2+ sensitivity for force is very likely modulated through the Ca2+ 
sensitivity for cTnC structural change by cTnC, the SL-dependent maximum force is 
not. It was suggested that this SL-dependent increase in the maximum force was the 
result of an increasing number of force-generating cross-bridges formed at longer SL 
(Allen and Kentish, 1985; Wannenburg et al., 2000; Wannenburg et al., 1997), thus 
leads us to the next investigation on the thick filament cross-bridges. 
 
2. The role of force-generating cross-bridges 
As the cellular basis of the Frank-Starling relationship between ventricular volume and 
pressure, the SL-dependent modulation of the force development at a given [Ca2+] 
largely depends on alterations in the number of the force-generating cross-bridges 
(Allen and Kentish, 1985). In order to investigate the role of force-generating 
cross-bridges in the other outcome of LDA — the SL-dependent Ca2+ sensitivity, our 
next focus moved onto the thick filament. We determined whether the SL-dependent 
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variation in the number of the strong cross-bridge attachments may be responsible for 
the length modulation of not only the maximum force development, but also the Ca2+ 
sensitivity. In our experiments, active force inhibition by blebbistatin depressed the 
amplitude of cTnC structural change upon activation in both the regulatory head and 
the IT arm, with the effect being stronger in the IT arm. The results indicate an 
important role of the force-generating cross-bridges on the structural changes of cTnC 
upon activation, possibly, by keeping the inhibitory region of cTnI off the actin and 
stabilizing the Ca2+-sensitizing cTnI/cTnC interactions. The inhibition of 
force-generating cross-bridges also reduced the Ca2+ sensitivity for cTnC structural 
changes, but had no significant effect on the cooperativity. Thus, the formation of 
strong binding cross-bridges may be involved in regulating the Ca2+ sensitivity through 
stabilising the Ca2+-sensing cTnI/cTnC interactions, which in turn, stabilises the 
conformational change in cTnC in Ca2+-activation.  
  To further investigate the role of the force-generating cross-bridges in LDA, we 
examined the impact of cross-bridges inhibition on the SL-dependent Ca2+ sensitivity 
by increasing SL from 1.9 to 2.3 μm in the presence of blebbistatin. We found that 
stretching SL after the inhibition of the force-generating cross-bridges still produced 
an increase in the Ca2+ sensitivity, although to a less degree as that without force 
inhibition. That is, even without force-generating myosin cross-bridges, there was still 
SL-dependent Ca2+ sensitivity in the thin filament. These results suggested that, even 
though the force-generating cross-bridges modulated the myofilament Ca2+ sensitivity 
in certain ways, they were not essential for the SL-dependent Ca2+ sensitivity in LDA. 
The two outcomes of LDA are very likely due to two independent pathways: the 
control centre for regulating the SL-dependent Ca2+ sensitivity locates on the thin 
filament by cTnC, and that for regulating the SL-dependent maximum force locates on 
the thick filament by force-generating cross-bridges. In the meantime, the thick 
filament cross-bridges may provide a positive feedback to support the increasing Ca2+ 





3. The role of interfilament spacing 
Lastly, we examined one of the most popular hypotheses of LDA — the interfilament 
spacing theory. It has been suggested that the SL increasing-induced closer 
approximation of the myosin heads and actin favours more actomyosin interactions, 
thereby enhances the probability of cross-bridges formation, and may in turn increase 
the Ca2+ sensitivity. The role of IS in LDA has been tested in this study. High molecular 
weight molecule dextran was used to osmotically compress the skinned cardiac 
trabeculae at a short SL (1.9 μm) to mimic the impact of stretching to a long SL (2.3 
μm) on thin filament activation. According to the different impact of dextran 
compression on the IS and fibre width, two concentrations of dextran, 1% and 4%, 
were chosen to mimic the corresponding reductions in the IS and fibre width as those 
induced by SL increasing from 1.9 to 2.3 μm, respectively. 
The results showed that mimicking the SL increasing-induced reductions in the IS 
with 1% dextran did not reproduce the SL-dependent increase in the Ca2+ sensitivity. 
However, further compression with 4% dextran did increase the Ca2+ sensitivity 
significantly. Our results suggested there was no simple relationship between the 
changes in the IS and the changes in the Ca2+ sensitivity. Osmotic compression at a 
short SL was not functionally equivalent to sarcomere lengthening. Consistent with 
the recent findings from other researchers, our investigations disagreed with the 
hypothesis, indicating that change in IS was not completely responsible for the 
SL-dependent Ca2+ sensitivity in LDA.  
The different impact of 1% dextran and 4% dextran compression on the Ca2+ 
sensitivity may be due to various factors, including: the existence of an optimal IS at 
which the regulation of Ca2+ sensitivity is most sensitive to the change in IS; the 
additional impacts of SL variation on the entire trabeculae in addition to inducing 
inverse change in IS; and a possible osmotic pressure-sensitive effect of compression 
in the regulation of Ca2+ sensitivity that depends on the extent of compression in a 
narrow range rather than the IS.  
  
From our current findings we know that the two outcomes of LDA come from two 
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independent signally pathways: the thin filament-regulated Ca2+ sensitivity and the 
thick filament-regulated maximum force. This specifies the direction for the future 
investigations of the signal pathway in LDA. Next task on the list would be to 
investigate how the signal of sarcomere lengthening is transmitted to affect both the 
thick and thin filaments, is there a primary length sensing component in LDA or is the 
effect of multiple protein networks in the sarcomere? Further considerations should 
focus on the giant protein titin and cMyBP-C, as the two proteins have interactions 
with both filaments. Also, the structural impact of LDA on other sarcomeric proteins 
that involved in the cardiac muscle contraction could provide insights in the molecular 
mechanisms of LDA as well. Using more BR-probes on various sites and proteins in 
the sarcomere is desired. 
 
7.2 Limitations and Future Improvements of FISS 
 
In this study, fluorescence for in situ structure was used to study the orientation 
changes in the two major domains, the regulatory head and the IT arm in the Tn 
complex, and their relationships with [Ca2+]. This approach measures the orientation 
distributions of all labelled proteins. Thus, the accuracy of FISS is largely dependent 
on the normal structure and function of the target protein domain after labelling and 
reconstitution. Previous studies using NMR spectroscopy have shown that neither the 
mutagenesis nor the BR labelling substantially altered the structure of the labelled 
domain (Mercier et al., 2003). However, current studies cannot exclude the possibility 
that these modifications may affect the in situ interactions between cTnC and other 
sarcomeric proteins. The force recovery after reconstitution with each BR-cTnC was 
similar compared to that obtained for unlabelled recombinant cTnC, indicating that the 
functional properties of cTnC were not significantly affected by BR probes either. 
Previous studies show that the presence of BR probe on either the C- or E-helix of 
cTnC did reduce the Ca2+ affinity of the regulatory site of cTnC with no significant 
effect on the cooperativity of Ca2+ regulation (Sun et al., 2009). The orientation 
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information obtained by the fluorescence polarization measurement in this study has 
limitations, including the limited orientational resolution obtained from the first two 
order parameters and the lack of the information in the azimuthal orientation 
distribution of the probe dipole around the symmetric actin filament axis.  
Further development of the fluorescence polarization technique for in situ 
measurements of protein structure may focus on the above limitations in various ways, 
e.g. increasing the number of probe labelling sites on the desired protein, in 
combination with using pulsed rather than continuous excitation, may help improve 
the resolution of the orientation measurements, also allow the measurement of 
azimuthal motions in the labelled-domain (Bell et al., 2002; Cone, 1972; van der 
Heide et al., 2000). 
 
7.3 Other Limitations 
 
The conclusions we drew in this study were based on experiments performed with 
skinned preparations of the rat cardiac trabeculae. Permeabilization allows easy 
access and control of the free [Ca2+], MgATP and other small molecules in the 
trabeculae, direct measurement of the Ca2+ binding, and the replacement and 
modification of the sarcomeric proteins for mechanistic studies (Sun and Irving, 2010). 
However, demembranation of muscle fibres has a number of downsides compared to 
the intact cells, such as the non-constant myofilament volume which results in the 
greater interfilament spacing at a given SL. Also, the experimental temperature was 
lower than the physiological one. Moreover, in terms of the impact of skinning on SL, 
Kentish et al. (1986) reported an increasing intensity with a decreasing dispersion of 
the first order diffraction pattern upon the skinning procedure. Initially, it seemed not 
only did the permeabilization not interfere with the measurement of SL, but made it 
even easier due to the increasing intensity and decreasing dispersion. However, as 
described previously, the first order diffraction pattern deteriorated during activations 
at high [Ca2+] and high SLs in the skinned fibres, whilst remained constant in the intact 
204 
  
cardiac muscle. It is therefore necessary to seek for an effective solution to elucidate 
the mechanisms and events underlying the LDA under more realistic physiological 
conditions in the living heart in the future. 
Additionally, it may be argued that the measurements of the force-pCa and cTnC 
structural change-pCa relationships in this study were under activation conditions, 
whereas the SL was set under relaxing conditions prior to the activation. Although the 
SL was checked after each series of continuous activation to make sure it did not 
deviate from the original setting, it was not measured during activation due to 
technical difficulties and the deterioration of the laser diffraction pattern after 
maximum Ca2+-activation. Therefore, the relationships reported in the current 
experiments between myofilament Ca2+ sensitivity and SL under various conditions 
actually included some uncertainty about SL. Further experiments are still in need for 
assessing the quantitive relationships between SL and myofilament activation during 
contraction more specifically. Powerful techniques as to simultaneously measure the 
























Adhikari, B.B., and P.G. Fajer. 1996. Myosin head orientation and mobility during isometric 
contraction: effects of osmotic compression. Biophys. J. 70:1872-1880. 
Adhikari, B.B., M. Regnier, A.J. Rivera, K.L. Kreutziger, and D.A. Martyn. 2004. Cardiac length 
dependence of force and force redevelopment kinetics with altered cross-bridge 
cycling. Biophys. J. 87:1784-1794. 
Agianian, B., U. Krzic, F. Qiu, W.A. Linke, K. Leonard, and B. Bullard. 2004. A troponin switch 
that regulates muscle contraction by stretch instead of calcium. EMBO J. 23:772-779. 
Allen, D.G., B.R. Jewell, and J.W. Murray. 1974. The contribution of activation processes to the 
length-tension relation of cardiac muscle. Nature. 248:606-607. 
Allen, D.G., and J.C. Kentish. 1985. The cellular basis of the length-tension relation in cardiac 
muscle. J. Mol. Cell. Cardiol. 17:821-840. 
Allen, D.G., and S. Kurihara. 1982. The effects of muscle length on intracellular calcium 
transients in mammalian cardiac muscle. J Physiol. 327:79-94. 
Allhouse, L.D., J.D. Potter, and C.C. Ashley. 1999. A novel method of extraction of TnC from 
skeletal muscle myofibrils. Pflugers Arch. 437:695-701. 
Allingham, J.S., R. Smith, and I. Rayment. 2005. The structural basis of blebbistatin inhibition 
and specificity for myosin II. Nat Struct Mol Biol. 12:378-379. 
Anson, M., M.A. Geeves, S.E. Kurzawa, and D.J. Manstein. 1996. Myosin motors with artificial 
lever arms. EMBO J. 15:6069-6074. 
Babu, A., E. Sonnenblick, and J. Gulati. 1988. Molecular basis for the influence of muscle 
length on myocardial performance. Science. 240:74-76. 
Bell, M.G., R.E. Dale, U.A. van der Heide, and Y.E. Goldman. 2002. Polarized fluorescence 
depletion reports orientation distribution and rotational dynamics of muscle 
cross-bridges. Biophys. J. 83:1050-1073. 
Bell, M.G., E.B. Lankford, G.E. Gonye, G.C. Ellis-Davies, D.A. Martyn, M. Regnier, and R.J. 
Barsotti. 2006. Kinetics of cardiac thin-filament activation probed by fluorescence 
polarization of rhodamine-labeled troponin C in skinned guinea pig trabeculae. 
Biophys. J. 90:531-543. 
Blix, M. 1894. Die Länge und die Spannung des Muskels1. Skandinavisches Archiv Für 
Physiologie. 5:173-206. 
Brack, A.S., B.D. Brandmeier, R.E. Ferguson, S. Criddle, R.E. Dale, and M. Irving. 2004. 
Bifunctional rhodamine probes of Myosin regulatory light chain orientation in relaxed 
skeletal muscle fibers. Biophys. J. 86:2329-2341. 
Bremel, R.D., and A. Weber. 1972. Cooperation within actin filament in vertebrate skeletal 
muscle. Nat New Biol. 238:97-101. 
Brenner, B., T. Kraft, L.C. Yu, and J.M. Chalovich. 1999. Thin filament activation probed by 
fluorescence of 
N-((2-(iodoacetoxy)ethyl)-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole-labeled 
troponin I incorporated into skinned fibers of rabbit psoas muscle. Biophys. J. 
77:2677-2691. 
Brown, J.H., Z. Zhou, L. Reshetnikova, H. Robinson, R.D. Yammani, L.S. Tobacman, and C. 
Cohen. 2005. Structure of the mid-region of tropomyosin: bending and binding sites 
for actin. Proc. Natl. Acad. Sci. U. S. A. 102:18878-18883. 
Campbell, A.P., and B.D. Sykes. 1991. Interaction of troponin I and troponin C. Use of the 
207 
  
two-dimensional nuclear magnetic resonance transferred nuclear Overhauser effect to 
determine the structure of the inhibitory troponin I peptide when bound to skeletal 
troponin C. J. Mol. Biol. 222:405-421. 
Campbell, K.B., H. Taheri, R.D. Kirkpatrick, T. Burton, and W.C. Hunter. 1993. Similarities 
between dynamic elastance of left ventricular chamber and papillary muscle of rabbit 
heart. Am. J. Physiol. 264:H1926-1941. 
Cazorla, O., G. Vassort, D. Garnier, and J.Y. Le Guennec. 1999. Length modulation of active 
force in rat cardiac myocytes: is titin the sensor? J. Mol. Cell. Cardiol. 31:1215-1227. 
Cazorla, O., Y.M. Wu, T.C. Irving, and H. Granzier. 2001. Titin-based modulation of calcium 
sensitivity of active tension in mouse skinned cardiac myocytes. Circ. Res. 
88:1028-1035. 
Cone, R.A. 1972. Rotational diffusion of rhodopsin in the visual receptor membrane. Nat New 
Biol. 236:39-43. 
Cooke, R. 1997. Actomyosin interaction in striated muscle. Physiol. Rev. 77:671-697. 
Corrie, J.E., B.D. Brandmeier, R.E. Ferguson, D.R. Trentham, J. Kendrick-Jones, S.C. 
Hopkins, U.A. van der Heide, Y.E. Goldman, C. Sabido-David, R.E. Dale, S. Criddle, 
and M. Irving. 1999. Dynamic measurement of myosin light-chain-domain tilt and twist 
in muscle contraction. Nature. 400:425-430. 
Corrie, J.E., J.S. Craik, and V.R. Munasinghe. 1998. A homobifunctional rhodamine for 
labeling proteins with defined orientations of a fluorophore. Bioconjug. Chem. 
9:160-167. 
Craig, R., K.H. Lee, J.Y. Mun, I. Torre, and P.K. Luther. 2014. Structure, sarcomeric 
organization, and thin filament binding of cardiac myosin-binding protein-C. Pflugers 
Arch. 466:425-431. 
Dale, R.E., S.C. Hopkins, U.A. an der Heide, T. Marszalek, M. Irving, and Y.E. Goldman. 1999. 
Model-independent analysis of the orientation of fluorescent probes with restricted 
mobility in muscle fibers. Biophys. J. 76:1606-1618. 
Davis, J.P., C. Norman, T. Kobayashi, R.J. Solaro, D.R. Swartz, and S.B. Tikunova. 2007. 
Effects of thin and thick filament proteins on calcium binding and exchange with 
cardiac troponin C. Biophys. J. 92:3195-3206. 
de Tombe, P.P., R.D. Mateja, K. Tachampa, Y. Ait Mou, G.P. Farman, and T.C. Irving. 2010. 
Myofilament length dependent activation. J. Mol. Cell. Cardiol. 48:851-858. 
Dobesh, D.P., J.P. Konhilas, and P.P. De Tombe. 2002. Cooperative activation in cardiac 
muscle: imapct of sarcomere length. Am J Physiol Heart Circ Physiol. 282:1055-1062. 
Dou, Y., P. Arlock, and A. Arner. 2007. Blebbistatin specifically inhibits actin-myosin interaction 
in mouse cardiac muscle. Am J Physiol. Cell Physiol. 293:C1148-1153. 
Ebashi, S., F. Ebashi, and A. Kodama. 1967. Troponin as the Ca
2+
-receptive protein in the 
contractile system. J Biochem. 62:137-138. 
Ebashi, S., and M. Endo. 1968. Calcium ion and muscle contraction. Prog. Biophys. Mol. Biol. 
18:123-183. 
Ebashi, S., M. Endo, and I. Otsuki. 1969. Control of muscle contraction. Q. Rev. Biophys. 
2:351-384. 
Endo, M. 1972. Stretch-Induced Increase in Activation of Skinned Muscle Fibers by Calcium. 
Nat-New Biol. 237:211-&. 
208 
  
Fabiato, A. 1981. Myoplasmic free calcium concentration reached during the twitch of an intact 
isolated cardiac cell and during calcium-induced release of calcium from the 
sarcoplasmic reticulum of a skinned cardiac cell from the adult rat or rabbit ventricle. J. 
Gen. Physiol. 78:457-497. 
Fabiato, A., and F. Fabiato. 1975. Dependence of the contractile activation of skinned cardiac 
cells on the sarcomere length. Nature. 256:54-56. 
Fabiato, A., and F. Fabiato. 1978. Myofilament-Generated Tension Oscillations during Partial 
Calcium Activation and Activation Dependence of Sarcomere Length-Tension Relation 
of Skinned Cardiac Cells. J. Gen. Physiol. 72:667-699. 
Farah, C.S., C.A. Miyamoto, C.H. Ramos, A.C. da Silva, R.B. Quaggio, K. Fujimori, L.B. 
Smillie, and F.C. Reinach. 1994. Structural and regulatory functions of the NH2- and 
COOH-terminal regions of skeletal muscle troponin I. J. Biol. Chem. 269:5230-5240. 
Farman, G.P., E.J. Allen, K.Q. Schoenfelt, P.H. Backx, and P.P. de Tombe. 2010. The Role of 
Thin Filament Cooperativity in Cardiac Length-Dependent Calcium Activation. Biophys. 
J. 99:2978-2986. 
Farman, G.P., D. Gore, E. Allen, K. Schoenfelt, T.C. Irving, and P.P. de Tombe. 2011. Myosin 
head orientation: a structural determinant for the Frank-Starling relationship. Am J 
Physiol-Heart C. 300:H2155-H2160. 
Farman, G.P., K. Tachampa, R. Mateja, O. Cazorla, A. Lacampagne, and P.P. de Tombe. 2008. 
Blebbistatin: use as inhibitor of muscle contraction. Pflugers Arch. 455:995-1005. 
Farman, G.P., J.S. Walker, P.P. de Tombe, and T.C. Irving. 2006. Impact of osmotic 
compression on sarcomere structure and myofilament calcium sensitivity of isolated 
rat myocardium. Am J Physiol-Heart C. 291:H1847-H1855. 
Ferguson, R.E., Y.B. Sun, P. Mercier, A.S. Brack, B.D. Sykes, J.E.T. Corrie, D.R. Trentham, 
and M. Irving. 2003. In Situ Orientations of Protein Domains:Troponin C in Skeletal 
Muscle Fibers. Mol. Cell:865-874. 
Fitzsimons, D.P., and R.L. Moss. 1998. Strong binding of myosin modulates length-dependent 
Ca
2+
 activation of rat ventricular myocytes. Circ. Res. 83:602-607. 
Flicker, P.F., G.N. Phillips, Jr., and C. Cohen. 1982. Troponin and its interactions with 
tropomyosin. An electron microscope study. J. Mol. Biol. 162:495-501. 
Ford, L.E., K. Nakagawa, J. Desper, and C.Y. Seow. 1991. Effect of osmotic compression on 
the force-velocity properties of glycerinated rabbit skeletal muscle cells. J. Gen. 
Physiol. 97:73-88. 
Frey, N., M. Luedde, and H.A. Katus. 2012. Mechanisms of disease: hypertrophic 
cardiomyopathy. Nat Rev Cardiol. 9:91-100. 
Fuchs, F., and D.A. Martyn. 2005. Length-dependent Ca
2+
 activation in cardiac muscle: some 
remaining questions. J Muscle Res Cell M. 26:199-212. 
Fuchs, F., and S.H. Smith. 2001. Calcium, cross-bridges, and the Frank-Starling relationship. 
News Physiol Sci. 16:5-10. 
Fuchs, F., and Y.P. Wang. 1996. Sarcomere length versus interfilament spacing as 
determinants of cardiac myofilament Ca
2+
 sensitivity and Ca
2+
 binding. J. Mol. Cell. 
Cardiol. 28:1375-1383. 
Fujii, T., A.H. Iwane, T. Yanagida, and K. Namba. 2010. Direct visualization of secondary 
structures of F-actin by electron cryomicroscopy. Nature. 467:724-728. 
209 
  
Fukuda, N., and H.L. Granzier. 2005. Titin/connectin-based modulation of the Frank-Starling 
mechanism of the heart. J Muscle Res Cell M. 26:319-323. 
Fukuda, N., H. Kajiwara, S. Ishiwata, and S. Kurihara. 2000. Effects of MgADP on length 
dependence of tension generation in skinned rat cardiac muscle. Circ. Res. 86:E1-E6. 
Fukuda, N., T. Terui, I. Ohtsuki, S. Ishiwata, and S. Kurihara. 2009. Titin and Troponin Central 
Players in the Frank-Starling Mechanism of the heart. Current Cardiology Reviews. 
5:119-124. 
Gasmi-Seabrook, G.M., J.W. Howarth, N. Finley, E. Abusamhadneh, V. Gaponenko, R.M. Brito, 
R.J. Solaro, and P.R. Rosevear. 1999. Solution structures of the C-terminal domain of 
cardiac troponin C free and bound to the N-terminal domain of cardiac troponin I. 
Biochemistry (Mosc). 38:8313-8322. 
Geeves, M.A., and K.C. Holmes. 1999. Structural mechanism of muscle contraction. Annu. 
Rev. Biochem. 68:687-728. 
Godt, R.E., and D.W. Maughan. 1981. Influence of osmotic compression on calcium activation 
and tension in skinned muscle fibers of the rabbit. Pflugers Arch. 391:334-337. 
Goo, S., P. Joshi, G. Sands, D. Gerneke, A. Taberner, Q. Dollie, I. LeGrice, and D. Loiselle. 
2009. Trabeculae carneae as models of the ventricular walls: implications for the 
delivery of oxygen. J. Gen. Physiol. 134:339-350. 
Gordon, A.M., E. Homsher, and M. Regnier. 2000. Regulation of contraction in striated muscle. 
Physiol. Rev. 80:853-924. 
Gordon, A.M., A.F. Huxley, and F.J. Julian. 1966. The variation in isometric tension with 
sarcomere length in vertebrate muscle fibres. J Physiol. 184:170-192. 
Gordon, A.M., M. Regnier, and E. Homsher. 2001. Skeletal and cardiac muscle contractile 
activation: tropomyosin "rocks and rolls". News Physiol Sci. 16:49-55. 
Gordon, A.M., and E.B. Ridgway. 1993. Cross-bridges affect both TnC structure and calcium 
affinity in muscle fibers. Adv. Exp. Med. Biol. 332:183-192; discussion 192-184. 
Granzier, H.L., and T.C. Irving. 1995. Passive tension in cardiac muscle: contribution of 
collagen, titin, microtubules, and intermediate filaments. Biophys. J. 68:1027-1044. 
Greaser, M.L., and J. Gergely. 1971. Reconstitution of troponin activity from three protein 
components. J. Biol. Chem. 246:4226-4233. 
Hamdani, N., V. Kooij, S. van Dijk, D. Merkus, W.J. Paulus, C.D. Remedios, D.J. Duncker, G.J. 
Stienen, and J. van der Velden. 2008. Sarcomeric dysfunction in heart failure. 
Cardiovasc. Res. 77:649-658. 
Hanft, L.M., F.S. Korte, and K.S. McDonald. 2008. Cardiac function and modulation of 
sarcomeric function by length. Cardiovasc. Res. 77:627-636. 
Hanson, J., and H.E. Huxley. 1953. Structural basis of the cross-striations in muscle. Nature. 
172:530-532. 
Haselgrove, J.C., and H.E. Huxley. 1973. X-ray evidence for radial cross-bridge movement 
and for the sliding filament model in actively contracting skeletal muscle. J. Mol. Biol. 
77:549-568. 
Herzberg, O., and M.N. James. 1985. Structure of the calcium regulatory muscle protein 
troponin-C at 2.8 A resolution. Nature. 313:653-659. 
Hibberd, M.G., and B.R. Jewell. 1982. Calcium- and length-dependent force production in rat 
ventricular muscle. J Physiol. 329:527-540. 
210 
  
Hofmann, P.A., and F. Fuchs. 1987a. Effect of Length and Cross-Bridge Attachment on Ca
2+
 
Binding to Cardiac Troponin-C. Am J of Physiol. 253:C90-C96. 
Hofmann, P.A., and F. Fuchs. 1987b. Evidence for a Force-Dependent Component of 
Calcium-Binding to Cardiac Troponin-C. Am J of Physiol. 253:C541-C546. 
Hofmann, P.A., and F. Fuchs. 1988. Bound calcium and force development in skinned cardiac 
muscle bundles: effect of sarcomere length. J. Mol. Cell. Cardiol. 20:667-677. 
Holmes, K.C., D. Popp, W. Gebhard, and W. Kabsch. 1990. Atomic model of the actin filament. 
Nature. 347:44-49. 
Holroyde, M.J., S.P. Robertson, J.D. Johnson, R.J. Solaro, and J.D. Potter. 1980. The calcium 
and magnesium binding sites on cardiac troponin and their role in the regulation of 
myofibrillar adenosine triphosphatase. J. Biol. Chem. 255:11688-11693. 
Hopkins, S.C., C. Sabido-David, J.E. Corrie, M. Irving, and Y.E. Goldman. 1998. Fluorescence 
polarization transients from rhodamine isomers on the myosin regulatory light chain in 
skeletal muscle fibers. Biophys. J. 74:3093-3110. 
Hopkins, S.C., C. Sabido-David, U.A. van der Heide, R.E. Ferguson, B.D. Brandmeier, R.E. 
Dale, J. Kendrick-Jones, J.E. Corrie, D.R. Trentham, M. Irving, and Y.E. Goldman. 
2002. Orientation changes of the myosin light chain domain during filament sliding in 
active and rigor muscle. J. Mol. Biol. 318:1275-1291. 
Huxley, A.F., and R. Niedergerke. 1954. Structural changes in muscle during contraction; 
interference microscopy of living muscle fibres. Nature. 173:971-973. 
Huxley, H., and J. Hanson. 1954. Changes in the Cross-Striations of Muscle during 
Contraction and Stretch and their Structural Interpretation. Nature. 173:973-976. 
Huxley, H.E. 1953a. Electron microscope studies of the organisation of the filaments in striated 
muscle. Biochim. Biophys. Acta. 12:387-394. 
Huxley, H.E. 1953b. X-ray analysis and the problem of muscle. Proc. R. Soc. Lond. B. Biol. Sci. 
141:59-62. 
Huxley, H.E. 1957. The double array of filaments in cross-striated muscle. J Biophys Biochem 
Cytol. 3:631-648. 
Irving, M. 1996. Steady-state polarization from cylindrically symmetric fluorophores 
undergoing rapid restricted motion. Biophys. J. 70:1830-1835. 
Irving, M., T. St Claire Allen, C. Sabido-David, J.S. Craik, B. Brandmeier, J. Kendrick-Jones, 
J.E. Corrie, D.R. Trentham, and Y.E. Goldman. 1995. Tilting of the light-chain region of 
myosin during step length changes and active force generation in skeletal muscle. 
Nature. 375:688-691. 
Irving, T.C., J. Konhilas, D. Perry, R. Fischetti, and P.P. De Tombe. 2000. Myofilament lattice 
spacing as a function of sarcomere length in isolated rat myocardium. Am J 
Physiol-Heart C. 279:H2568-H2573. 
Jewell, B.R. 1977. A reexamination of the influence of muscle length on myocardial 
performance. Circ. Res. 40:221-230. 
Johnson, J.D., J.H. Collins, S.P. Robertson, and J.D. Potter. 1980. A fluorescent probe study of 
Ca
2+
 binding to the Ca
2+
-specific sites of cardiac troponin and troponin C. J. Biol. 
Chem. 255:9635-9640. 
Julien, O., Y.B. Sun, A.C. Knowles, B.D. Brandmeier, R.E. Dale, D.R. Trentham, J.E. Corrie, 
B.D. Sykes, and M. Irving. 2007. Toward protein structure in situ: comparison of two 
211 
  
bifunctional rhodamine adducts of troponin C. Biophys. J. 93:1008-1020. 
Kabsch, W., H.G. Mannherz, D. Suck, E.F. Pai, and K.C. Holmes. 1990. Atomic structure of the 
actin:DNase I complex. Nature. 347:37-44. 
Kawai, M., J.S. Wray, and Y. Zhao. 1993. The effect of lattice spacing change on cross-bridge 
kinetics in chemically skinned rabbit psoas muscle fibers. I. Proportionality between 
the lattice spacing and the fiber width. Biophys. J. 64:187-196. 
Kentish, J.C., H.E. ter Keurs, L. Ricciardi, J.J. Bucx, and M.I. Noble. 1986. Comparison 
between the sarcomere length-force relations of intact and skinned trabeculae from rat 
right ventricle. Influence of calcium concentrations on these relations. Circ. Res. 
58:755-768. 
Kirschenlohr, H.L., A.A. Grace, J.I. Vandenberg, J.C. Metcalfe, and G.A. Smith. 2000. 
Estimation of systolic and diastolic free intracellular Ca
2+
 by titration of Ca
2+
 buffering 
in the ferret heart. Biochem. J. 346 Pt 2:385-391. 
Knowles, A.C., M. Irving, and Y.B. Sun. 2012. Conformation of the Troponin Core Complex in 
the Thin Filaments of Skeletal Muscle during Relaxation and Active Contraction. J. Mol. 
Biol. 421:125-137. 
Kobayashi, T., L. Jin, and P.P. de Tombe. 2008. Cardiac thin filament regulation. Pflugers Arch. 
457:37-46. 
Kobayashi, T., and R.J. Solaro. 2005. Calcium, thin filaments, and the integrative biology of 
cardiac contractility. Annu. Rev. Physiol. 67:39-67. 
Kobayashi, T., X. Zhao, R. Wade, and J.H. Collins. 1999. Ca
2+
-dependent interaction of the 
inhibitory region of troponin I with acidic residues in the N-terminal domain of troponin 
C. Biochim. Biophys. Acta. 1430:214-221. 
Kohler, J., Y. Chen, B. Brenner, A.M. Gordon, T. Kraft, D.A. Martyn, M. Regnier, A.J. Rivera, 
C.K. Wang, and P.B. Chase. 2003. Familial hypertrophic cardiomyopathy mutations in 
troponin I (K183D, G203S, K206Q) enhance filament sliding. Physiol Genomics. 
14:117-128. 
Konhilas, J.P., T.C. Irving, and P.P. de Tombe. 2002a. Frank-Starling law of the heart and the 
cellular mechanisms of length-dependent activation. Pflug Arch Eur J Phy. 
445:305-310. 
Konhilas, J.P., T.C. Irving, and P.P. de Tombe. 2002b. Myofilament calcium sensitivity in 
skinned rat cardiac trabeculae - Role of interfilament spacing. Circ. Res. 90:59-65. 
Konhilas, J.P., T.C. Irving, S.H. Smith, and P.P. de Tombe. 2001. Length-dependent activation 
compared in three striated muscle types of the rat. Biophys. J. 80:258a-259a. 
Konhilas, J.P., T.C. Irving, B.M. Wolska, E.E. Jweied, A.F. Martin, R.J. Solaro, and P.P. de 
Tombe. 2003. Troponin I in the murine myocardium: influence on length-dependent 
activation and interfilament spacing. J Physiol-London. 547:951-961. 
Korte, F.S., E.R. Feest, M.V. Razumova, A.Y. Tu, and M. Regnier. 2012. Enhanced Ca
2+
 
binding of cardiac troponin reduces sarcomere length dependence of contractile 
activation independently of strong crossbridges. Am J Physiol Heart Circ Physiol. 
303:H863-870. 
Kovacs, M., J. Toth, C. Hetenyi, A. Malnasi-Csizmadia, and J.R. Sellers. 2004. Mechanism of 
blebbistatin inhibition of myosin II. J. Biol. Chem. 279:35557-35563. 
Labeit, S., and B. Kolmerer. 1995. Titins: giant proteins in charge of muscle ultrastructure and 
212 
  
elasticity. Science. 270:293-296. 
Lakatta, E.G., and B.R. Jewell. 1977. Length-dependent activation: its effect on the 
length-tension relation in cat ventricular muscle. Circ. Res. 40:251-257. 
Lehman, W., R. Craig, and P. Vibert. 1994. Ca
2+
-induced tropomyosin movement in Limulus 
thin filaments revealed by three-dimensional reconstruction. Nature. 368:65-67. 
Lehman, W., P. Vibert, P. Uman, and R. Craig. 1995. Steric-blocking by tropomyosin visualized 
in relaxed vertebrate muscle thin filaments. J. Mol. Biol. 251:191-196. 
Lehrer, S.S. 1994. The regulatory switch of the muscle thin filament: Ca
2+
 or myosin heads. J. 
Muscle Res. Cell Motil. 15:232-236. 
Li, A.Y., C.M. Stevens, B. Liang, K. Rayani, S. Little, J. Davis, and G.F. Tibbits. 2013. Familial 
hypertrophic cardiomyopathy related cardiac troponin C L29Q mutation alters 
length-dependent activation and functional effects of phosphomimetic troponin I*. 
PLoS One. 8:e79363. 
Li, M.X., L. Spyracopoulos, and B.D. Sykes. 1999. Binding of cardiac troponin-I147-163 
induces a structural opening in human cardiac troponin-C. Biochemistry (Mosc). 
38:8289-8298. 
Li, X.E., L.S. Tobacman, J.Y. Mun, R. Craig, S. Fischer, and W. Lehman. 2011. Tropomyosin 
position on F-actin revealed by EM reconstruction and computational chemistry. 
Biophys. J. 100:1005-1013. 
Linke, W.A., M. Ivemeyer, N. Olivieri, B. Kolmerer, J.C. Ruegg, and S. Labeit. 1996. Towards a 
molecular understanding of the elasticity of titin. J. Mol. Biol. 261:62-71. 
Llinas, P., O. Pylypenko, T. Isabet, M. Mukherjea, H.L. Sweeney, and A.M. Houdusse. 2012. 
How myosin motors power cellular functions: an exciting journey from structure to 
function: based on a lecture delivered at the 34th FEBS Congress in Prague, Czech 
Republic, July 2009. FEBS J. 279:551-562. 
Luther, P.K. 2009. The vertebrate muscle Z-disc: sarcomere anchor for structure and signalling. 
J. Muscle Res. Cell Motil. 30:171-185. 
Luther, P.K., H. Winkler, K. Taylor, M.E. Zoghbi, R. Craig, R. Padron, J.M. Squire, and J. Liu. 
2011. Direct visualization of myosin-binding protein C bridging myosin and actin 
filaments in intact muscle. Proc. Natl. Acad. Sci. U. S. A. 108:11423-11428. 
Martyn, D.A., B.B. Adhikari, M. Regnier, J. Gu, S.G. Xu, and L.C. Yu. 2004. Response of 
equatorial X-ray reflections and stiffness to altered sarcomere length and myofilament 
lattice spacing in relaxed skinned cardiac muscle. Biophys. J. 86:1002-1011. 
Martyn, D.A., and A.M. Gordon. 2001. Influence of length on force and activation-dependent 
changes in troponin C structure in skinned cardiac and fast skeletal muscle. Biophys. 
J. 80:2798-2808. 
Martyn, D.A., M. Regnier, D. Xu, and A.M. Gordon. 2001. Ca
2+
 - and cross-bridge-dependent 
changes in N- and C-terminal structure of troponin C in rat cardiac muscle. Biophys. J. 
80:360-370. 
Mateja, R.D., and P.P. de Tombe. 2012. Myofilament length-dependent activation develops 
within 5 ms in guinea-pig myocardium. Biophys. J. 103:L13-15. 
McDonald, K.S., L.J. Field, M.S. Parmacek, M. Soonpaa, J.M. Leiden, and R.L. Moss. 1995. 
Length dependence of Ca
2+
 sensitivity of tension in mouse cardiac myocytes 
expressing skeletal troponin C. J Physiol. 483 ( Pt 1):131-139. 
213 
  
McDonald, K.S., and R.L. Moss. 1995. Osmotic compression of single cardiac myocytes 
eliminates the reduction in Ca
2+
 sensitivity of tension at short sarcomere length. Circ. 
Res. 77:199-205. 
McKillop, D.F., and M.A. Geeves. 1993. Regulation of the interaction between actin and 
myosin subfragment 1: evidence for three states of the thin filament. Biophys. J. 
65:693-701. 
McLachlan, A.D., and M. Stewart. 1982. Periodic charge distribution in the intermediate 
filament proteins desmin and vimentin. J. Mol. Biol. 162:693-698. 
Mercier, P., R.E. Ferguson, M. Irving, J.E. Corrie, D.R. Trentham, and B.D. Sykes. 2003. NMR 
structure of a bifunctional rhodamine labeled N-domain of troponin C complexed with 
the regulatory "switch" peptide from troponin I: implications for in situ fluorescence 
studies in muscle fibers. Biochemistry (Mosc). 42:4333-4348. 
Milligan, R.A., and P.F. Flicker. 1987. Structural relationships of actin, myosin, and tropomyosin 
revealed by cryo-electron microscopy. J. Cell Biol. 105:29-39. 
Millman, B.M. 1998. The filament lattice of striated muscle. Physiol. Rev. 78:359-391. 
Moss, R.L., and D.P. Fitzsimons. 2002. Frank-Starling relationship: long on importance, short 
on mechanism. Circ. Res. 90:11-13. 
Moss, R.L., L.O. Nwoye, and M.L. Greaser. 1991. Substitution of Cardiac Troponin C into 
Rabbit Muscle Does Not Alter the Length Dependence of Ca
2+
 Sensitivity of Tension. J 
Physiol-London. 440:273-289. 
Moss, R.L., M. Razumova, and D.P. Fitzsimons. 2004. Myosin crossbridge activation of 
cardiac thin filaments: implications for myocardial function in health and disease. Circ. 
Res. 94:1290-1300. 
Mueller, H., and S.V. Perry. 1962. The degradation of heavy meromyosin by trypsin. Biochem. 
J. 85:431-439. 
Ohtsuki, I. 1979. Molecular arrangement of troponin-T in the thin filament. J Biochem. 
86:491-497. 
Ohtsuki, I., Y. Onoyama, and F. Shiraishi. 1988. Electron microscopic study of troponin. J 
Biochem. 103:913-919. 
Pan, B.S., and R.J. Solaro. 1987. Calcium-binding properties of troponin C in 
detergent-skinned heart muscle fibers. J. Biol. Chem. 262:7839-7849. 
Parry, D.A., and J.M. Squire. 1973. Structural role of tropomyosin in muscle regulation: 
analysis of the x-ray diffraction patterns from relaxed and contracting muscles. J. Mol. 
Biol. 75:33-55. 
Pearlstone, J.R., and L.B. Smillie. 1983. Effects of troponin-I plus-C on the binding of 
troponin-T and its fragments to alpha-tropomyosin. Ca
2+
 sensitivity and cooperativity. J. 
Biol. Chem. 258:2534-2542. 
Potter, J.D., and J. Gergely. 1975. The calcium and magnesium binding sites on troponin and 
their role in the regulation of myofibrillar adenosine triphosphatase. J. Biol. Chem. 
250:4628-4633. 
Previs, M.J., H. Yu, S.B. Previs, J. Gulick, J. Robbins, and D.M. Warshaw. 2013. 
Dephosphorylated Cardiac Myosin-Binding Protein C (cMyBP-C) Activates Native 




Putkey, J.A., W. Liu, X. Lin, S. Ahmed, M. Zhang, J.D. Potter, and W.G. Kerrick. 1997. 
Fluorescent probes attached to Cys 35 or Cys 84 in cardiac troponin C are 
differentially sensitive to Ca
2+
-dependent events in vitro and in situ. Biochemistry 
(Mosc). 36:970-978. 
Rayment, I., H.M. Holden, M. Whittaker, C.B. Yohn, M. Lorenz, K.C. Holmes, and R.A. Milligan. 
1993a. Structure of the actin-myosin complex and its implications for muscle 
contraction. Science. 261:58-65. 
Rayment, I., W.R. Rypniewski, K. Schmidt-Base, R. Smith, D.R. Tomchick, M.M. Benning, D.A. 
Winkelmann, G. Wesenberg, and H.M. Holden. 1993b. Three-dimensional structure of 
myosin subfragment-1: a molecular motor. Science. 261:50-58. 
Razumova, M.V., A.E. Bukatina, and K.B. Campbell. 2000. Different myofilament 
nearest-neighbor interactions have distinctive effects on contractile behavior. Biophys. 
J. 78:3120-3137. 
Regnier, M., H. Martin, R.J. Barsotti, A.J. Rivera, D.A. Martyn, and E. Clemmens. 2004. 
Cross-bridge versus thin filament contributions to the level and rate of force 
development in cardiac muscle. Biophys. J. 87:1815-1824. 
Regnier, M., A.J. Rivera, C.K. Wang, M.A. Bates, P.B. Chase, and A.M. Gordon. 2002. Thin 
filament near-neighbour regulatory unit interactions affect rabbit skeletal muscle 
steady-state force-Ca
2+
 relations. J Physiol. 540:485-497. 
Rieck, D.C., K.L. Li, Y. Ouyang, R.J. Solaro, and W.J. Dong. 2013. Structural basis for the in 
situ Ca
2+
 sensitization of cardiac troponin C by positive feedback from 
force-generating myosin cross-bridges. Arch. Biochem. Biophys. 537:198-209. 
Robinson, J.M., W.J. Dong, J. Xing, and H.C. Cheung. 2004. Switching of troponin I: Ca
2+
 and 
myosin-induced activation of heart muscle. J. Mol. Biol. 340:295-305. 
Rome, E. 1972. Relaxation of glycerinated muscle: low-angle x-ray diffraction studies. J. Mol. 
Biol. 65:331-345. 
Rosenfeld, S.S., and E.W. Taylor. 1985. Kinetic studies of calcium binding to regulatory 
complexes from skeletal muscle. J. Biol. Chem. 260:252-261. 
Ruegg, C., C. Veigel, J.E. Molloy, S. Schmitz, J.C. Sparrow, and R.H. Fink. 2002. Molecular 
motors: force and movement generated by single myosin II molecules. News Physiol 
Sci. 17:213-218. 
Ruegg, J.C. 1998. Cardiac contractility: how calcium activates the myofilaments. 
Naturwissenschaften. 85:575-582. 
Sevrieva, I. 2014. Structural and functional effects of troponin C cardiomyopathy mutations 
studied by polarized fluorescence. King's Thesis. 
Sevrieva, I., A.C. Knowles, T. Kampourakis, and Y.B. Sun. 2014. Regulatory domain of 
troponin moves dynamically during activation of cardiac muscle. J. Mol. Cell. Cardiol. 
75:181-187. 
She, M., D. Trimble, L.C. Yu, and J.M. Chalovich. 2000. Factors contributing to troponin 
exchange in myofibrils and in solution. J. Muscle Res. Cell Motil. 21:737-745. 
Shiels, H.A., and E. White. 2008. The Frank-Starling mechanism in vertebrate cardiac 
myocytes. J. Exp. Biol. 211:2005-2013. 
Shiner, J.S., and R.J. Solaro. 1984. The Hill coefficient for the Ca
2+
-activation of striated 
muscle contraction. Biophys. J. 46:541-543. 
215 
  
Sia, S.K., M.X. Li, L. Spyracopoulos, S.M. Gagne, W. Liu, J.A. Putkey, and B.D. Sykes. 1997. 
Structure of cardiac muscle troponin C unexpectedly reveals a closed regulatory 
domain. J. Biol. Chem. 272:18216-18221. 
Smith, S.H., A.F. Martin, R.J. Solaro, and P.P. de Tombe. 2003. Chimeric troponin I and the 
sarcomere length dependence of calcium sensitivity in skinned rat trabeculae. Biophys. 
J. 84:251a-251a. 
Spudich, J.A. 2001. The myosin swinging cross-bridge model. Nat Rev Mol Cell Biol. 
2:387-392. 
Spudich, J.A., H.E. Huxley, and J.T. Finch. 1972. Regulation of skeletal muscle contraction. II. 
Structural studies of the interaction of the tropomyosin-troponin complex with actin. J. 
Mol. Biol. 72:619-632. 
Spyracopoulos, L., M.X. Li, S.K. Sia, S.M. Gagne, M. Chandra, R.J. Solaro, and B.D. Sykes. 
1997. Calcium-induced structural transition in the regulatory domain of human cardiac 
troponin C. Biochemistry (Mosc). 36:12138-12146. 
Starling, E.H., and M.B. Visscher. 1927. The regulation of the energy output of the heart. J 
Physiol. 62:243-261. 
Straight, A.F., A. Cheung, J. Limouze, I. Chen, N.J. Westwood, J.R. Sellers, and T.J. Mitchison. 
2003. Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor. 
Science. 299:1743-1747. 
Strauss, J.D., C. Zeugner, J.E. Van Eyk, C. Bletz, M. Troschka, and J.C. Ruegg. 1992. 
Troponin replacement in permeabilized cardiac muscle. Reversible extraction of 
troponin I by incubation with vanadate. FEBS Lett. 310:229-234. 
Sumandea, M.P., W.G. Pyle, T. Kobayashi, P.P. de Tombe, and R.J. Solaro. 2003. Identification 
of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. 
J. Biol. Chem. 278:35135-35144. 
Sun, Y.B., B. Brandmeier, and M. Irving. 2006. Structural changes in troponin in response to 
Ca
2+
 and myosin binding to thin filaments during activation of skeletal muscle. Proc. 
Natl. Acad. Sci. U. S. A. 103:17771-17776. 
Sun, Y.B., and M. Irving. 2010. The molecular basis of the steep force-calcium relation in heart 
muscle. J. Mol. Cell. Cardiol. 48:859-865. 
Sun, Y.B., F. Lou, and M. Irving. 2009. Calcium- and myosin-dependent changes in troponin 
structure during activation of heart muscle. J Physiol. 587:155-163. 
Syska, H., J.M. Wilkinson, R.J. Grand, and S.V. Perry. 1976. The relationship between 
biological activity and primary structure of troponin I from white skeletal muscle of the 
rabbit. Biochem. J. 153:375-387. 
Szent-Gyorgyi, A.G. 1953. Meromyosins, the subunits of myosin. Arch. Biochem. Biophys. 
42:305-320. 
Tachampa, K., H. Wang, G.P. Farman, and P.P. de Tombe. 2007. Cardiac troponin I threonine 
144: role in myofilament length dependent activation. Circ. Res. 101:1081-1083. 
Takacs, B., N. Billington, M. Gyimesi, B. Kintses, A. Malnasi-Csizmadia, P.J. Knight, and M. 
Kovacs. 2010. Myosin complexed with ADP and blebbistatin reversibly adopts a 
conformation resembling the start point of the working stroke. Proc. Natl. Acad. Sci. U. 
S. A. 107:6799-6804. 
Takeda, S., T. Kobayashi, H. Taniguchi, H. Hayashi, and Y. Maeda. 1997. Structural and 
216 
  
functional domains of the troponin complex revealed by limited digestion. Eur. J. 
Biochem. 246:611-617. 
Takeda, S., A. Yamashita, K. Maeda, and Y. Maeda. 2003. Structure of the core domain of 
human cardiac troponin in the Ca
2+
-saturated form. Nature. 424:35-41. 
Talbot, J.A., and R.S. Hodges. 1981. Synthetic studies on the inhibitory region of rabbit 
skeletal troponin I. Relationship of amino acid sequence to biological activity. J. Biol. 
Chem. 256:2798-2802. 
Tanokura, M., Y. Tawada, A. Ono, and I. Ohtsuki. 1983. Chymotryptic subfragments of troponin 
T from rabbit skeletal muscle. Interaction with tropomyosin, troponin I and troponin C. 
J Biochem. 93:331-337. 
ter Keurs, H.E., W.H. Rijnsburger, R. van Heuningen, and M.J. Nagelsmit. 1980. Tension 
development and sarcomere length in rat cardiac trabeculae. Evidence of 
length-dependent activation. Circ. Res. 46:703-714. 
Tobacman, L.S. 1996. Thin filament-mediated regulation of cardiac contraction. Annu. Rev. 
Physiol. 58:447-481. 
Tskhovrebova, L., and J. Trinick. 2003. Titin: properties and family relationships. Nat Rev Mol 
Cell Biol. 4:679-689. 
Uyeda, T.Q., P.D. Abramson, and J.A. Spudich. 1996. The neck region of the myosin motor 
domain acts as a lever arm to generate movement. Proc. Natl. Acad. Sci. U. S. A. 
93:4459-4464. 
Uyeda, T.Q., and J.A. Spudich. 1993. A functional recombinant myosin II lacking a regulatory 
light chain-binding site. Science. 262:1867-1870. 
van der Heide, U.A., S.C. Hopkins, and Y.E. Goldman. 2000. A maximum entropy analysis of 
protein orientations using fluorescence polarization data from multiple probes. 
Biophys. J. 78:2138-2150. 
van Eerd, J.P., and K. Takahshi. 1976. Determination of the complete amino acid sequence of 
bovine cardiac troponin C. Biochemistry (Mosc). 15:1171-1180. 
Vibert, P., R. Craig, and W. Lehman. 1997. Steric-model for activation of muscle thin filaments. 
J. Mol. Biol. 266:8-14. 
Wang, Y.P., and F. Fuchs. 1994. Length, Force, and Ca
2+
-Troponin-C Affinity in Cardiac and 
Slow Skeletal-Muscle. Am J of Physiol. 266:C1077-C1082. 
Wang, Y.P., and F. Fuchs. 1995. Osmotic compression of skinned cardiac and skeletal muscle 
bundles: effects on force generation, Ca
2+
 sensitivity and Ca
2+
 binding. J. Mol. Cell. 
Cardiol. 27:1235-1244. 
Wannenburg, T., G.H. Heijne, J.H. Geerdink, H.W. Van Den Dool, P.M. Janssen, and P.P. De 
Tombe. 2000. Cross-bridge kinetics in rat myocardium: effect of sarcomere length and 
calcium activation. Am J Physiol Heart Circ Physiol. 279:H779-790. 
Wannenburg, T., P.M. Janssen, D. Fan, and P.P. de Tombe. 1997. The Frank-Starling 
mechanism is not mediated by changes in rate of cross-bridge detachment. Am. J. 
Physiol. 273:H2428-2435. 
White, S.P., C. Cohen, and G.N. Phillips, Jr. 1987. Structure of co-crystals of tropomyosin and 
troponin. Nature. 325:826-828. 
Wu, Y., O. Cazorla, D. Labeit, S. Labeit, and H. Granzier. 2000. Changes in titin and collagen 




Xu, C., R. Craig, L. Tobacman, R. Horowitz, and W. Lehman. 1999. Tropomyosin positions in 
regulated thin filaments revealed by cryoelectron microscopy. Biophys. J. 77:985-992. 
Zhao, Y., M. Kawai, and J. Wray. 1993. The effect of lattice spacing change on cross-bridge 
kinetics in rabbit psoas fibers. Adv. Exp. Med. Biol. 332:581-592. 
Zhou, X., E.P. Morris, and S.S. Lehrer. 2000. Binding of troponin I and the troponin I-troponin C 
complex to actin-tropomyosin. Dissociation by myosin subfragment 1. Biochemistry 
(Mosc). 39:1128-1132. 
Zhou, Z., K.L. Li, D. Rieck, Y. Ouyang, M. Chandra, and W.J. Dong. 2012. Structural dynamics 
of C-domain of cardiac troponin I protein in reconstituted thin filament. J. Biol. Chem. 
287:7661-7674. 
Zimmer, H.G. 2002. Who discovered the Frank-Starling mechanism? News Physiol Sci. 
17:181-184. 
 
 
